,BRCA1,TP53,BRCA2,RB1,PIK3CA,GATA3
Cap-dependent Translation Initiation,5.0,0.025284091957227584,0.13773615487321256,0.2672680268941563,0.09382438596303785,0.26929485789829444
Eukaryotic Translation Elongation,5.0,0.015568723490496532,0.26015701115425754,0.2685477369489961,-0.0,0.6197973619309183
Eukaryotic Translation Initiation,5.0,0.028291103155196746,0.19343432770502697,0.29019143300974387,0.07663300704748384,0.23924323751966795
Eukaryotic Translation Termination,5.0,0.03695861445595039,0.30146859951828636,0.2451502055371769,0.0807157413810379,0.6315790344563972
Formation of a pool of free 40S subunits,5.0,0.0804356632940549,0.24282365867533107,0.21445310851899244,0.02245240665728376,0.3657119246066895
GTP hydrolysis and joining of the 60S ribosomal subunit,5.0,0.027894029652769693,0.22795334517335405,0.2633503326028574,0.03565465539241833,0.24632963954105366
L13a-mediated translational silencing of Ceruloplasmin expression,5.0,0.03799640525248839,0.1390085333621436,0.21120270672114616,0.002206388762761003,0.2995949537019968
Major pathway of rRNA processing in the nucleolus and cytosol,5.0,0.08197213025532989,0.1491959735294994,0.1864076448778456,0.0989947697946803,0.6703017484463235
Mitochondrial translation elongation,5.0,-0.0,-0.0,0.1783121836122754,-0.0,0.9272441147180925
Mitochondrial translation termination,5.0,-0.0,0.006322610602490555,0.1986862162962693,-0.0,0.959485641857671
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),5.0,0.015361985210714269,0.25623549006306084,0.29492082846080064,0.07533754255679431,0.4358634896744143
Peptide chain elongation,5.0,0.01507516564232566,0.5484651666329399,0.3438787508984647,-0.0,0.6805876763900314
"Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.",5.0,0.07907604625265142,-0.0,0.1803411506216229,-0.0,2.574812099068741
Response of EIF2AK4 (GCN2) to amino acid deficiency,5.0,0.016813225846905543,0.12503115424791486,0.3028328016067034,-0.0,0.6174011947809813
SRP-dependent cotranslational protein targeting to membrane,5.0,0.025916350971112195,0.1916720416539457,0.1507639881937153,-0.0,0.7335461467190605
Selenoamino acid metabolism,5.0,0.014977338589785732,0.19211635761833148,0.14089590937769134,-0.0,0.4885364009529322
Selenocysteine synthesis,5.0,0.016295634755127342,0.49213603040558507,0.2965229607485241,0.015316556731776215,0.5151871282863159
Translation,5.0,0.07410154803778811,0.005158877436525729,0.009800918376344142,0.022274669732566487,0.7238113772187971
Viral mRNA Translation,5.0,0.016177637008039505,0.3996944796776181,0.29466491034003717,0.04081039362258952,0.638841034494695
rRNA processing,5.0,0.08229396193731038,0.22707767782985816,0.0972558452776571,0.09278991869175503,0.6106591413369409
rRNA processing in the nucleus and cytosol,5.0,0.08016129306425274,0.17813622987671793,0.11060257849961261,0.0807239228201782,0.72325400951238
Mitochondrial translation,4.398861765995124,-0.0,-0.0,0.18893696495224296,-0.0,1.0958850434858158
Respiratory electron transport,4.380378360301111,0.08025135136890721,-0.0,0.17757983275724326,-0.0,2.051933353788403
The citric acid (TCA) cycle and respiratory electron transport,4.361073205105725,0.4494381015929555,-0.0,0.16869882001149014,0.04372079913427169,2.875842094732722
Influenza Viral RNA Transcription and Replication,4.115560537291574,0.07386208910401329,0.22449782870306095,0.24656871389754081,-0.0,0.6050446451042556
Cristae formation,3.847954297114543,0.00913714881001613,0.12118418767088827,0.32199228007740266,-0.0,1.6286874798515953
"Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S",3.8315638809263737,0.015847939097558147,0.03481861437384543,0.18473016304676473,-0.0,0.04187527536004817
"Formation of the ternary complex, and subsequently, the 43S complex",3.7668385512897182,0.030779944629159773,0.06078533047326112,0.2612693422198217,-0.0,0.03615529831862534
Mitochondrial translation initiation,3.7028972717988307,-0.0,-0.0,0.19637864043678482,-0.0,1.0488422768112613
Metabolism of RNA,3.0978317703311427,0.16438480908052222,0.10840259296069397,0.5407304581462598,-0.0,0.7755864575353698
Influenza Life Cycle,2.9797324582531486,0.08122954619588989,0.2556515398136244,0.2469322450859737,-0.0,0.6732470175924505
Regulation of expression of SLITs and ROBOs,2.9785333010755357,-0.0,0.21270842433553908,0.2608187363570382,-0.0,0.5935300639364851
Formation of ATP by chemiosmotic coupling,2.92438060744167,0.019864074204559518,-0.0,0.3276482881554156,0.22251849594660278,2.135479405238478
Influenza Infection,2.890620710698076,0.0372625171152205,0.24430438545281924,0.29883233304002566,-0.0,0.49039125939015044
Nonsense-Mediated Decay (NMD),2.8780315833900554,0.0565929061021838,0.21573844871831596,0.2961713330322494,-0.0,0.23650855880869975
Ribosomal scanning and start codon recognition,2.850677155450016,0.015561673256679395,0.06217747053778658,0.24857534956925634,-0.0,0.022882306361179192
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),2.7739388917076573,0.05567599469595796,0.24443141972423763,0.32886570434470436,-0.0,0.21215096992657853
Interconversion of nucleotide di- and triphosphates,2.5415292695638554,0.07956256889408872,0.1468649929677951,0.0973421660537006,0.04635416977681903,0.635044701800821
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers,2.506527840948705,-0.0,-0.0,0.10415560510381235,0.07995796485878176,0.004690272315923371
Mitochondrial protein import,2.4138154789007835,0.011435412266970172,-0.0,0.23617234649491262,-0.0,0.19568864015630927
Interleukin-2 family signaling,2.381589104340405,-0.0,0.3705578512764679,0.009081057981773385,0.020191035992809615,0.20153746056400032
Signaling by ROBO receptors,2.367857484631587,0.03938334211461772,0.2348116969175243,0.2593461097954719,-0.0,0.5377855530982151
Translation initiation complex formation,2.330404385339272,0.0162947298950023,0.041961444041967076,0.23667814571283716,-0.0,0.026397128528184773
Complex I biogenesis,2.1353947822765464,0.08227367821357694,-0.0,0.1119940517198454,0.01742544036015184,0.9581311424632942
Metabolism,2.12837251305154,5.0,0.03558449984171916,0.015896091681831342,0.02197302110327302,0.7229500394174841
MET activates PTK2 signaling,1.9817676873551422,-0.0,0.14846194259284679,0.03561365227204229,-0.0,0.23630758733487148
Metabolism of amino acids and derivatives,1.9426982483660917,0.3210523663136693,0.05985900225826472,0.010109836356244377,0.04426609565069052,0.6568494462989439
"Interleukin-3, Interleukin-5 and GM-CSF signaling",1.8942486844390567,-0.0,0.11100824774446881,0.007205654048677192,-0.0,0.013198809949323678
FCGR activation,1.8487437640988782,-0.0,-0.0,0.01643403093409727,0.0014172461716017181,0.005490623221913407
Interleukin-35 Signalling,1.8479864936682946,0.08544752176160525,0.254836493676483,0.2668492935872387,-0.0,0.014828427100525447
HDACs deacetylate histones,1.8375210599901297,-0.0,-0.0,0.11734145235352819,0.3678211325712809,0.17511257719208007
Initial triggering of complement,1.8351413582447749,-0.0,-0.0,0.0020464910237337638,0.02088588036054332,0.015595525921269454
Metabolism of proteins,1.831375098275323,0.9213081731943559,0.006641675941275031,0.007171215405581382,0.009972801237550188,0.9827885725051606
VEGFR2 mediated vascular permeability,1.8189658522819159,-0.0,0.39953833096151153,0.3031161158894022,0.05598340365966902,0.020622150548841468
Interleukin-15 signaling,1.8183579007031203,0.010264425265825865,0.22517655127895506,0.009590896154337383,0.12974247746773382,0.29379610410215745
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,1.8133873802734102,-0.0,0.08836457201288689,0.296680498319233,0.1418518201558134,0.02327708255920399
Costimulation by the CD28 family,1.812854176422635,-0.0,0.22600904710072248,0.2476631224336948,0.009051565959558697,0.19139133830543878
DNA methylation,1.8099773107360992,0.018732804289437882,-0.0,0.010052707801910534,0.44723982409324514,0.02187552432798006
RNA Polymerase I Promoter Opening,1.7974575097083607,0.013827505093875012,-0.0,0.009577994199812624,0.44340948077578396,0.020768902028604215
Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3,1.7915697312285561,0.08208673637282675,-0.0,0.010178187955324831,1.041666577312547,0.01805929367280948
PRC2 methylates histones and DNA,1.7886724924523125,0.07219866715197149,-0.0,0.010285050452115464,0.4295567277159872,0.011404792497205388
Interleukin-9 signaling,1.7821219235907224,0.01271380579213881,-0.0,0.19704734508832294,0.004054809802883507,0.022492127926860936
CD22 mediated BCR regulation,1.7795291130124429,-0.0,-0.0,0.087041002946331,0.036449735306029074,0.005814665113741864
ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression,1.7741340811257367,0.015067144971560488,-0.0,0.11783950696284665,0.4485323681482297,0.09625371363680454
Interleukin receptor SHC signaling,1.7705742703595164,-0.0,0.22305124929444597,0.03111401077352397,-0.0,0.019114409102764667
Interleukin-21 signaling,1.7532001742900938,0.008418214529311636,-0.0,0.17533039710427692,-0.0,0.02568695647865814
Signal regulatory protein family interactions,1.752040508762855,-0.0,-0.0,0.03696898839734749,0.01512082086933152,0.0294177501729147
HDMs demethylate histones,1.7447670067532308,0.03531483405674812,-0.0,0.05540266504747074,1.154680957111372,0.07106202415470358
Interleukin-7 signaling,1.6845114536820913,-0.0,0.040176230155636324,0.16966401335222922,0.0070012461802829475,-0.0
Complement cascade,1.654590376404143,0.010703418990804382,-0.0,0.07238283981700408,0.01733849434226425,0.027932067692158828
Protein localization,1.6221914871468723,0.7405985140449467,0.06208366645436525,0.1991754623147899,0.0768537333506567,0.6240021302004699
FCERI mediated Ca+2 mobilization,1.5962592693296382,-0.0,-0.0,0.17652911375128807,0.051956758805090625,0.024767200084042516
Nef and signal transduction,1.5948114003417149,-0.0,0.00012878039760655724,0.07704163444607778,0.07103119121760453,0.025317562085453223
PKMTs methylate histone lysines,1.5924424696552986,0.017371508149806352,-0.0,0.04697039565340395,0.2041536627584118,0.10137306652128719
RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function,1.588822322420473,-0.0,-0.0,0.21034898342858974,0.09738246474179454,0.09512152295653502
Triglyceride catabolism,1.586951785575025,0.35819819752430204,-0.0,0.41910303008089933,-0.0,0.5221374514566196
rRNA modification in the nucleus and cytosol,1.5462821977890127,0.012865072275065798,0.1558872723424839,0.018842845595970527,-0.0,0.2844083180768733
Glycoprotein hormones,1.5033066311951373,-0.0,0.19388698865190382,0.06202026571039729,-0.0,0.24376645370155425
HCMV Early Events,1.4799053608282913,0.08617304041017612,0.00720804939047209,0.11091181127819856,0.37053934303854097,0.027398111050906566
Creation of C4 and C2 activators,1.4517446083011198,-0.0,-0.0,0.003846537302634375,0.029520256308429263,0.005322327700743023
Phosphorylation of CD3 and TCR zeta chains,1.4371860389142985,-0.0,1.3482830088616458,0.10100262434377986,0.013109289237617245,0.03669478272723502
Transcriptional regulation of granulopoiesis,1.4198714623062019,0.081401936703667,-0.0,0.00846902400917367,0.1937413188102669,0.02695131347651666
"Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)",1.4100406014880018,-0.0,0.0007780745481573693,0.048826845909292864,-0.0,0.5394289065658084
Interferon alpha/beta signaling,1.4076919069046103,0.00837699636022424,0.0738925556314157,0.5908165817626698,-0.0,2.857493128620607
Formation of the beta-catenin:TCF transactivating complex,1.3016102557143179,0.06589682685644693,-0.0,0.18470562345150698,0.40904962321643357,0.006076668961207505
Pre-NOTCH Transcription and Translation,1.298803734023955,0.0065169277553176,0.0009247522241551714,0.0862983175214332,0.2805444772083791,0.01705504642081044
Lysosphingolipid and LPA receptors,1.2923181979523413,0.10638738962180402,0.0009784492833816924,0.021100546231385135,-0.0,0.05207217694201119
Signaling by the B Cell Receptor (BCR),1.292223763525932,-0.0,0.08031718098225214,0.21711146481893948,0.015953680740910754,0.20979600687471872
Role of phospholipids in phagocytosis,1.2910641510803864,-0.0,-0.0,0.03523830529902748,0.06369890763623727,0.039696907165762504
Role of LAT2/NTAL/LAB on calcium mobilization,1.289043896734799,-0.0,0.054447003733131695,0.010903383518914591,0.06919747360922018,0.003888574371775408
Generation of second messenger molecules,1.2805727680526908,0.011687064432802307,0.19613212765341193,0.2385095770720307,-0.0,0.22118321849580672
Condensation of Prophase Chromosomes,1.237927040897868,0.08703440653207374,-0.0,0.029110645433850082,0.40478827657938254,0.006247496976887504
SIRT1 negatively regulates rRNA expression,1.2296832298032074,0.0162110000190123,0.003134269671447598,0.00612872114221499,1.12271175103633,0.023022392693723734
Regulation of TP53 Degradation,1.226535672697519,0.005889067492070956,0.19063284053809004,0.22358138062083324,-0.0,0.013145530725777713
Classical antibody-mediated complement activation,1.2259639227355663,-0.0,-0.0,0.00834482385090698,0.16279923351358175,0.038686175930281855
TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway,1.214928796165203,-0.0,-0.0,0.12643430292022073,0.141712109360455,0.2268618846001071
"Incretin synthesis, secretion, and inactivation",1.1644017886093139,-0.0,0.015558591195917505,0.1703564345501727,-0.0,0.7196716776029347
Zinc influx into cells by the SLC39 gene family,1.1634110173580934,0.016000963112215476,-0.0,0.07188859695776091,-0.0,0.01717002983333842
GAB1 signalosome,1.1357278963177317,-0.0,0.010305661703861832,0.11042495515184714,-0.0,0.18180196571892787
CD28 co-stimulation,1.1246514067340572,-0.0,0.01594383749600293,0.17475391750725353,0.014028169025476272,0.012619386327318056
Interleukin-27 signaling,1.1076238041740507,0.08381730644282077,0.30474762167080893,0.20841674721500114,-0.0,0.01750599579652007
Regulation of signaling by CBL,1.1043542213480981,-0.0,0.14626955167073316,0.10169651113123983,-0.0,0.02823723039492237
TP53 Regulates Metabolic Genes,1.0978317703311429,0.08030889249257644,0.007351091997983847,0.09507433437722727,-0.0,0.9741114030035032
NOTCH2 intracellular domain regulates transcription,1.0882265496289598,-0.0,-0.0,0.13623866847447344,-0.0,0.053566535662416856
Abacavir transport and metabolism,1.0642325777657005,0.12247046773989961,0.22468128296995662,0.05215296575084892,0.09426411689739164,0.1059878184350436
Interleukin-6 signaling,1.0255444907724105,0.3238792997614304,0.22317332382291447,0.011104312837679126,0.0035413727824358085,0.04430018221442634
Transcriptional regulation by small RNAs,1.020497198019813,0.027804016395957754,0.003318007374409708,0.01687899700512356,0.2846949389530173,0.009587397463830125
RA biosynthesis pathway,1.0184954468021692,-0.0,0.03994042618849277,0.059090164901430556,0.014567198804520726,-0.0
GPVI-mediated activation cascade,1.003605834809562,-0.0,0.0007363649667948375,0.0843353689402644,-0.0,0.11428424931491049
Other interleukin signaling,1.0022673963725983,0.005892620088282528,0.0009546681421172138,0.053761199138673936,-0.0,0.02404183469714474
Regulation of TP53 Expression and Degradation,0.9980396872243187,0.010233524088086178,0.19497720009034586,0.17632617156526145,-0.0,0.01593452118257509
Striated Muscle Contraction,0.9963079014772575,-0.0,0.007519945874066979,0.05241048491700804,0.024169840392634694,0.21470666344664813
Interleukin-20 family signaling,0.9917546174093028,0.028829930213499652,0.0035937165310905104,0.30966639912281957,-0.0,0.020334182204160924
IRS activation,0.9902647973899257,-0.0,0.005726251660630158,0.14889245059306613,0.0036794309568170948,-0.0
Citric acid cycle (TCA cycle),0.9740026497551485,0.31292720666883317,-0.0,0.2034908373889965,0.6538065774184144,0.5956531814246275
Phase 1 - inactivation of fast Na+ channels,0.9675066171576636,0.009749102509290335,0.19562408535247752,0.1780584757513854,-0.0,1.5681284534330766e-05
Translocation of ZAP-70 to Immunological synapse,0.9661592563841186,-0.0,0.9634268621042762,0.10286055601716722,-0.0,0.1967785333823979
Scavenging of heme from plasma,0.9657549146964512,-0.0,-0.0,0.030576371800371416,0.12361692483367165,-0.0
CD209 (DC-SIGN) signaling,0.9639790346879876,0.05673859754782384,-0.0,0.2586053742578534,0.0006382516654338498,0.022250024668660943
VEGFA-VEGFR2 Pathway,0.9625299062897439,-0.0,-0.0,0.01623647879568393,-0.0,0.33771015782841984
CD28 dependent Vav1 pathway,0.960131134279847,-0.0,0.016064987551174432,0.037160147471801255,0.10844378548312443,0.005894119081075518
Vasopressin-like receptors,0.9576374046641256,-0.0,0.19709037985492414,0.10364347148458455,0.0031186401070245977,0.010460947935847386
Meiotic synapsis,0.9407405469051934,-0.0,-0.0,0.02336190287056069,0.22753546591096055,0.01254463014591001
The role of Nef in HIV-1 replication and disease pathogenesis,0.9373195030024216,-0.0,-0.0,0.30790497431283237,0.005184047457669435,0.18610245794765162
Regulation of Complement cascade,0.9281415548467151,0.03922826234788772,-0.0,0.0986714538808183,0.021083271449848406,0.025234052300520685
RMTs methylate histone arginines,0.9244103434801295,0.015197056346926023,-0.0,0.05386446810446802,0.27637826738565996,0.01820350128631807
Synthesis of IP3 and IP4 in the cytosol,0.9205973499212787,-0.0,-0.0,0.14941243866441126,-0.0,0.017601917289555274
HCMV Late Events,0.9190826006365367,0.014472036433679955,-0.0,0.049678533333321374,0.3498306832093129,0.02828464313200549
Elevation of cytosolic Ca2+ levels,0.9132852229285247,-0.0,0.0004636588489340206,0.01820977564248098,-0.0,0.022549027985979294
Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant,0.9114143106958097,-0.0,0.25495502440087714,0.20777499430867588,-0.0,0.01623489982009338
Interleukin-2 signaling,0.9083981432491752,-0.0,0.10195623183751032,0.016608566028230663,0.01606345014887523,0.06268604408921175
DNA Double Strand Break Response,0.9083941951354676,0.013558577406053872,0.09981351443234678,0.2718814472136373,0.2902200071736415,0.014186355510815225
Activation of C3 and C5,0.9082655769730817,0.01368216993615882,-0.0,0.05271478364893643,-0.0,0.008919517470995291
Regulation of PTEN mRNA translation,0.9010017938578978,0.012589758978058217,-0.0,0.20551104349128083,-0.0,0.015039913614526482
STAT5 Activation,0.8998653467929209,-0.0,-0.0,0.007334079662878504,0.06262140381259716,0.18903818316436394
Cleavage of the damaged purine,0.8980862648602361,-0.0,0.04089371148692787,0.03660849915179489,0.3499485278461739,0.004833940782516824
Oxidative Stress Induced Senescence,0.8953979163398994,0.01574195848413077,0.015953330417395176,0.00768537872657241,0.31508038900833296,0.018516634790375235
HCMV Infection,0.8952914846565084,0.05218312137508293,0.007688680474820476,0.029181584157556468,0.3678039465159735,0.016563002478514874
Signaling by cytosolic FGFR1 fusion mutants,0.8897952336549609,-0.0,0.005449934805177411,0.18217426571253967,-0.0,0.029413472487316693
Fcgamma receptor (FCGR) dependent phagocytosis,0.8815378889745035,-0.0,-0.0,0.06911740478673757,0.002139366406614294,0.5229234377011026
Collagen biosynthesis and modifying enzymes,0.8812320364299383,-0.0,0.0717484321265624,0.06696666098538435,-0.0,0.08702838937622863
"Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)",0.8800320903840256,0.019507290573686442,0.07026913518538241,0.17580690800962942,0.0008177707103922588,0.6998044555896841
Dectin-2 family,0.8776822176484379,0.03497622453570797,0.39813732368186794,0.26125953841128735,-0.0,0.01394029070446157
Amyloid fiber formation,0.8724185966406909,0.0767037625488811,0.055377970686274106,0.011332839089983913,0.12730230556093922,0.06895530036240224
Pre-NOTCH Expression and Processing,0.8693914357799429,-0.0,0.009146203394747919,0.054623537410184046,0.272185609537058,0.011093560812307285
Estrogen-dependent gene expression,0.8646081504591113,-0.0,0.013993514254007765,0.23939896416806958,0.020797657401469286,0.19743465013732592
Meiotic recombination,0.858315725246541,0.07248184584429308,-0.0,0.017993929526581177,0.25916833901231373,0.014128503490667008
Reproduction,0.8575176884063833,0.08110841021046061,-0.0,0.028525476819324956,0.0616426068728194,0.005676476460872996
DNA Damage/Telomere Stress Induced Senescence,0.857346184111477,0.056224629691090926,-0.0,0.01175002688739164,0.25643537611993733,0.02353946563509815
Recognition and association of DNA glycosylase with site containing an affected purine,0.856936243779762,-0.0,0.05039411952432016,0.051987755999647556,0.3682940933011261,0.027792474377482265
Surfactant metabolism,0.8559458287459719,-0.0,0.005774694671045559,0.09218422819080016,-0.0,0.1417710440273047
B-WICH complex positively regulates rRNA expression,0.8556511463833109,0.018973431213496303,-0.0,0.024904069569433855,0.9627954308724588,0.0210011672891141
Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks,0.855509745852721,0.012387818820086733,0.10836993409227633,0.30775546385521074,0.25027831800582656,0.018469669176693824
Depurination,0.851142596736374,-0.0,0.042285814141351026,0.03865512880010273,0.4288146795740178,0.009107788954691727
Activation of HOX genes during differentiation,0.8508662592309679,0.05571268224907347,0.029743922790594908,0.009964391486567793,0.07704393052850106,0.14396193052833003
tRNA modification in the nucleus and cytosol,0.8488701283237333,0.01784205364752622,0.10872596685652515,0.026382307960277903,-0.0,0.12633783606573737
HDR through MMEJ (alt-NHEJ),0.8466616603988532,-0.0,-0.0,0.019981424961279484,0.00793841623826975,0.00685628120350098
Chromatin modifying enzymes,0.8439607821592405,0.08253020831410589,0.015455189445766555,0.3040970915017534,0.07910926208985049,0.01632143412107505
Packaging Of Telomere Ends,0.8436736813346294,0.008794836890525012,-0.0,0.052438096736187656,0.35218997714154987,0.005608557020052888
Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant,0.8420992582571885,-0.0,0.25547990656644787,0.20123946627674402,-0.0,0.021514547465332858
EPH-ephrin mediated repulsion of cells,0.8261621062835189,0.017189516219985653,-0.0,0.018844627271116996,-0.0,0.14153801084139578
Activated NTRK2 signals through PI3K,0.8251373255728501,-0.0,0.3002247991933522,0.25335724095251383,0.0026807334045023602,0.10267625252680214
Beta defensins,0.8194392739997389,0.04448387159562925,0.04251011261126031,0.06989376008085287,0.00826320052104115,0.003843141585562958
HATs acetylate histones,0.8193828879370035,0.025055332990339487,-0.0,0.13323190892667364,0.07960533045031148,0.02154326823281295
FCERI mediated MAPK activation,0.8171725462540751,-0.0,0.06751895474561148,0.23961424039729726,0.008054716492270311,0.1387897369149127
Competing endogenous RNAs (ceRNAs) regulate PTEN translation,0.8040425971299384,-0.0,-0.0,0.2245186720803447,-0.0,0.028520117429448093
CD28 dependent PI3K/Akt signaling,0.7983689360279814,-0.0,0.07231727219020197,0.18266639705988616,-0.0,0.016294012734878006
Folding of actin by CCT/TriC,0.7940924006842113,0.07775284118330363,0.05269036973749557,0.02975360646471871,-0.0,0.94324151023224
PD-1 signaling,0.7908055361977868,-0.0,1.1868184001349136,0.057592977791027226,0.0002644807670829859,0.17339616364925337
"Base-Excision Repair, AP Site Formation",0.7907049752988313,0.005726019225813011,0.03680090718003108,0.03498127008167013,0.29108668874417687,0.006715046103573313
Signaling by VEGF,0.7896927144752002,0.0075282425778527675,-0.0,0.05254378303372498,-0.0,0.48995442515350723
Collagen formation,0.767417996981952,-0.0,0.0414511577292939,0.09796310599111747,-0.0,0.5959966775721394
Recognition and association of DNA glycosylase with site containing an affected pyrimidine,0.76485109755663,0.008410253387705048,0.009844330134160455,0.05210881282591929,0.2867295698729115,0.018101779750844652
tRNA Aminoacylation,0.7386486936176557,0.08132192627792814,0.04542313780840569,0.2740672316442535,0.009263016889083672,0.0031185673074200495
RUNX2 regulates osteoblast differentiation,0.7334395426321383,0.04709964216515173,0.07362401518767503,0.03306377343355621,-0.0,0.14008248609292576
Signaling by Erythropoietin,0.7316493602497225,-0.0,-0.0,0.09154216558430432,-0.0,0.016831482755549822
"POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation",0.7241533416995456,0.06630699573529598,-0.0,0.06665713004248032,0.39764361399435183,0.02321643604514585
RUNX2 regulates genes involved in differentiation of myeloid cells,0.7228835649148871,-0.0,0.11819362471607787,0.09233241785787709,-0.0,0.6242364606271928
Activation of anterior HOX genes in hindbrain development during early embryogenesis,0.7133310420199117,0.04684253756025001,0.017929762652277935,0.006576131928293811,0.0790957680945926,0.1891091109215462
Regulation of RUNX1 Expression and Activity,0.6967712923353113,-0.0,-0.0,0.1290493685125149,-0.0,-0.0
Transcriptional regulation by RUNX2,0.6741116236069394,-0.0,-0.0,0.03370731994133561,0.0021814881409561076,0.9185396215792911
Collagen chain trimerization,0.6738156292650784,-0.0,0.2703252774891964,0.007814302344171277,-0.0,0.05756938947120555
MET promotes cell motility,0.6732767937244297,-0.0,0.0193169882385249,0.032590486332061325,0.0029064782261499864,0.16882405453336125
Triglyceride metabolism,0.6730353256737828,0.6083505346068043,-0.0,0.5541302829662206,-0.0,0.505767141626708
Zinc transporters,0.6725693406183338,0.017765969501723728,-0.0,0.06166297406200373,0.05845203391669238,0.038780986457976785
Class I peroxisomal membrane protein import,0.6708795533450106,0.2957681055365468,0.16022435281262554,0.19066942921744037,0.060544140316599666,0.26831816536371605
Axon guidance,0.6683471147775559,0.16193528530561527,0.10725224005075899,0.306279187204593,-0.0,0.500640847942379
Nef Mediated CD4 Down-regulation,0.6658400208536559,-0.0,-0.0,0.09159427702723483,0.14345038495897966,0.1588334454709986
Formation of TC-NER Pre-Incision Complex,0.662366204616598,-0.0,0.11071580891990877,0.040895280959214506,-0.0,1.7894822640579737
Positive epigenetic regulation of rRNA expression,0.6579671464276635,0.013716213817768896,-0.0,0.07753334855904154,0.42471832011611016,0.024277850864508028
Signaling by Retinoic Acid,0.6494099214540412,0.04002094524169638,0.04247750003056249,0.09040313585366808,0.015025059105200245,0.21457595986405276
"Defective AVP does not bind AVPR1A,B and causes neurohypophyseal diabetes insipidus (NDI)",0.6471722565408072,-0.0,-0.0,0.09454683280820575,0.004446242136082031,0.08386612924226867
Ephrin signaling,0.6450984936849258,-0.0,0.01952899694571968,0.0912250540127778,0.02855522725631482,0.07740360904709748
Meiosis,0.6422930925755348,0.07746051508326945,-0.0,0.028227081744751317,0.17360594340459104,0.006192289465709832
Regulation of actin dynamics for phagocytic cup formation,0.6390367827940303,-0.0,-0.0,0.07657398131109731,-0.0,0.4269228870546392
Defensins,0.6381375254474755,0.016180491441571746,0.07881022088381036,0.037696474023836864,0.011926255449579828,0.010067133351458018
DAP12 interactions,0.6371699278471177,-0.0,0.14895650422165593,0.1495826677789928,0.0015214905723987318,0.010835875574243065
Cholesterol biosynthesis via lathosterol,0.6364257090244317,-0.0,0.11432195796835001,0.048847532259976206,-0.0,-0.0
RHO GTPases activate PKNs,0.6352693348909701,0.10360837835085755,-0.0,0.0316394193033432,1.0775150022990727,0.30006821073546686
Chromatin organization,0.6340636167180821,0.0777038116314583,0.016482367850424624,0.3202424465660093,0.036099862473070427,0.034002264722545396
Depyrimidination,0.6334010773342049,0.0016345857781221234,0.008651912338371764,0.030914782789619896,0.2875564030701421,0.014018542834351952
LDL clearance,0.6330069210688467,0.01586539489607122,0.07219063980905437,0.053614322268951166,-0.0,0.027678849130589968
Chemokine receptors bind chemokines,0.6316757326637481,0.009612728434238153,1.5386147070319371,0.15509084870075232,-0.0,-0.0
APC truncation mutants have impaired AXIN binding,0.6313716601745045,-0.0,-0.0,0.24674693773511877,-0.0,0.00895611680393758
Senescence-Associated Secretory Phenotype (SASP),0.630542342969164,0.011950293335582856,0.053127061058460594,0.09614057758476444,0.18630315187762211,0.40254773850221914
Organic cation transport,0.6255604501433392,0.04354000042744699,0.000993782160164006,0.25126057101983057,0.012708449470877776,0.022885446642862513
Regulation of gene expression in early pancreatic precursor cells,0.6132024003979443,0.007701754291235789,0.8462574647508887,0.006428783435389739,0.00741063232737109,-0.0
ESR-mediated signaling,0.6124978701968292,-0.0,0.02307642318199347,0.20693521016871314,0.036601465254069314,0.27215654511802223
Signaling by MST1,0.6106534538955175,0.08045729739960535,0.2541553057743098,0.24276722654632046,0.001985025123103533,-0.0
Sulfur amino acid metabolism,0.5953620849755201,0.015316010038845038,0.04278326280710149,0.03574986348935366,0.0795766849575517,-0.0
Butyrophilin (BTN) family interactions,0.593663612446052,0.015554843601214325,0.058558017779832716,0.17880456013315502,0.07000132006636521,0.006227236798812906
Deposition of new CENPA-containing nucleosomes at the centromere,0.5832838223184287,-0.0,-0.0,0.03455781652621473,0.28462403635646805,0.012867331973959242
Interferon Signaling,0.5829460742443646,0.08845799431131084,0.3417267291177593,0.5748477799623305,0.005834677930523742,0.2455928825452635
Utilization of Ketone Bodies,0.5821856619665069,-0.0,-0.0,0.16757224484823588,0.007423905492823398,0.01859416279206637
Interleukin-23 signaling,0.5773558137526617,-0.0,-0.0,0.03267322708898386,-0.0,0.004634383058483983
TCR signaling,0.5770599074783412,0.06405857795674658,0.10593351788739057,0.21084112477814623,0.002881975970699923,0.015298676321687316
Transcriptional regulation of pluripotent stem cells,0.5667490403868549,0.16890766553612213,0.010135344220943435,0.02253581775687199,0.33334942363106723,0.16207196290686784
BBSome-mediated cargo-targeting to cilium,0.5658294607487087,0.13905818685759488,-0.0,0.00524845315341697,-0.0,0.045559691233758706
ADP signalling through P2Y purinoceptor 1,0.5640401645409121,-0.0,0.3135377705547195,0.1881849110231444,0.007609744531818422,0.7196649249930185
AXIN missense mutants destabilize the destruction complex,0.563705142408907,-0.0,-0.0,0.27615464897741965,-0.0,0.004850422929791373
Mitotic Prophase,0.5628857650275826,0.0727075764517285,-0.0,0.007246119553252217,0.2780714051568115,0.34635962170405116
S45 mutants of beta-catenin aren't phosphorylated,0.5618281671725792,-0.0,-0.0,0.14885652565760948,-0.0,0.20070582434340628
Collagen degradation,0.5606537145619344,0.041449331556721127,0.05231882346551183,0.009483984241987434,0.013593483290154822,0.09111334830456828
Truncations of AMER1 destabilize the destruction complex,0.5599764079906734,-0.0,-0.0,0.2379768674435469,-0.0,0.0064114992411186825
Synthesis of PIPs at the Golgi membrane,0.5584768307699408,0.08956325404360016,-0.0,0.054507069531685035,-0.0,0.02526947146114809
Protein repair,0.5559819660091391,-0.0,0.07247843390899343,0.18156815539549565,0.00759059152917154,0.23616467327758126
RNA Polymerase I Promoter Clearance,0.5545542383885752,-0.0,-0.0,0.11176962907715253,0.2811791010751933,0.029818484868843077
Peptide hormone biosynthesis,0.5528325806478622,0.012795768012743522,0.12145424998028023,0.0545288780614057,-0.0,0.6662270607331869
Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins,0.544920320114634,-0.0,-0.0,0.03246281094362837,0.0005660386013031657,0.6681977553684686
Nef Mediated CD8 Down-regulation,0.5416175149635137,-0.0,-0.0,0.18589677451528216,0.10231698041999696,0.21005147402756497
TCF dependent signaling in response to WNT,0.540793634669651,-0.0,0.018756906650859786,0.30207391541246753,0.01724342023968173,0.2765411408873633
mRNA Splicing - Major Pathway,0.5370561595139373,-0.0,0.10591947975172265,0.026725371129930436,0.012212448715181564,1.0931432165983577
Disassembly of the destruction complex and recruitment of AXIN to the membrane,0.5341706964810027,-0.0,-0.0,0.1369000206876364,-0.0,0.002673223267845293
Interleukin-10 signaling,0.5340749130931361,0.018721972923819236,1.6733132809293934,0.14804701418083152,0.01314136057413263,0.05633442963134035
Cdc20:Phospho-APC/C mediated degradation of Cyclin A,0.5333914294360993,-0.0,0.01827074386684686,0.033115236252665055,-0.0,0.7764234283127205
VEGFR2 mediated cell proliferation,0.5330796921190297,-0.0,-0.0,0.2112758228230836,-0.0,0.031004138028860068
PTK6 Activates STAT3,0.5330601090399183,0.0754974858710238,0.0001629216659614196,0.0500421077732392,-0.0,0.090385500292266
RORA activates gene expression,0.5327924974165459,-0.0,0.11448874100819023,0.3458406505396351,-0.0,0.22000339910809644
Interaction With Cumulus Cells And The Zona Pellucida,0.5323710377415939,-0.0,0.1476000920987167,0.14126727867307587,0.011901605167810705,0.16909583840371925
Negative epigenetic regulation of rRNA expression,0.5317915251334865,0.0843048629648002,0.038904641547694754,0.0706102514413951,0.28122108750829733,0.00797570281362431
phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex,0.5296012960753683,-0.0,-0.0,0.11515997226833724,-0.0,0.15066119304027317
Integrin signaling,0.5291364817527152,-0.0,0.24334813223898102,0.09192023751530315,0.10669817344652376,0.026922390387790443
Estrogen-stimulated signaling through PRKCZ,0.5265673732407067,-0.0,-0.0,0.21828640010318603,0.17582529703992414,0.023926099259968334
"Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2",0.5250016860549006,-0.0,-0.0,0.0984611855292743,-0.0,0.005928364156862174
Regulation of TP53 Activity,0.5229235767980914,0.08837244714362472,-0.0,0.500665678235573,-0.0,0.017369749102394604
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,0.519495011525086,-0.0,0.21710986641448535,0.2076657299536221,-0.0,0.6374128032900921
YAP1- and WWTR1 (TAZ)-stimulated gene expression,0.5171820254259796,0.04848953191064352,0.10504364064720964,0.15946939773479576,0.25821059384115974,0.5146192160704777
Cellular Senescence,0.5152310073265352,0.0797395619025716,-0.0,0.035774051720642686,0.09155409665282269,0.36741199144228665
Interleukin-18 signaling,0.515017098645836,0.009344618312678792,0.019509620065076127,0.07828266520264075,-0.0,0.018499431051066984
NOSIP mediated eNOS trafficking,0.5139163121708767,-0.0,-0.0,0.03262867818392119,-0.0,-0.0
Signaling by NOTCH,0.5139078778286922,-0.0,-0.0,0.2655855371422673,-0.0,0.0125963329725242
Cleavage of the damaged pyrimidine,0.5136076790168859,0.009082930316951949,0.011329328300086488,0.03533175808775567,0.24489983899622683,0.028907070571688672
DSCAM interactions,0.5129283418469514,-0.0,0.03052989674876131,0.07164803715531397,0.15349016407784805,0.39331389348918966
Cytokine Signaling in Immune system,0.5115480227001691,-0.0,0.14574289155978978,0.6655724160395289,-0.0,0.01785203478312304
Interferon gamma signaling,0.5099818331434905,0.07291820856383632,0.7111279459530743,0.3163861921720854,0.011741041139197416,0.12498338682822092
Cholesterol biosynthesis via desmosterol,0.5093374194286168,-0.0,0.1133233885271795,0.05136946341121341,-0.0,-0.0
Adaptive Immune System,0.5085473847823976,-0.0,0.03318863086173525,0.5822088796086996,0.012464516637922082,0.015159906139752237
Activation of gene expression by SREBF (SREBP),0.5079177492068597,0.07208822527397998,0.3388341928845589,0.306245761331771,0.23674560376079476,0.015508324030493171
RNA Polymerase I Promoter Escape,0.503784309930427,0.011920022346821775,0.010428855923399372,0.018789968554510164,0.43829112730538405,0.003733195506011377
Nucleosome assembly,0.500453577015568,-0.0,-0.0,0.033391979228306945,0.28675019627755355,0.009049330161090536
Wax and plasmalogen biosynthesis,0.4864029827426072,0.015299293470679902,0.1620056719577324,0.01756863908269849,0.06908572547274129,-0.0
APC-Cdc20 mediated degradation of Nek2A,0.48142588792122853,-0.0,-0.0,0.059709226784613725,-0.0,0.2761074356726768
Activation of Ca-permeable Kainate Receptor,0.4756149787486502,-0.0,-0.0,0.0670181352139758,0.3925990179238918,0.4315669878579886
T41 mutants of beta-catenin aren't phosphorylated,0.475244084374005,-0.0,-0.0,0.10182465318388642,-0.0,0.1352762337794392
activated TAK1 mediates p38 MAPK activation,0.47355349955660475,0.01575615986980409,0.16676864184998982,0.21360362344105088,-0.0,0.6029753066994368
Pre-NOTCH Processing in the Endoplasmic Reticulum,0.4730697172045538,-0.0,0.05254648808875655,0.006278894912012828,-0.0,0.05781570733199831
"AXIN mutants destabilize the destruction complex, activating WNT signaling",0.4730280891951516,-0.0,-0.0,0.24295226236601433,-0.0,0.007508848565532743
DAP12 signaling,0.47262409514067394,-0.0,0.03274772991271832,0.007411698116757707,0.012971431753443572,0.1296089753803402
Inositol phosphate metabolism,0.4726017204758345,-0.0,0.007037356014650277,0.00895745045220016,-0.0,-0.0
Regulation of IFNA signaling,0.47193193735389916,0.013929563721280472,0.010152033517846305,0.03422567109787032,0.08172261229746464,0.08132298663652662
Regulation of TP53 Activity through Acetylation,0.47182141703868213,-0.0,-0.0,0.2383079472787264,0.013121523458046049,0.00894913112544541
Class C/3 (Metabotropic glutamate/pheromone receptors),0.47153370408643636,0.06686030363038677,0.14801479965984696,0.17559329373311186,-0.0,-0.0
Misspliced GSK3beta mutants stabilize beta-catenin,0.4709403183286619,-0.0,-0.0,0.1189292501314961,-0.0,0.13421886196230828
Activation of AKT2,0.47081990795044343,0.003735173665322765,0.007521242181720915,0.1960569434686093,-0.0,0.012200935291827109
Gene Silencing by RNA,0.47038781938156515,0.010469496128965245,-0.0,0.015969390975142654,0.24778909835835577,0.023871710453212576
Presynaptic nicotinic acetylcholine receptors,0.4703666911115516,-0.0,0.015643322143333818,0.2341414767431849,-0.0,0.007435804192132994
Fc epsilon receptor (FCERI) signaling,0.4702362443849804,-0.0,0.07427184080711596,0.22448850146315846,-0.0,0.21427625376685575
Activation of the TFAP2 (AP-2) family of transcription factors,0.469554014532984,0.0615750625063188,1.3894186387540126,0.005891303109830505,-0.0,0.4239915813423081
Telomere Maintenance,0.4694766796390277,0.014837788954344875,0.050356621240461724,0.05280861289538053,0.12896545225094094,0.02067358019685554
NoRC negatively regulates rRNA expression,0.4691759627711392,0.055574249448759626,0.019144258037412785,0.0546772833374674,0.2832619295008435,0.002081726594904887
truncated APC mutants destabilize the destruction complex,0.4685513663853039,-0.0,-0.0,0.26809170364179863,-0.0,0.002493696908025571
Processing of DNA double-strand break ends,0.4684783878304051,0.07916622278885824,0.10108519702555446,0.20231704068783948,0.04986613210872749,0.24230640932134015
RNA Polymerase I Transcription,0.46830816501518935,-0.0,-0.0,0.10097226256499657,0.26194607876666776,0.005718070165501267
TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling,0.46766100726257204,0.00895412328876587,0.5558076386598626,0.22220001686861945,-0.0,0.0167526444702376
NRAGE signals death through JNK,0.4674894675712168,-0.0,0.010637406655046013,0.09987944189069814,0.040499753886801736,0.028332745591600893
Interleukin-4 and Interleukin-13 signaling,0.4663578716686115,-0.0,0.3921103993770313,0.0649025009402327,0.12755983746742483,0.4949707218373623
S33 mutants of beta-catenin aren't phosphorylated,0.46471661629731387,-0.0,-0.0,0.1341035846786272,-0.0,0.23165785050313606
TNFs bind their physiological receptors,0.4606023392970924,-0.0,0.17303049415942873,0.06020505644189735,0.17210627629775538,0.016278714001476922
Beta-catenin phosphorylation cascade,0.4590535184622246,-0.0,-0.0,0.11301480593376646,-0.0,0.12365487147573498
Sema4D mediated inhibition of cell attachment and migration,0.45764877249398017,-0.0,-0.0,0.0015679365840122579,-0.0,0.20433620908469965
Regulation of TNFR1 signaling,0.45737318285674533,-0.0,0.2516583739468246,0.3092013126465773,0.01353559449073474,0.20809421184060226
mRNA Splicing,0.45720459917894324,-0.0,0.07456951318941468,0.02975808140629605,0.010895399936535054,1.1069574453763553
S37 mutants of beta-catenin aren't phosphorylated,0.4566640271083721,-0.0,-0.0,0.11480153505154549,-0.0,0.1411655372802203
Phase 4 - resting membrane potential,0.45655278079461453,-0.0,-0.0,0.15049064145343666,0.09340715952184411,0.0056711634158264
Regulation of cortical dendrite branching,0.45615453018598096,0.009709090502550187,-0.0,0.025192512928929156,-0.0,0.02568190892115396
Nephrin family interactions,0.45478353849812964,0.16291573852147848,0.38473758270853253,0.10030082944868082,-0.0,0.9871011340498294
Regulation of TP53 Activity through Association with Co-factors,0.4523738597699655,0.011707553650185557,-0.0,0.09977391685637911,0.12861666065300845,0.0021429351469755575
Neddylation,0.45004912884785786,0.0498755711760332,0.06946608785278349,0.06816902462745265,-0.0,1.0629287380898664
Downstream signal transduction,0.44657147254259394,-0.0,0.1259386306814792,0.22202723403131586,-0.0,0.028371589329521503
Activation of RAS in B cells,0.4452977472500003,0.0744891215874907,0.00762005600786093,0.20259703931682116,0.12378032088990178,-0.0
AMER1 mutants destabilize the destruction complex,0.4443280057950368,-0.0,-0.0,0.2463549236923086,-0.0,0.005369448995134657
Resolution of D-loop Structures through Holliday Junction Intermediates,0.439222472736449,0.055232018810377044,-0.0,0.025070032798944958,-0.0,0.002914841193903766
Phosphate bond hydrolysis by NUDT proteins,0.437601666220687,0.04760194059356112,0.0699633038885858,0.06990112847531754,0.011328214167807897,0.11813993263919371
AKT phosphorylates targets in the nucleus,0.4309292382851526,-0.0,-0.0,0.05834970499654215,-0.0,0.13994180535758022
Metabolism of nucleotides,0.4298307064661208,0.0833581095088359,0.018513473397484072,0.06617662962242549,-0.0,0.39949869474266503
Peptide hormone metabolism,0.42865440718826947,0.021952115435023775,0.010250707150655397,0.018380433513444837,-0.0,0.6332730615093703
Inactivation of APC/C via direct inhibition of the APC/C complex,0.4283954788711695,-0.0,0.18737306496851241,0.18877688666970446,-0.0,0.3764917180223091
RNA Polymerase III Chain Elongation,0.4262230298298123,-0.0,0.22098037448937427,0.0574615834546759,-0.0,-0.0
Acyl chain remodeling of CL,0.4236841475225623,-0.0,0.012378063337927845,0.18586002239393976,0.11262811631795766,0.6671755238265974
TRAIL  signaling,0.4208993877154599,0.07437223500893844,-0.0,0.1970049920030352,-0.0,-0.0
APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint,0.42068396196546765,-0.0,0.01715035942728039,0.028643463422793176,-0.0,0.7478407137952919
Methylation,0.4198928369832625,0.08292004414100886,-0.0,0.07030575937339507,-0.0,0.6393272813347817
RAF activation,0.419867363983438,-0.0,-0.0,0.5397806829636222,-0.0,0.02270131480574153
Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters,0.4189063386885391,-0.0,-0.0,0.24616488316639115,0.018469020360652337,0.17433597895451738
Negative feedback regulation of MAPK pathway,0.4185022105642331,-0.0,-0.0,0.0785888706210523,-0.0,0.01926011855480364
Ionotropic activity of kainate receptors,0.4184888555424441,-0.0,-0.0,0.04792535424611585,0.45117728790604283,0.5048333314757418
Phase II - Conjugation of compounds,0.41844134196871546,0.17734214948496477,-0.0,0.16120221953884903,-0.0,0.8821714019490596
ECM proteoglycans,0.41806260733122746,0.008708164480726527,0.057766506119528986,0.15921481282490746,0.0005460086833248997,0.2480477177404525
Homology Directed Repair,0.4175762837972294,0.07796116075568506,0.05932082556980316,0.010986703068785353,0.011437183747874207,0.008914165519350559
Sensing of DNA Double Strand Breaks,0.41659048550588434,0.08021283979326703,-0.0,0.049832246849377655,0.07522664964237102,0.5282426169615467
Signaling by Interleukins,0.4160777874534962,-0.0,0.22844468002620488,0.0352675833310433,0.010389737116002868,0.5041568756434167
Assembly of collagen fibrils and other multimeric structures,0.41141418692559584,-0.0,0.06354440489380053,0.053896390595404436,-0.0,0.23744297849008386
Highly sodium permeable acetylcholine nicotinic receptors,0.4106138985070671,-0.0,0.05854892948624589,0.23081041993310103,-0.0,0.0901604006324217
RHO GTPases activate CIT,0.4100216479954065,0.00047314951332163744,0.010077268445133934,0.19150115173891005,-0.0,0.23674926620408265
Epigenetic regulation of gene expression,0.40681283479621555,0.08173671515782394,0.023811335928268382,0.16453788071668876,0.23024694969759482,0.029071041527269928
DNA Damage Recognition in GG-NER,0.40558695449588805,0.01572147224039939,0.22237858428870033,0.19131499866846835,-0.0,0.8646770972746787
Organic cation/anion/zwitterion transport,0.4022800519922486,-0.0,0.14997062233606218,0.02787154823498485,0.02805527515077486,0.0270861612314506
Interleukin-17 signaling,0.40067001198814217,0.036693558574276475,0.19750342048483405,0.1351098673765989,-0.0,0.755268163526872
Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA),0.3975211616011854,0.08189289412580911,0.0003765917661111049,0.03423788267535523,-0.0,0.006518718456573024
G2/M DNA damage checkpoint,0.39505411808269625,0.07906046190776092,0.00799130343595573,0.07550481488999958,0.28281442924574823,0.28447964321488944
MECP2 regulates transcription of neuronal ligands,0.39461345376487267,0.04390912037700164,0.15608828216655987,0.07574369340848683,0.021604609046161884,-0.0
Pyrimidine salvage,0.3939422661539475,-0.0,0.09327464428047172,0.24781991489286143,-0.0,0.10697187740295687
Signaling by FGFR3 fusions in cancer,0.39369949434266,-0.0,0.14354375360755897,0.01854451254426501,-0.0,-0.0
DNA Double-Strand Break Repair,0.39335383247796474,0.049460288085309626,0.041508528444035166,0.009146499162219924,0.07833574998459265,0.15903579131781972
Digestion of dietary carbohydrate,0.3921810657044812,0.0816176871189391,0.07392929948893946,0.01578568738418012,-0.0,0.19558223918256654
Lactose synthesis,0.392169538142837,-0.0,0.0013936463938901207,0.08764952353784607,-0.0,0.09303715582927984
NTF3 activates NTRK2 (TRKB) signaling,0.390315070512996,0.014300399459738038,0.009841257014628948,0.12878884960569986,0.012355144160455184,0.039357478993507736
Synthesis of dolichyl-phosphate mannose,0.38933621326111273,0.06097623903293429,0.062083957619261325,0.2317496380970573,0.105729073631749,0.31262896572199894
Growth hormone receptor signaling,0.3879818655787272,-0.0,-0.0,0.14855378803024125,0.014711610096745252,0.02860488312078769
Signaling by EGFR,0.3793399478774539,-0.0,0.17408641548130865,0.030982787893786792,-0.0,0.6035419786379329
Synthesis of Prostaglandins (PG) and Thromboxanes (TX),0.37911792226583063,-0.0,-0.0,0.028854871518335018,0.01245993726215976,0.052535028638133655
Factors involved in megakaryocyte development and platelet production,0.3780527644453564,0.12463235600871264,0.09468886331189906,0.24362696576924928,-0.0,0.06722788306479535
G1/S-Specific Transcription,0.37626252457487536,-0.0,0.10935595360507047,0.06820306996403798,-0.0,0.603381614586825
Signaling by WNT in cancer,0.37624860123547743,-0.0,-0.0,0.09355548774492183,-0.0,0.33934178146373184
MAPK3 (ERK1) activation,0.3710351104941924,0.012770454004357876,0.10078674333364321,0.10838452979392882,0.06762896868261378,0.3348360688147375
Intestinal absorption,0.3710115205251637,0.0006455241804956276,0.16727049995169357,0.0057626602341880806,-0.0,0.02598433327842883
Signaling by NTRK2 (TRKB),0.3708652389486322,-0.0,0.1567832522951299,0.09132213375069455,0.011164976894017865,0.20454461591923595
Autodegradation of Cdh1 by Cdh1:APC/C,0.36880715476430637,-0.0,0.10369541414832303,0.010461152274608627,-0.0,0.6400829324811631
Abacavir metabolism,0.36862573346048294,0.31222822221258834,0.22389791155279373,0.18125891790992776,0.1276932477175387,0.3823224970073038
Signaling by SCF-KIT,0.36848404190075823,0.015188986380550436,0.006848317203436373,0.010704908020308001,-0.0,-0.0
RNA Polymerase I Transcription Termination,0.36634426937753045,-0.0,0.11608122532884159,0.020317825025646125,-0.0,0.1380016269144882
Cargo trafficking to the periciliary membrane,0.3662919278984697,0.19060680740677416,-0.0,0.057678443909766855,-0.0,0.19458843233902273
APC/C:Cdc20 mediated degradation of mitotic proteins,0.366022775796465,-0.0,-0.0,0.03347077156058491,-0.0,0.7420511535774623
PI3K Cascade,0.3650585511803457,0.014520125795854797,0.013992005608690131,0.22864667376420786,0.007463623899977781,0.01670204977830691
Interconversion of polyamines,0.3628593841572204,-0.0,0.00660919411037049,0.0038335543775987273,0.007225835694953948,0.02666238432011105
GP1b-IX-V activation signalling,0.3619728511846084,-0.0,-0.0,0.02862605901926392,0.010009889558013393,0.04544327626940419
Cellular responses to stress,0.3607647370219026,0.6254616344135049,0.03718073619884852,0.009386206937452525,-0.0,0.9480744808250189
Interconversion of 2-oxoglutarate and 2-hydroxyglutarate,0.3601110414570513,0.07881038322476726,0.032721233312962304,0.1999453404328315,-0.0,0.015307398662049625
Lectin pathway of complement activation,0.359513793914809,-0.0,0.041523726859680976,0.02642984045114806,-0.0,0.3663860545916003
MAPK1 (ERK2) activation,0.3588557394930654,0.0052740572729824175,0.10293920397656957,0.07267204234280022,0.00045909527080169175,0.025716810376348043
Synthesis of GDP-mannose,0.3585677362250711,0.07809789491487981,0.0058464824924250305,0.03862299589310455,0.27503690218244686,0.012940690773444508
Global Genome Nucleotide Excision Repair (GG-NER),0.35752950862075933,0.08192681364765533,0.2241319545355175,0.24864178738911463,-0.0,0.4947533593589128
Transcriptional regulation by RUNX1,0.352107140329316,0.07983214054931619,0.07068482305036049,0.2590242601230378,0.0594396726028603,0.15685340098428474
Advanced glycosylation endproduct receptor signaling,0.3503690642173897,-0.0,5.7513399149455116e-05,0.0668551940667534,-0.0,0.010827836875121195
Processing of Capped Intron-Containing Pre-mRNA,0.3493177471404676,-0.0,0.09766330447806855,0.01855065884952334,0.011440533706661093,0.9472222391277622
MTF1 activates gene expression,0.3475505337287204,0.015554267333366815,0.10330977445401046,0.13817888837525552,-0.0,0.026083462816623642
Post-transcriptional silencing by small RNAs,0.3474634097303141,-0.0,-0.0,0.10222148729195628,-0.0,-0.0
Digestion and absorption,0.33763221308933666,0.060391537095585326,0.043230988932350514,0.030688089838006822,-0.0,0.24444128623156594
Regulation of APC/C activators between G1/S and early anaphase,0.3330150388098385,-0.0,-0.0,0.034435606841824805,0.009552783227186676,0.7779909040963293
RNA Polymerase III Transcription Termination,0.32980781833989203,-0.0,0.11016070619672562,0.11050341618884547,-0.0,0.10011792277383343
Defective DPM3 causes DPM3-CDG (CDG-1o),0.3291178250962355,0.06756451820442648,0.07919777965323223,0.24279616831302936,0.09187707773397255,0.2719693716283714
Galactose catabolism,0.32716975955909827,-0.0,0.03721627757156826,0.20432737957651959,0.003816442146301883,0.3628288983734623
Alpha-oxidation of phytanate,0.3269773253327009,0.1728421783030365,-0.0,0.17775134878194812,-0.0,0.19458155883623307
Organelle biogenesis and maintenance,0.3261267298682254,0.5202952223376033,0.016305375268583187,0.26084301852483704,-0.0,0.6266545637131685
VLDL assembly,0.32583769821141567,-0.0,0.03844110931242799,0.11961415850565685,-0.0,0.08663482901231562
The NLRP3 inflammasome,0.32533479090348966,0.01559160352294151,-0.0,0.034888700531477565,-0.0,0.10452604928700938
Formation of Incision Complex in GG-NER,0.3243521539664208,0.08264681574600198,0.14376341072123233,0.30507049151986254,-0.0,0.621912077504925
G beta:gamma signalling through CDC42,0.32059175649142146,-0.0,0.10472028667219478,0.052097875879790055,0.13189745897206592,0.38321023195651027
Regulation of PAK-2p34 activity by PS-GAP/RHG10,0.3202821031213498,0.010310333920372573,0.016294608123198655,0.17626091256053472,-0.0,0.008700314649190095
ALKBH3 mediated reversal of alkylation damage,0.31649787881869357,0.0005414585828579205,0.3072704794407672,0.11217828947904843,-0.0,0.2730062555475211
HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA),0.316088390766472,0.08401098243027272,0.12410653199815268,0.010699689308176611,0.07602189028264346,0.06677052692214051
Ovarian tumor domain proteases,0.3159689251774277,0.01566558397678342,0.03346712284477078,0.2802193312367139,0.00021166672175866578,0.6296064240069336
Base Excision Repair,0.31527045999570963,-0.0,0.07006400762430377,0.05109716795126269,0.07873391991669966,0.02221083154431628
Response of EIF2AK1 (HRI) to heme deficiency,0.3146659955343517,-0.0,0.19832846784970767,0.0575494745350676,0.011810418618788537,0.028985869022800283
HDR through Single Strand Annealing (SSA),0.314490230478086,0.07802490841258608,0.0075362066933674495,0.03462153476510612,-0.0,0.13661177835252358
Hyaluronan metabolism,0.3140405587760601,0.07458162843872425,0.01817196454256699,0.0659043254814556,-0.0,0.007800353650386816
Plasma lipoprotein clearance,0.3134423546093421,0.07941723919584746,-0.0,0.005906139961156566,0.0006339709876348197,0.0194296621923676
Eicosanoid ligand-binding receptors,0.3133456972805377,-0.0,0.08930907281772794,0.030483324561900685,0.11903658622902225,0.030264140453710058
"Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1",0.31301324448951057,-0.0,-0.0,0.0758145030515175,-0.0,0.0030790027933944183
Erythropoietin activates RAS,0.31189308929548143,-0.0,-0.0,0.13526025683329518,0.017544681898874433,0.00926680802173382
Fanconi Anemia Pathway,0.31188485064044463,-0.0,0.042956380887111054,0.3016199228947285,-0.0,0.017934655476212157
"PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases",0.31171331815323017,0.10198963052074324,-0.0,0.12253464154911407,-0.0,0.23193816655423244
G2 Phase,0.31113204604596834,0.07641738666207586,-0.0,0.09895418908770873,-0.0,0.6066424840345093
IRS-related events triggered by IGF1R,0.31051892003905307,0.008009771008032802,-0.0,0.2258296598402714,0.00041073625883824254,0.01059214125960304
Extracellular matrix organization,0.31049951477173054,-0.0,0.07216702058384944,0.051979442711376896,0.005225645951371969,0.7237380311187152
MET activates PI3K/AKT signaling,0.3104900728313329,-0.0,0.03260906000613619,0.11761593509843636,-0.0,0.017414927072864142
Constitutive Signaling by AKT1 E17K in Cancer,0.3103643307536133,-0.0,0.038887995189457805,0.1447628773355882,0.0009457829189552615,0.013865632315717918
Intestinal saccharidase deficiencies,0.30801225421072775,0.02082955934406536,-0.0,0.03234692904081511,-0.0,0.19500504548427458
APC/C:Cdc20 mediated degradation of Cyclin B,0.30587590731417225,-0.0,0.040372231534234464,0.09539721701187667,-0.0,0.20056018332951567
Trafficking of myristoylated proteins to the cilium,0.3035029335993021,0.029088106558178,0.009005812833087597,0.18831468122661643,-0.0,0.0317252621035798
Downregulation of SMAD2/3:SMAD4 transcriptional activity,0.30339661849409183,-0.0,0.2120934686649111,0.30510630658768595,-0.0,0.1621833795426161
Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding,0.30144463162982343,-0.0,0.16821044703874594,0.09377271436100597,0.06905319564065915,0.6948494160265503
Platelet Aggregation (Plug Formation),0.3009902639326872,-0.0,0.14828873063743417,0.070158560420564,0.10771725220769768,0.01632673542717535
Synthesis of very long-chain fatty acyl-CoAs,0.29998324797291215,0.17493276459130674,0.0005299176931674065,0.03428327808525452,-0.0,0.4975318926414222
Cell surface interactions at the vascular wall,0.29941862636224037,-0.0,0.01900996990261793,0.01108820654396848,0.010562134289174916,0.1389541280676691
Assembly of Viral Components at the Budding Site,0.29479576107595645,0.008273182829423594,-0.0,0.1370436474128143,0.013913640324487159,0.16680692157961927
Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding,0.29468126482885804,0.07374721152751788,0.0015906483701201004,0.033183578759692724,0.28387057087333045,1.1023691066268488
Rab regulation of trafficking,0.29459723524843,-0.0,-0.0,0.29405389028493506,0.1599089847730234,0.020492221079381364
PTK6 Down-Regulation,0.293834393914113,0.02639372153445244,0.2476930874124404,0.03175499822321231,-0.0,-0.0
TNFR1-induced NFkappaB signaling pathway,0.29348808708454993,0.014815785073253053,0.19814659829446565,0.4738320659617213,0.010663112418508654,0.2706808591772313
Infectious disease,0.2925191629264068,-0.0,0.0473846065332042,0.3397710637544089,6.229264574289305e-06,0.673090305631387
RUNX1 regulates transcription of genes involved in interleukin signaling,0.2918750328202971,0.07609753972427429,0.11016409809749013,0.11487382440599977,-0.0,0.6791590277026498
Transcription-Coupled Nucleotide Excision Repair (TC-NER),0.29184543585533773,-0.0,0.11545131194203206,0.06640516381758325,-0.0,0.8402946456159167
CREB1 phosphorylation through the activation of Adenylate Cyclase,0.29169651382421535,0.010379634218985523,0.16048276615013898,0.031064560138509036,-0.0,0.31032244816504373
PKA-mediated phosphorylation of CREB,0.2909903143327107,0.018578845304774484,0.15669739222776102,0.0068878888702094635,-0.0,0.1364833470226338
Resolution of AP sites via the single-nucleotide replacement pathway,0.2908382566490356,0.04250210381668256,0.16561249598527736,0.027374365406415503,0.048533246732830146,0.01526357908705838
Defective DPM1 causes DPM1-CDG (CDG-1e),0.29049393004374036,0.04049819040392639,0.08791883186644432,0.16506024393014912,0.12796441462741515,0.31073223776474157
Regulation of cytoskeletal remodeling and cell spreading by IPP complex components,0.29034794548866444,-0.0,-0.0,0.028257618657345506,-0.0,-0.0
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex,0.28998789662207913,0.08352858421548442,0.16347004619440594,0.03274583991894191,0.2877944920834389,1.5717210220915987
Cellular responses to external stimuli,0.28815290808775224,0.22461746664918253,0.0719671157873075,0.007849220249361041,-0.0,0.9387676104304109
SOS-mediated signalling,0.2879350178619117,-0.0,-0.0,0.10412714408838074,-0.0,-0.0
Mitochondrial biogenesis,0.2871932119431032,0.05445445345688313,-0.0,0.07270442665280974,-0.0,0.6408957057010212
MASTL Facilitates Mitotic Progression,0.28523807908469534,0.04182345455576697,-0.0,0.053929005412802614,-0.0,0.24049679253958808
Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha,0.2842958851091148,-0.0,0.06286489172956522,0.017104003994381316,-0.0,0.7263861157055564
Virus Assembly and Release,0.28417474633864925,0.007052736956555543,-0.0,0.14775259003085925,0.012533109305649975,0.157422283116214
Immune System,0.2830364542250354,1.0847051616218315,0.041773459393634346,0.7790515304807781,0.0031916485523978432,0.49723018650165096
IRF3-mediated induction of type I IFN,0.2828710168981081,0.06104154136036338,0.0059496770235846815,0.23230639798296268,-0.0,0.4332191666071306
Activation of RAC1,0.2738993244222619,0.038696817822238265,0.2217247506129638,0.0719860131278335,0.007566182677206897,0.10182235593710459
NTF3 activates NTRK3 signaling,0.2736163966026141,0.016034004522750195,0.009241972637165662,0.14064060712946533,0.0019757186319866505,0.029203692032871594
PAOs oxidise polyamines to amines,0.2735375892669161,-0.0,0.017008145175199225,0.038910594934629714,0.007555628669721186,0.11390626335371948
GRB7 events in ERBB2 signaling,0.27316909751332613,0.007323473147783779,0.017042331868197532,0.05354969347716273,0.360432605363128,0.004276191079373039
FGFR1 mutant receptor activation,0.27304655138461803,-0.0,0.03321452132469129,0.20732067461414444,0.008526179985392788,0.09941966728830041
Loss of MECP2 binding ability to 5mC-DNA,0.27265653756989644,-0.0,0.3061349774199399,0.0321012397070283,0.014975627658788356,0.01318035541719646
"TET1,2,3 and TDG demethylate DNA",0.27060352487456374,0.0002205362583945156,0.4006203579797943,0.16180336665937806,-0.0,0.01697826475538718
Role of second messengers in netrin-1 signaling,0.2692820945053881,0.08239754063524828,0.015298003899663987,0.18243651881695636,-0.0,0.00016233863344304632
RUNX2 regulates genes involved in cell migration,0.2671815924475564,-0.0,0.12042063436812962,0.102723953137202,-0.0,-0.0
Attachment of GPI anchor to uPAR,0.26699948666462286,0.06165561055644404,0.0320477797164247,0.007663969767347186,0.007062343807009683,0.378039784982289
Synthesis of PA,0.2645502387354937,-0.0,0.03347244166066385,0.03477737390517749,-0.0,0.08398991313731055
SLIT2:ROBO1 increases RHOA activity,0.2622634760683795,-0.0,-0.0,0.23824362087496603,0.0225690766076851,0.027460781464433866
GLI proteins bind promoters of Hh responsive genes to promote transcription,0.2622628416177324,-0.0,0.003522318079449983,0.005691518447115282,0.0178104617251189,0.21055360484049218
RNA Polymerase II Transcription Initiation And Promoter Clearance,0.26156843478150243,-0.0,0.04822652757473135,0.11315590855693261,-0.0,0.597756382388116
Adrenoceptors,0.2615460697955061,-0.0,0.05465824217321221,0.03266290263806748,-0.0,-0.0
"Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3",0.26140125653698054,0.015838327621849908,-0.0,0.04163473821008431,0.05933644557299263,-0.0
Adenylate cyclase activating pathway,0.25758199729616144,0.0808516189716686,0.16344954681384527,0.07672455552722614,-0.0,0.01666421273587356
Keratinization,0.2574918108847522,-0.0,0.07196842106730929,0.07176838825950198,0.13685890728114794,0.09823177631061664
Resolution of D-Loop Structures,0.2572440768504585,0.08384814213917292,-0.0,0.026859868319296043,-0.0,0.007610881373861828
Tryptophan catabolism,0.25622520778160585,-0.0,-0.0,0.09880882049402227,0.00014387490813779353,0.003703741717210317
Olfactory Signaling Pathway,0.25597552758904385,-0.0,0.10134021653752723,0.0105563852933331,0.0013590268731431447,0.02704491880378067
Intracellular oxygen transport,0.2559389395612925,0.0003785111831386939,-0.0,0.009708292305855277,0.0163933086404705,0.24249282803399413
"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways",0.2557176369227235,0.07184123597346831,0.007946576131966964,0.16784303538853318,-0.0,0.26007524621411765
SUMOylation of chromatin organization proteins,0.25514228047234233,0.015126995571154812,-0.0,0.2664130491067515,0.2262276031453094,0.13466123535332342
RUNX1 regulates transcription of genes involved in differentiation of HSCs,0.25493138535001303,0.019532421116167598,0.06157401762236874,0.11308501515263633,0.25394152283252686,0.2691929134118434
Integrin cell surface interactions,0.25475479294580106,-0.0,0.02222855213131537,0.030388698799796433,0.003114156714528424,0.1366173990180908
tRNA processing,0.2547220403855924,0.07993855749305276,0.10535971017165333,0.016628919347124,0.07690578293997466,0.4961964118728412
Purine catabolism,0.2541622594211522,-0.0,-0.0,0.18711620845495386,0.0010302179586522428,0.2870651114663411
Synthesis of glycosylphosphatidylinositol (GPI),0.2530201727688903,0.08291569735563967,0.09687221259430973,0.17913188652808895,0.12802528075630895,0.3462442479976805
Degradation of the extracellular matrix,0.25079116114298966,-0.0,0.03292861267139675,0.04103018383669998,0.00630136554546873,0.3269531751228071
Syndecan interactions,0.250566442070683,0.001671958597995346,0.0012566146181657168,0.05014344756269559,-0.0,0.7426439431331466
Glycogen storage disease type IV (GBE1),0.25053355407295624,0.01946665740990268,-0.0,0.04106232890306126,-0.0,0.23015338094345683
Metabolism of steroid hormones,0.25035846677499063,0.05183541619672709,0.1500868821318685,0.19465639393123915,-0.0,0.6723109345308794
Neurotransmitter clearance,0.24929250833752223,0.06060609279423565,-0.0,0.007922399269308848,0.007996155958708328,0.12601627564322718
APC/C-mediated degradation of cell cycle proteins,0.248608511909879,-0.0,0.004799402962641056,0.05201166863301703,0.00018372076985420877,0.6902285456603092
IRS-mediated signalling,0.24845219318088235,0.015241196315408068,-0.0,0.30277767989710125,-0.0,0.02166774873962176
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,0.24763673388736834,-0.0,0.3937999988642797,0.3060725228710014,-0.0,0.5860533075431256
Signaling by NOTCH2,0.2474695174072453,-0.0,0.13797261935678426,0.2862117501295335,-0.0,0.005692290790831307
TNFR2 non-canonical NF-kB pathway,0.24634283766359633,-0.0,0.1664984122891323,0.16335097805742396,0.15248311004447349,0.1945199404581204
Signal amplification,0.24616535908999976,-0.0,0.2532885642874455,0.14587577765337598,-0.0,0.6401786437885536
Stimulation of the cell death response by PAK-2p34,0.246162706174547,0.008487160723064524,-0.0,0.18583730183434385,0.002442353834964161,0.008883058804689349
Signaling by WNT,0.2460395157268167,-0.0,0.06358408528565142,0.3833744934144587,-0.0,0.42949912990794453
Pervasive developmental disorders,0.2455421833032801,-0.0,0.06315850683385899,0.2995877466081418,0.1322125514128648,0.023708753964128196
Rhesus blood group biosynthesis,0.24533193845588414,-0.0,0.10692544210146523,0.11138341762769334,-0.0,0.02195957760671759
Cytochrome P450 - arranged by substrate type,0.24505323855419242,0.0195496659235229,0.40539149067859637,0.1699507973421372,-0.0,0.09793566463413819
Metal ion SLC transporters,0.24498595231614612,0.014338541300648855,0.019495685891106177,0.06678262203571053,0.0346993371881911,0.1366423805726063
FLT3 Signaling,0.24492677651406916,-0.0,0.10326274548560566,0.3069399189616896,-0.0,0.49814208488504563
CHL1 interactions,0.2447922395602857,0.005465572013935458,0.19327965862107963,0.20646222813185688,0.006208119992165392,0.6322359875915713
"POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation",0.24472870531311414,0.08727558203908387,1.1738188384146577,0.06650734360866563,0.08174380379157142,0.027794113250293302
C-type lectin receptors (CLRs),0.24456463220604624,-0.0,0.15392658106651516,0.0246369127773994,0.005363486468692932,0.002691142015109159
MET activates RAP1 and RAC1,0.24456285385156465,0.001609209939583057,0.20711357437287373,0.037590234302756265,0.005831376768082342,0.14546501127254569
GDP-fucose biosynthesis,0.24439693813221575,-0.0,0.00349424870463556,0.0013609629945634057,0.12451176262449337,0.2650225428964329
Negative regulation of NOTCH4 signaling,0.24426314712224284,-0.0,0.1395524252827152,0.22307869206030623,0.010980543840557997,0.6073917751748765
Mitotic Spindle Checkpoint,0.24332780464289347,0.008902131864796922,0.4056727201484384,0.02504975543121879,-0.0,0.16157180050069272
G-protein mediated events,0.24327621756678972,0.016039801743103536,0.20810388652169187,0.00959926839800369,0.0006499050710013109,0.13776090738303945
RUNX1 regulates transcription of genes involved in differentiation of keratinocytes,0.2430015330406786,0.011929959206782926,-0.0,0.10279018049104571,0.007015605457374437,0.24247299351706506
Separation of Sister Chromatids,0.24234219688492759,0.0166950023447778,0.05325171908357805,0.20468570416076973,-0.0,0.40561588998890014
RNA Polymerase III Transcription Initiation From Type 3 Promoter,0.24205552943890007,-0.0,0.13777994263907098,0.3011576470536824,-0.0,0.008220432835923252
Mitotic Metaphase and Anaphase,0.24195366320324702,0.06497782003520354,0.11145821857861775,0.17012810018778532,-0.0,0.610198025305385
RNA Polymerase II Transcription Pre-Initiation And Promoter Opening,0.24168849231623354,-0.0,0.05138785999284432,0.10971923838643281,-0.0,0.6912689519403412
Transport and synthesis of PAPS,0.2413775693189564,0.010628095958172027,0.2048682756162129,0.1544056581784194,-0.0,0.22652294202141005
NADE modulates death signalling,0.24123189442937698,0.05365491855008349,-0.0,0.06843024793664018,-0.0,0.24289542953823595
Defective DHDDS causes retinitis pigmentosa 59,0.24104630910944813,-0.0,-0.0,0.04365347420579942,-0.0,0.20027802050296162
Interactions of Tat with host cellular proteins,0.24064992180717987,0.04999874725277886,0.019693392237604045,0.10342573668219901,-0.0,0.03641651623045433
RSK activation,0.24059173643319728,-0.0,-0.0,0.03236202516451291,0.001857690980745869,0.05341679460219447
Activation of the AP-1 family of transcription factors,0.24028144060462328,0.1392630368390541,0.541986304738122,0.13888689239656063,-0.0,0.626929462725909
RUNX2 regulates bone development,0.24002860730710032,0.03130176117654277,0.0797795912868316,0.03280505232196194,-0.0,0.34779423752789745
Phase 3 - rapid repolarisation,0.23939957732127382,-0.0,0.12228535267994448,0.07082361744169796,0.09433163975367628,0.2473158970579823
Mitochondrial tRNA aminoacylation,0.23898845439485492,0.07967907785499444,0.11621702858318839,0.33652486244953195,0.13001843419313236,0.01851664517412727
Vif-mediated degradation of APOBEC3G,0.23842601152629048,-0.0,0.1061161310767242,0.10279657080707309,-0.0,0.724001553601476
Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components,0.2370527533237176,-0.0,0.10402974699115967,0.17224274466746275,-0.0,0.4901757894666489
Transcriptional regulation by RUNX3,0.23655652472546793,-0.0,0.1290181502033983,0.23653569019480927,-0.0,0.6096103980428287
Erythropoietin activates Phosphoinositide-3-kinase (PI3K),0.2351519199419402,-0.0,-0.0,0.009620923505217352,-0.0,0.010436968787325522
PKA activation in glucagon signalling,0.23473163408684258,0.06063622471921369,0.40577496723117157,0.014787604808258912,-0.0,0.020158770430991752
Sema3A PAK dependent Axon repulsion,0.23464812440625615,0.008349740628529598,-0.0,0.01887133170696846,0.11794324822267784,0.0068487384568465684
Nucleotide Excision Repair,0.23462724640136273,0.08209213264825298,0.10074437704849595,0.11016661268711389,-0.0,0.6589152955367316
Scavenging by Class F Receptors,0.23427898149235638,0.08276434427537974,0.0635306719812242,0.10204241987572947,-0.0,0.10668841737044585
Signaling by high-kinase activity BRAF mutants,0.23360810041548022,-0.0,0.24218234883836787,0.1375369385153528,0.016210583724979036,0.01636674310972378
Defective AVP does not bind AVPR2 and causes neurohypophyseal diabetes insipidus (NDI),0.23161232981151117,0.03872028445725412,0.1938213753203083,0.16534598196014222,-0.0,0.0192752668762248
p38MAPK events,0.23086073751197833,-0.0,0.09652265136767313,0.1468231602474236,-0.0,0.05079744737388553
"Cell death signalling via NRAGE, NRIF and NADE",0.2308210388063332,-0.0,0.07152278218186209,0.17070120779201514,0.1260717593956161,0.023382244594669106
Prostanoid ligand receptors,0.22954634409279961,-0.0,-0.0,0.03111008579477547,0.010288290200615934,-0.0
SUMO is conjugated to E1 (UBA2:SAE1),0.2274083962362582,0.008736599559543494,-0.0,0.19170131499673168,-0.0,0.6053121080202718
HIV Transcription Initiation,0.22692886613425584,-0.0,0.055045331954788765,0.09658458162441948,-0.0,0.6351701123863115
TNF signaling,0.2257251103357533,-0.0,0.0696064504811072,0.3913342774027705,0.0018540541798964937,0.19428033536672945
Asymmetric localization of PCP proteins,0.22530645553572526,-0.0,0.21448084384161215,0.13353120057389856,-0.0,0.5233804553485999
G beta:gamma signalling through BTK,0.22508674966662373,-0.0,0.22564420259649487,0.037137088914218075,0.026307432207274873,0.4204653733588699
Caspase-mediated cleavage of cytoskeletal proteins,0.22494273291943978,-0.0,-0.0,0.051306528124467524,0.11300440337744279,0.0962994543862413
Regulation of ornithine decarboxylase (ODC),0.22420819163001188,-0.0,0.009944468508721778,0.033601358943408995,-0.0,0.6532185108664046
RNA Polymerase II Transcription Initiation,0.2237488868667794,-0.0,0.06952439793248098,0.07753243983506247,-0.0,0.6472086955540353
Degradation of GLI2 by the proteasome,0.22351749208698626,-0.0,0.10896392033884164,0.14953852865974374,0.012180334349700506,0.42329915432838533
Defective B3GALTL causes Peters-plus syndrome (PpS),0.22342004792115241,-0.0,0.054290921498838844,0.053615740145048614,0.11269522292269869,0.15782173330770743
Serotonin Neurotransmitter Release Cycle,0.22326928778682043,-0.0,-0.0,0.06155377250412154,-0.0,0.24243367225713294
Uptake and function of anthrax toxins,0.22317087901782678,0.009985483095408861,0.0008549799836343247,0.15645279514900842,-0.0,0.09845461697569965
Cyclin E associated events during G1/S transition,0.22295459290733982,-0.0,0.07383091077714901,0.03179450637867371,0.0064237003420838735,1.023195779086338
Phosphorylation of the APC/C,0.22289121186261163,-0.0,-0.0,0.18273214180486658,-0.0,0.27432443580575666
Defective DPM2 causes DPM2-CDG (CDG-1u),0.22262938416403324,0.06470442573863,0.054686643175583485,0.16636843418583794,0.11364520632446239,0.4388755105837041
Mitotic G2-G2/M phases,0.22215887514318344,0.079628359906835,-0.0,0.24893087557805,0.0028884275672301954,0.4061245689463585
Adrenaline signalling through Alpha-2 adrenergic receptor,0.2213549983069584,-0.0,-0.0,0.07144829550603661,-0.0,0.01961767830084123
Conjugation of salicylate with glycine,0.22051539526342767,0.08090116484089735,0.062491867890791655,0.16191946578305602,-0.0,0.028687757200648114
IGF1R signaling cascade,0.22050697452411733,0.005663423542374119,-0.0,0.18699299913834985,0.012688052661058428,0.010495947160870815
Pregnenolone biosynthesis,0.21977096265933316,-0.0,0.00044563801682221223,0.20301686848035547,-0.0,0.6221265340476493
Regulation of gene expression by Hypoxia-inducible Factor,0.21973699569358485,0.17620486762642934,-0.0,0.07458734078081543,0.291638897679365,0.9363228421141034
NOSTRIN mediated eNOS trafficking,0.21949310582072748,0.07630412656944831,0.3275794645999138,0.010421687409096828,0.2794756729981057,0.09346399261743957
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),0.21918607344416816,0.0126271985477312,-0.0,0.2211265781145475,0.004361391169333863,0.004919156964375695
"Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation",0.21909603250300452,0.002310075976798698,-0.0,0.007872173914538105,-0.0,0.6713986687801945
SUMOylation of ubiquitinylation proteins,0.21904218899412817,0.01650684040825233,0.08973577672572407,0.16829550786249534,-0.0,0.00651596560785798
Metabolism of lipids,0.2186140695938597,0.6223071637228754,-0.0,0.0128978893510423,0.017170306579892394,0.6025821259761364
Beta-oxidation of pristanoyl-CoA,0.21812025676371813,0.019431471952433152,-0.0,0.06699922123449098,0.1317144621168879,-0.0
Signaling by NTRKs,0.21768350731014413,-0.0,0.051128332844568136,0.03215771238786517,0.0024973255846875426,0.6062815017702405
RNA Polymerase II Promoter Escape,0.21763657746898551,-0.0,0.06249776000044838,0.08666668536024799,-0.0,0.6270732003995014
Hemostasis,0.21732549631774473,0.45292328867418064,0.01744334572455359,0.008207966827125978,0.0012993697418860574,0.6078410407629293
Antimicrobial peptides,0.21699478673997852,-0.0,-0.0,0.06638483439970318,0.015239546042437718,0.02486297841129678
Insulin receptor signalling cascade,0.21695294239608956,0.013225025608233009,-0.0,0.2322489462451524,0.007940089793153695,0.00290572960053096
TBC/RABGAPs,0.21686248125244928,-0.0,-0.0,0.25921739633398205,-0.0,0.016015936306349125
Synthesis of dolichyl-phosphate-glucose,0.21683995632660602,0.008674411578699567,-0.0,0.05307188511156168,0.006109002543422699,0.02605204175020449
Activation of BMF and translocation to mitochondria,0.21670358752878688,0.1624213221840117,0.19349917869972463,0.11839581547498577,-0.0,-0.0
Neurophilin interactions with VEGF and VEGFR,0.21657430204289674,0.0009644795655653492,0.0026577628587638948,0.054541407433738774,-0.0,0.02787232030339561
Processing and activation of SUMO,0.21652041632017233,0.011647537544787274,-0.0,0.09126849878695513,-0.0,0.700536251997571
Triglyceride biosynthesis,0.21640614302035052,0.08588503618351279,0.03196363452905916,0.2000394084578345,0.007524555517963393,0.12957382010281504
Transcriptional Regulation by MECP2,0.21618328583032448,0.03383382693558644,0.05647068831800528,0.239328949754895,0.0012887509275640553,0.030103660050402357
"BMAL1:CLOCK,NPAS2 activates circadian gene expression",0.2160421283835135,-0.0,-0.0,0.3001792577050882,0.017077085241390864,0.017958292662346383
Serotonin and melatonin biosynthesis,0.21572363511163362,-0.0,0.10760839266946715,0.0034846699569828824,0.01734180689929191,0.00460935525453641
Neurexins and neuroligins,0.2155999611797254,-0.0,0.11690006840930688,0.061811120389111116,-0.0,0.025356223083519893
vRNP Assembly,0.21520630779974234,-0.0,-0.0,0.09185794010935641,0.008107656452964213,0.014741962707506296
G alpha (s) signalling events,0.2151288633137637,-0.0,0.10155526601653783,0.019188229203352173,0.010804881891176153,0.015341612335063223
GPCR ligand binding,0.21484161154105774,-0.0,0.2586383146136677,0.051806223860670964,0.0010910049450876284,0.09123813178530549
DEx/H-box helicases activate type I IFN and inflammatory cytokines production,0.2144757902551042,0.08102128444085427,0.01941801412750754,0.026994828199408703,-0.0,0.1493296084516548
COPII-mediated vesicle transport,0.2141292568960849,-0.0,-0.0,0.13288841942817595,0.05304922772013197,0.614037803037787
GPCR downstream signalling,0.2138284076757429,-0.0,0.1337226870728258,0.03440941826912918,0.01257160244283619,-0.0
RUNX3 regulates CDKN1A transcription,0.21336130941838338,-0.0,-0.0,0.10038754152947087,0.0028244903970188625,0.13284428885137012
Signaling by Nuclear Receptors,0.2116984257550566,-0.0,-0.0,0.2235946419890347,-0.0,0.39511521083673923
Xenobiotics,0.21044673985264617,0.014714149808053014,1.73243473304805,0.05975972841858149,-0.0,-0.0
Signaling by TGF-beta Receptor Complex,0.2104153711042627,0.027735667326750223,0.04743939147123113,0.1369097218294871,-0.0,0.6506544811633919
Innate Immune System,0.21003791686834894,0.6919430918642699,0.03007539990716546,0.010149828260511756,0.0063085909331291575,0.6282440010285871
ER to Golgi Anterograde Transport,0.2098869550400768,-0.0,0.07444581326849418,0.2247813818779657,0.12407663576197803,0.5934513452735615
APC/C:Cdc20 mediated degradation of Securin,0.20801818231420613,-0.0,0.048156863613594225,0.01887546444697081,0.0016570806498729773,0.6117712524403676
Formation of the cornified envelope,0.20766679243196362,-0.0,0.05620493721468654,0.05106413027467016,0.12366905006149138,0.21997501419610654
Death Receptor Signalling,0.20765290149401408,0.08488708895596948,0.04264489472669883,0.3040406350167198,0.1127284592178866,0.02870623860121918
GRB2 events in EGFR signaling,0.20749442326453768,-0.0,-0.0,0.017488464247401952,0.008377680115453803,0.10183369006559109
Manipulation of host energy metabolism,0.20721104072884416,-0.0,-0.0,0.0666968040344974,-0.0,0.3063993314541306
Lysine catabolism,0.20690798905419366,-0.0,0.0006253843619797502,0.13777639640934553,0.0067897272075527985,0.026406712997777616
Signaling by FGFR4 in disease,0.20686155600138068,-0.0,0.024996106590300594,0.02744319624250544,-0.0,-0.0
CTLA4 inhibitory signaling,0.20666762875656505,-0.0,-0.0,0.10010178624945201,-0.0,0.00783999428733807
MyD88 deficiency (TLR2/4),0.2063851453453978,0.008980355683872641,0.37176791683658417,0.19961961435246228,-0.0,-0.0
Homologous DNA Pairing and Strand Exchange,0.2063821216899515,0.08491677155860496,-0.0,0.03207354407605612,-0.0,0.1057663555221817
Molybdenum cofactor biosynthesis,0.20627061147064754,-0.0,-0.0,0.02059446683253784,0.01694511901601806,0.04092787691960239
Aggrephagy,0.20625471015590913,0.01896394237135338,0.25604339902809065,0.2892492440020268,-0.0,0.37651260102698336
Glycogen storage disease type II (GAA),0.2060592206948526,0.009067777511211548,-0.0,0.1547244884992985,-0.0,0.019282453587702305
"Antigen Presentation: Folding, assembly and peptide loading of class I MHC",0.20572577564799294,0.005917282088064027,-0.0,0.3479580115625308,-0.0,0.13959123336394066
Nonhomologous End-Joining (NHEJ),0.20561784357961818,0.017370187432765756,0.03942716513573772,0.05547049056595395,0.08101619095289568,0.18950746856558884
Regulation of gene expression in beta cells,0.20558425198631952,-0.0,0.00869966082633026,0.3028762979945917,0.18017032117221843,-0.0
ROS and RNS production in phagocytes,0.20553881839498636,0.08405235481663535,-0.0,0.024905752620221818,-0.0,0.23159622525114018
Signaling by NOTCH4,0.20542149230182788,-0.0,0.04006180640370571,0.1831104551536787,-0.0,0.6307455108279288
Prevention of phagosomal-lysosomal fusion,0.2053622687873631,0.04822680868123983,0.8807396879805626,0.32303492528748523,-0.0,0.005479489973568656
Muscle contraction,0.2046266655681167,-0.0,0.7517248422706345,0.09637777525155788,0.0014816088118703448,0.5075223887142122
Hyaluronan uptake and degradation,0.20345901038395375,0.0814898842719893,0.10905646043918667,0.05967046156027579,-0.0,0.09522719239206923
Activation of RAC1 downstream of NMDARs,0.20328723593540854,0.017322554974253564,-0.0,0.03459170216765183,0.013300989187208309,-0.0
Mucopolysaccharidoses,0.20295682927884223,0.0980145831191486,0.42705896857070863,0.03113664847212945,-0.0,-0.0
Activation and oligomerization of BAK protein,0.20226671387049217,-0.0,-0.0,0.03313729434444678,-0.0,0.026866232783112877
LDL remodeling,0.20224819691615473,0.07648439964657563,-0.0,0.012602688361588614,-0.0,-0.0
Transport of Mature mRNA Derived from an Intronless Transcript,0.2018243788799342,0.00557705777465979,0.10995673422998106,0.11771168367612662,0.05115070132011048,0.024621113682013848
Neurotransmitter receptors and postsynaptic signal transmission,0.2014981677288225,0.12939164181998117,-0.0,0.011086701878265682,0.021133338881064313,0.45666182335267286
Signalling to RAS,0.20133245607869982,-0.0,0.12796148197982682,0.025238855968285685,-0.0,0.03899568162617787
Dopamine Neurotransmitter Release Cycle,0.20087250021391798,0.01443427094581889,0.0035730435108778484,0.030926847790397553,0.09186909525511341,0.638048430468584
Signaling by TGF-beta family members,0.20040339089581666,-0.0,0.030888519031415967,0.10387637070892622,-0.0,0.6254898715081487
Transport of glycerol from adipocytes to the liver by Aquaporins,0.20036285960374922,0.07904979447239006,0.05553771488306118,0.03187213092129748,-0.0,0.30508986793910486
Regulation of mitotic cell cycle,0.19920659378529665,-0.0,-0.0,0.035711734294893355,0.010845249926373484,0.670926634491824
ISG15 antiviral mechanism,0.19911709634621258,0.010941835783767376,0.12605959720760726,0.5358568381563912,-0.0,0.22332131246170858
Loss of function of MECP2 in Rett syndrome,0.19855906786880742,-0.0,0.05848407750025084,0.3302557031732382,0.13341632180468543,0.01133955407108704
Signalling to STAT3,0.19723290664011042,0.0740213303818648,-0.0,0.12324860104437307,-0.0,0.5924297668865223
PIP3 activates AKT signaling,0.19714083953246447,-0.0,0.06320172596823032,0.3008306139104447,0.005313680186376335,0.20983914746691146
RNF mutants show enhanced WNT signaling and proliferation,0.19692649200204093,-0.0,-0.0,0.19153629746150144,0.24660123050775737,0.19066604090673062
Transport of Mature mRNAs Derived from Intronless Transcripts,0.19673601542233463,0.007460553837942451,0.09729130503390183,0.03313638352661523,0.02917528869762149,0.2397620747809883
Defects in vitamin and cofactor metabolism,0.1939596986353899,0.11012930589817148,-0.0,0.15891724422890788,0.29448020633321786,0.10968531054314651
Interleukin-6 family signaling,0.19374610542512127,0.05576226849254003,0.987164709059062,0.028709573776427147,-0.0,0.14074120255719186
JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,0.19358273668181092,0.018024118839237612,0.22222138828686083,0.2967411600330174,0.0003079105605366406,0.27066665921004834
TRAF3-dependent IRF activation pathway,0.1935751472420629,0.02875771309598507,-0.0,0.5139633410514095,1.94965506206453e-05,0.961242566158969
MAP kinase activation,0.19325013496574406,0.02971693524475641,0.22334306453955818,0.13773497389883788,-0.0,0.9692170122381961
Type II Na+/Pi cotransporters,0.19235229471400023,-0.0,0.07480263170845851,0.014535558278008462,0.12746949686022166,0.0911469889785807
Classical Kir channels,0.1921552833415146,0.02840096949609766,3.849098205008404e-05,0.06917555194410092,-0.0,0.03338461196858786
Biosynthesis of DPAn-3-derived maresins,0.19215521961901205,0.015786644307922863,-0.0,0.023915784496121154,-0.0,0.02102243605780043
PI3K/AKT Signaling in Cancer,0.1913893004570987,-0.0,-0.0,0.06660329976530022,-0.0,0.20400290009734412
Adenylate cyclase inhibitory pathway,0.19135527767118524,0.08422514306382681,0.015072554943047281,0.010630142466663849,-0.0,0.01987096120745147
IRAK2 mediated activation of TAK1 complex,0.19120886111312269,0.01573209951168349,0.39450427113725695,0.44387852272073164,0.2790051148042069,0.5001984660223217
Transport of the SLBP independent Mature mRNA,0.1908050008131953,0.017566512481999932,0.21662919006382952,0.05101076391808702,0.03511350255970272,0.013526806530548557
PKB-mediated events,0.19049893343610047,0.04005750685907536,0.018891188891070075,0.033976855551242836,0.013170548971978701,0.20459110550945567
TRAF6 mediated IRF7 activation,0.19001217466865233,0.08946730875547806,0.007585124181575543,0.2886873691632591,0.12801155234333833,0.2328059588334171
Molecules associated with elastic fibres,0.18876264961543932,0.008915086743059119,0.000293141698837317,0.09177622360334853,0.002687420233506661,1.4153201018325212
Transport of the SLBP Dependant Mature mRNA,0.18863351593350655,0.018765133693246186,0.19113089487601165,0.06994275438111033,0.009074941779863946,0.1947030219728437
Activation of kainate receptors upon glutamate binding,0.18832700787661777,-0.0,0.051782143794708774,0.027776404936955615,0.0027475449720393277,0.413460304573198
FCERI mediated NF-kB activation,0.18813177121076585,-0.0,0.09103282400199408,0.245974488023559,0.004524063836658513,0.3554532319146373
Fatty acyl-CoA biosynthesis,0.1880002013431343,0.16853757214866205,-0.0,0.025233360933021122,-0.0,0.4973540974253848
Proton/oligopeptide cotransporters,0.1879279350703929,-0.0,5.390480778054976e-05,0.05082136640021597,-0.0,0.015596183377737174
Other semaphorin interactions,0.18774741621412575,0.008190898746595903,0.06648930698358531,0.006740924562659834,-0.0,0.1896476626458006
p75 NTR receptor-mediated signalling,0.18763722498096097,0.07265754914504433,0.0498776469875263,0.26812402049398465,0.12752043190647155,0.026104976489666656
Antiviral mechanism by IFN-stimulated genes,0.18743580011602376,0.07862493956359473,0.06199412357050273,0.4840956825289901,-0.0,0.2210291136277769
Displacement of DNA glycosylase by APEX1,0.18735101278862143,-0.0,0.16650363241723468,0.0061447811491965225,-0.0,-0.0
Regulation of MECP2 expression and activity,0.18728983126493476,-0.0,0.015061100649904763,0.3093630320287349,0.018668991885704565,0.019850233707080785
RNA Polymerase II HIV Promoter Escape,0.18727919290311065,-0.0,0.07263644668982573,0.09079124693080173,-0.0,0.5038324750251229
Signaling by Insulin receptor,0.18699032718474318,0.055634530517363126,0.11622045238996048,0.1453369999571819,0.00019543713410540527,0.17560238413558418
G2/M Transition,0.186308914081616,0.08669668910338779,-0.0,0.20890735875143343,-0.0,0.39496956802337474
Intestinal hexose absorption,0.18598124710752922,-0.0,0.06310298796574328,0.09366969118952627,-0.0,0.011740510307857931
Interleukin-12 family signaling,0.18583007386320494,0.035376214641268756,0.03295608783963678,0.05247339534644321,-0.0,0.2727401959005346
RNA Polymerase III Transcription Initiation,0.18564945933276217,-0.0,0.05305776030407116,0.3270779425855985,-0.0,0.01082022609876647
HuR (ELAVL1) binds and stabilizes mRNA,0.1855773584357242,-0.0,0.03566330051924949,0.11100417255098186,0.003231281615396474,0.027162281380415793
Defective ST3GAL3 causes MCT12 and EIEE15,0.18542103394512882,-0.0,-0.0,0.052333106633782774,0.12771207389173703,0.24225458028262595
Abacavir transmembrane transport,0.18539071183393863,0.015495334692721222,-0.0,0.03855192416262007,-0.0,-0.0
Signal attenuation,0.1852082670738045,-0.0,0.024081051166877355,0.03590883349738669,-0.0,-0.0
Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion,0.18487959145119498,-0.0,0.14086665757649208,0.08834439081115512,-0.0,0.10857598015855635
Prefoldin mediated transfer of substrate  to CCT/TriC,0.1842775875914023,0.021864532489092387,-0.0,0.02870928206550236,0.1890654251320663,0.9736578317018023
AMPK inhibits chREBP transcriptional activation activity,0.1841495734531371,0.2334177691270801,0.10813969190939493,0.0269137766360522,0.09546779040682786,-0.0
Signaling by Receptor Tyrosine Kinases,0.18374769137357255,0.1722331783543045,-0.0,0.01040211387310222,-0.0,0.6736263189315904
Chromosome Maintenance,0.1833451639603622,0.015415466506825432,0.007871171683264799,0.06954311078491275,0.17181715193507477,0.014991296922029449
Degradation of AXIN,0.1833099936568418,-0.0,0.22342009498632937,0.15040312402395234,0.0031687372806947535,0.6087348133237385
CLEC7A/inflammasome pathway,0.1818345661918514,0.177221163270657,0.4911451324120807,0.19745957422625326,0.0059427021656894095,0.12941108858693798
Negative regulation of MAPK pathway,0.18154860830772962,-0.0,0.08864140927907807,0.4333092781707719,-0.0,0.36615832174948787
TCF7L2 mutants don't bind CTBP,0.18128814504252916,-0.0,0.0014252884812410126,0.15686606200305295,0.017231928257337523,-0.0
MAPK1/MAPK3 signaling,0.181062372344097,-0.0,0.10903257430009149,0.2779266080611211,0.0011766543494046713,0.49620864677227733
VLDL clearance,0.18089286656950918,-0.0,-0.0,0.007590214219587819,-0.0,0.06071810135239938
MECP2 regulates neuronal receptors and channels,0.18046804757846627,0.015842681725192924,-0.0,0.09151134274143925,-0.0,0.004833969614774771
MAPK family signaling cascades,0.18044496219166917,-0.0,0.10586960052744501,0.31099899246269125,0.0041983865595239395,0.6497611256929398
RHO GTPases Activate NADPH Oxidases,0.18030370535773121,-0.0,0.0002669726530110964,0.004795031487225203,-0.0,0.002491742826898442
Creatine metabolism,0.17868134538980307,-0.0,0.2603051180413638,0.03222103673301932,-0.0,0.36948620983342695
TNFR1-mediated ceramide production,0.17855996203455046,-0.0,0.2538181417737729,0.12911583541301674,0.009658684009513363,0.215434657126025
ADP signalling through P2Y purinoceptor 12,0.17851261751265474,-0.0,0.23186954048799266,0.19132758099306274,0.015701168294908485,0.2481197017058322
Toll-like Receptor Cascades,0.17838105575199012,0.06656313217798275,0.1699971103428544,0.050576594686960234,-0.0,0.33975909077085575
Diseases associated with surfactant metabolism,0.17809225188587327,-0.0,0.014642245698020577,0.10445689497020431,-0.0,0.10425241151887157
Mitotic Anaphase,0.17504688216442324,0.046191825095105,0.1592418175142715,0.21320322972090686,-0.0,0.5312729318824152
Endosomal Sorting Complex Required For Transport (ESCRT),0.1749826539982712,-0.0,0.2548273657705848,0.10363716179490856,0.004332218503449135,0.6123954056229894
Elastic fibre formation,0.17492535211025506,-0.0,0.008671759531495342,0.09596575742207189,0.06827604995345771,1.0649378140640215
Protein folding,0.17406090910862893,-0.0,-0.0,0.01675363589720951,0.009154899716551364,0.49798185035342096
RHO GTPase Effectors,0.17397615480874273,0.08430962280040087,0.16291993407392127,0.024289532195177887,0.27504943742479776,0.4740005233130546
Signalling to ERKs,0.17364935321035307,-0.0,0.018921689786662362,0.017125475057643832,-0.0,0.08654726179226778
TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation,0.17357525259776274,0.0004850221908914495,-0.0,0.11332925626969531,-0.0,0.02916040480627639
Intracellular metabolism of fatty acids regulates insulin secretion,0.1732619339527481,0.03984487024930456,0.09655970434878941,0.09218407028591083,0.09337800635784789,0.612560168187853
Signaling by NODAL,0.1731287707671546,-0.0,0.0007612171554417212,0.20965938668516457,0.021305904536559703,0.0234981006912051
Intracellular signaling by second messengers,0.1730805664519548,-0.0,0.038884862088564766,0.2898805953381629,0.013874177293789687,0.24455551926741054
NOD1/2 Signaling Pathway,0.17307306916689527,0.04702883603009823,0.07927086609234879,0.17475220195761235,-0.0,0.7187178992278525
MET Receptor Activation,0.17281755175259939,0.08930187464247807,0.00022661518830009893,0.20756303822755764,0.0046321136033773405,0.6258475969135142
VLDLR internalisation and degradation,0.17266386116976573,-0.0,0.1386290045684846,0.009950135291076908,-0.0,0.023638235114620945
Unfolded Protein Response (UPR),0.17253463303466737,-0.0,-0.0,0.04772169610684189,-0.0,0.01767879370584011
Downregulation of ERBB2:ERBB3 signaling,0.17236247111811434,-0.0,0.1677233621883749,0.5160962864789278,0.3325143027085565,0.0004286033134732875
phospho-PLA2 pathway,0.17236057661078924,0.008207149191042656,0.008844112308539763,0.1976538123717187,-0.0,0.04652669436038086
Glycolysis,0.17207408979777433,0.08381876459828945,-0.0,0.14704946050484413,0.0018348251169466017,0.32000994788292897
CLEC7A (Dectin-1) induces NFAT activation,0.1719113346611298,-0.0,0.001010183377166527,0.1123035601488995,0.016395002828732262,0.026187459966469564
Alternative complement activation,0.17187073381885712,0.010521752261625744,-0.0,0.02904245995951363,-0.0,0.03958285469205243
Regulated proteolysis of p75NTR,0.17185566298435864,0.0826816063884961,0.03818969354085842,0.03520632170535755,0.010050905137482153,0.19144617146274145
Oncogene Induced Senescence,0.1717586358223062,-0.0,0.1967007135605614,0.13861874660189666,-0.0,0.05365122648684641
HDR through Homologous Recombination (HRR),0.1713157754796545,0.07489583490388224,0.0082983883662371,0.09994211019930928,-0.0,-0.0
Suppression of phagosomal maturation,0.17123639412634753,-0.0,0.2072549051856486,0.29754183260110023,-0.0,0.027974171235563866
Prolactin receptor signaling,0.17115033712627795,-0.0,0.009833763109864321,0.007083590576549624,-0.0,0.07980297089476064
Toll Like Receptor 9 (TLR9) Cascade,0.17114813133958445,0.08120701194710071,0.2423416120295443,0.07008697264342878,-0.0,0.6255947581093007
G alpha (12/13) signalling events,0.1709135524567326,0.0205319296842857,0.004105276869499931,0.10329612848466245,0.06533456090824154,0.057431550009660826
RAF-independent MAPK1/3 activation,0.17055691392634853,-0.0,0.07453514820118155,0.08404308553721661,0.014175469831459156,0.7013596064343184
Regulation of pyruvate dehydrogenase (PDH) complex,0.1705226759686665,0.0819420494607125,-0.0,0.010525370065324714,0.308242730764565,0.646767299204904
Degradation of DVL,0.17050774759270249,-0.0,0.07978345690607017,0.21160588271112793,-0.0,0.6710440565418668
Propionyl-CoA catabolism,0.17025611564003226,0.015539121105609389,0.008408353790669527,0.03249238164235871,0.06264777013724666,0.13987681263271456
Signaling by FGFR1 in disease,0.17017618518320124,-0.0,0.030128356906621197,0.24552157710927416,0.0753137682844131,0.0901300311473615
Autointegration results in viral DNA circles,0.1700666536842639,-0.0,0.020522423076307496,0.10038714730883803,0.08491733197282604,0.2739364842915485
Transcriptional activation of mitochondrial biogenesis,0.1700579774284222,0.049120578497190606,-0.0,0.24655191560702297,-0.0,0.016513160513130214
SUMOylation,0.1695961819573859,0.0663955388345719,-0.0,0.2886931964286773,-0.0,0.009813927858503347
Signaling by GPCR,0.16950585795798334,-0.0,0.14607250974018432,0.03083053533586192,0.012375457141555087,-0.0
APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1,0.16933533085044494,-0.0,0.012824587806881678,0.03538376146740264,0.002314258747704561,0.613765362849452
Netrin mediated repulsion signals,0.16923649892276008,-0.0,0.30345852015738356,0.18922300143103243,-0.0,-0.0
Diseases of carbohydrate metabolism,0.16911633080184757,0.1612948226152535,-0.0,0.2444996695395236,-0.0,0.04071209455667392
Nucleobase catabolism,0.16891627705825557,-0.0,0.06207848102104567,0.07222743606449243,-0.0,0.11011589133766742
Endogenous sterols,0.16864009684148962,0.08650305500779118,0.14631682982323652,0.14608164686205372,-0.0,0.19241384902532593
Mitochondrial ABC transporters,0.16811882350481633,0.0164167750872321,-0.0,0.1865220611811863,0.2104255975429413,0.023833068263807274
Antagonism of Activin by Follistatin,0.16790091826292916,-0.0,0.22742488698624092,0.0028095279095398623,0.045058492252499686,0.5142450900105614
Scavenging by Class B Receptors,0.16761393364145463,0.08087443321360262,-0.0,0.18699337024683665,-0.0,-0.0
Pink/Parkin Mediated Mitophagy,0.16754643056157817,-0.0,0.09589502718640293,0.11046714714670541,-0.0,0.08634976317100103
Zinc efflux and compartmentalization by the SLC30 family,0.16741820538146057,0.08033587641401975,-0.0,0.029397120515679075,0.05508395240875955,0.1369989743195653
Negative regulation of TCF-dependent signaling by WNT ligand antagonists,0.16698193316511004,-0.0,-0.0,0.19922834969026007,-0.0,0.11634737292497718
Pausing and recovery of Tat-mediated HIV elongation,0.16660947561881628,-0.0,-0.0,0.034787693495215044,-0.0,0.024787747020767664
Neuronal System,0.16657233958391188,0.46295706346148535,-0.0,0.028545700219321613,0.0002535983577962936,0.5194955102097126
Metallothioneins bind metals,0.1658146459195883,0.005228881827209741,0.8008542848216947,0.002140207383792061,-0.0,1.0818369254272864
Metabolism of non-coding RNA,0.16448588421909544,0.008263107322606456,0.01854975083685861,0.0788575744191459,-0.0,0.003500636467053143
Amine Oxidase reactions,0.1640127433980926,-0.0,0.0103733324738343,0.12500298977525526,0.00045739606273105104,0.00947038168731504
Transmission across Chemical Synapses,0.16387616223988385,0.3239795948579624,-0.0,0.01131902154039033,0.017927721586362872,0.49834342367491385
NOTCH3 Intracellular Domain Regulates Transcription,0.163628874972745,-0.0,0.3773922276017714,0.15262244492956104,0.33407146884760736,0.006407147776778929
Cell-Cell communication,0.16362020892312748,0.0729624690435528,0.019313985178917675,0.08347830728770905,-0.0,0.6375712402713775
Response of Mtb to phagocytosis,0.16356711196942406,-0.0,0.2248858082899831,0.2996583713395828,-0.0,-0.0
RAB GEFs exchange GTP for GDP on RABs,0.16353692283941343,0.07337518545148691,0.04357305638525552,0.20558076522173793,0.07853145670935152,0.10341017867419226
Synthesis of Dolichyl-phosphate,0.1630653562489065,-0.0,-0.0,0.013027165382142259,0.12524662138067885,-0.0
Deadenylation of mRNA,0.16297322162923158,0.01751434062204996,0.0041904873662236344,0.03074291683930945,-0.0,0.03622887343973952
Signaling by moderate kinase activity BRAF mutants,0.1629670147833598,-0.0,0.21896300600103932,0.21078990433604713,0.012906821004411595,0.011191873111818981
Synthesis of diphthamide-EEF2,0.16292106817026666,-0.0,0.10281386521806227,0.3139167027574455,0.061197799713321864,0.0830798366777051
Activated NTRK3 signals through RAS,0.16244538496326297,0.00522829039885703,-0.0,0.01788587979568937,0.002581919857922842,-0.0
Cytosolic tRNA aminoacylation,0.1622796285713386,0.08042845434664449,-0.0,0.04351498548042346,-0.0,0.006586411336718422
Regulation of lipid metabolism by PPARalpha,0.16038119007482177,0.08243504848645637,-0.0,0.2510230614279089,-0.0,0.016556726951268422
ABO blood group biosynthesis,0.1596724182631824,0.02747755178707101,0.2527228772311146,0.13775967198312464,0.000300323408898076,0.21642588503036225
RHO GTPases activate KTN1,0.15958405486012708,0.009219987958677879,0.022539211077904783,0.09701996712233667,-0.0,0.7284686091186723
Defective SLC7A9 causes cystinuria (CSNU),0.15933899730512052,-0.0,0.01799810214660317,0.10084742406224635,0.018032089767189605,-0.0
PKA activation,0.15931619932654156,0.07272028223459835,0.08543673834900427,0.007667095015282454,-0.0,0.029807507456573012
Integration of viral DNA into host genomic DNA,0.15925382595186274,-0.0,0.017403858470412908,0.10278357170570268,0.043739149951595745,0.26865061959384773
Binding and Uptake of Ligands by Scavenger Receptors,0.1591193548583958,0.014754851978549866,-0.0,0.03533552818132377,0.0048410273571518276,0.27587927507221904
EPH-Ephrin signaling,0.1590448814035141,0.08335696460856007,0.03673665239356173,0.06623245706949821,0.007187183210011479,0.6996725914678563
SHC1 events in EGFR signaling,0.15868169612361252,-0.0,-0.0,0.0069634120583048735,-0.0,0.09641513911507271
Semaphorin interactions,0.1585846742940665,-0.0,-0.0,0.08447365576919863,-0.0,0.007269374451163731
RUNX3 Regulates Immune Response and Cell Migration,0.15855548000238928,-0.0,0.005180520579366059,0.015367258166548759,-0.0,-0.0
Regulation of beta-cell development,0.15847241739457146,-0.0,0.23918292823777165,0.2510486286932531,0.1324501009228244,0.039390416393765344
Defective LARGE causes MDDGA6 and MDDGB6,0.15815352497550125,0.015536736628227904,0.005804460807830136,0.08114713521458972,-0.0,0.3320182556891196
Inhibition of Signaling by Overexpressed EGFR,0.1580707944539174,-0.0,-0.0,0.05034069464173643,0.01762332896059647,0.22694401126555527
HIV elongation arrest and recovery,0.15790313837111422,0.06638272076423077,-0.0,0.21203428805953392,-0.0,0.01705792968137443
Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD),0.157824070847254,0.0014336703060884852,-0.0,0.2055349397129252,-0.0,0.2737539946392144
Circadian Clock,0.15747518304054445,0.011439329595427612,-0.0,0.30332879079040237,-0.0,0.2845010502207731
Transport to the Golgi and subsequent modification,0.15739718921092194,0.08443120763159548,0.10137097416459943,0.26256302748326427,0.12526833859036526,0.6675646855925406
IRAK4 deficiency (TLR5),0.157259971401478,-0.0,0.0007309131131017174,0.007425444473667985,0.02609335116317855,0.017502108157969067
Synaptic adhesion-like molecules,0.15724838957209622,-0.0,-0.0,0.008932569237546881,-0.0,-0.0
Tat-mediated HIV elongation arrest and recovery,0.15723340552569706,0.11874475260396439,-0.0,0.034753637104524525,-0.0,0.008021682002257181
Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD,0.15715842982686226,0.018722940706019882,0.06996380154667303,0.05281521388668155,0.028931794908715915,0.34387786963674877
betaKlotho-mediated ligand binding,0.15698797759764335,-0.0,0.04088537741765966,0.11240248756912985,-0.0,0.01060134228599236
Carboxyterminal post-translational modifications of tubulin,0.15684360461822155,-0.0,0.149465505191145,0.2392535960152416,-0.0,0.0026962247859298872
MyD88 dependent cascade initiated on endosome,0.1567551308286616,0.08323414530722809,0.26466665776098397,0.06864549613157686,-0.0,0.5796444798003265
Fertilization,0.15669389485974228,-0.0,0.5839640783621226,0.01774185439318426,0.02300890791986178,0.006906057806903802
Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA,0.15667740943476427,0.12421134613815465,0.2788241431639238,0.18049739675059456,-0.0,0.18852250038513846
IRE1alpha activates chaperones,0.15654339260127795,-0.0,-0.0,0.006176581529783467,-0.0,0.013974024030487165
Signaling by RAS mutants,0.15639267834097648,-0.0,0.23076127571306565,0.22112572749612436,-0.0,0.009835778116107075
EGFR downregulation,0.15585849040925323,0.012420107349502647,0.07897437828566976,0.030723534869232676,0.008194710096103862,0.7745684154567766
Pausing and recovery of HIV elongation,0.15581375896044178,-0.0,-0.0,0.1481609112706774,-0.0,0.023441792787566296
Paradoxical activation of RAF signaling by kinase inactive BRAF,0.15546130530061214,-0.0,0.22465223001011628,0.22074190469030588,-0.0,0.00502525787160887
Nucleotide salvage,0.15458083806755285,-0.0,0.0425205099133041,0.0553078552002682,0.00177095619022874,0.009169583508516781
Regulation of insulin secretion,0.1543213537234671,-0.0,0.1464126098404761,0.02858340643448279,0.009536718116814986,0.42753004725912225
mRNA decay by 5' to 3' exoribonuclease,0.1498585023510598,-0.0,0.01568953965018842,0.12633698094223586,-0.0,0.024250367663959233
Regulation of TP53 Activity through Methylation,0.14920042950123513,-0.0,0.7576736497406801,0.28748339649910976,-0.0,0.16654433329000473
XBP1(S) activates chaperone genes,0.14896373587538037,-0.0,-0.0,0.011134735571122389,-0.0,0.10322350917120175
Glucagon-type ligand receptors,0.14865868168669683,-0.0,0.07085074332402679,0.053206589619511,-0.0,0.5349425596443146
Thyroxine biosynthesis,0.1486378063690029,0.008084411290608258,0.0001473632592476791,0.18601802290016453,0.0008043931961422401,0.017270241354917382
Glycogen breakdown (glycogenolysis),0.14858559672830077,0.08125132327211289,0.1323510283060584,0.10215665901948673,0.12764089243906263,0.010518306741451875
Diseases of Immune System,0.14845934431435984,0.07361617533946699,0.14877608395839145,0.03605113503797828,-0.0,0.029155528561602678
SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion,0.14821386403032105,-0.0,0.16820650575378573,0.007023912525076183,0.005784783966707895,0.0054431241943463035
Termination of O-glycan biosynthesis,0.14813394832651922,0.07765111186930075,0.07217123486493185,0.14912400042873522,-0.0,-0.0
ATF6 (ATF6-alpha) activates chaperones,0.14792250257082018,-0.0,0.07951405470100163,0.11331046692236495,-0.0,0.310743106199188
Ub-specific processing proteases,0.14786118283336958,0.0776779746666804,0.010699697920790056,0.031552376669406086,-0.0,0.3848639577574609
CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde,0.14767444844672561,0.007897900339628585,-0.0,0.03568194899798691,-0.0,0.2543110660348177
Synthesis of PS,0.14764465342999084,-0.0,-0.0,0.04342787404204125,-0.0,0.015380762252899095
Antigen processing-Cross presentation,0.1476157906360405,-0.0,0.25766190449763177,0.20439470343438254,0.007917935088051744,0.3057594908011706
Miscellaneous transport and binding events,0.14756972989155398,0.028784377908410718,0.007439390384008999,0.1597465352745213,0.2767639661239054,0.42885291816786436
PI-3K cascade:FGFR3,0.1475667913736633,-0.0,0.12824855991486409,0.026462748681925313,-0.0,-0.0
IRF3 mediated activation of type 1 IFN,0.14751228706897382,0.07677943554001747,0.03610458447479987,0.054179573297886245,0.024415115046030358,0.1217521802288498
RAS signaling downstream of NF1 loss-of-function variants,0.14734706479064222,-0.0,0.6859178913826375,0.06830263082204811,-0.0,0.01872835726392841
Sodium-coupled phosphate cotransporters,0.1472994139275298,0.039864138140082994,0.003375268160620945,0.1693076689678883,-0.0,0.005935272115638479
NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake,0.14721313395238161,-0.0,0.10219692882758807,0.1000866570757024,-0.0,0.2218745439067884
Defective SLC3A1 causes cystinuria (CSNU),0.14719718780303065,-0.0,0.01779532768009488,0.15792451684230674,0.01871556918891977,-0.0
Defective LFNG causes SCDO3,0.14712375763466404,-0.0,0.0003222674037991193,0.006869151290756852,0.21040396551532167,0.08646863855403715
TFAP2 (AP-2) family regulates transcription of other transcription factors,0.14691956326728173,-0.0,0.015782155066357186,0.09131044526063359,0.012111598480824968,0.13440327342660133
RIP-mediated NFkB activation via ZBP1,0.14648738185839105,0.07210286256076642,0.22450296483220447,0.033945719808529215,-0.0,0.03032761939283176
PDE3B signalling,0.14611316235728755,0.05123154529426836,-0.0,0.028445360538719714,0.04580584547880538,0.12278287261501668
Signaling by Rho GTPases,0.14486318473801635,0.1755887564405011,0.03527255244819995,0.007676469138068414,0.05990114816276177,0.3213962019251433
TRAF3 deficiency - HSE,0.14427990855129388,0.0005411190171865238,0.05827907877586373,0.17671504913344557,0.020423253795327702,0.08909981739004971
TNFR1-induced proapoptotic signaling,0.14373272566071804,-0.0,0.0018454438405952074,0.059830744938266206,-0.0,0.015302130435506692
Amplification of signal from the kinetochores,0.1406573723423899,0.015487221280463053,0.4089713421274178,0.10044058061447125,-0.0,0.12355072346437933
NCAM1 interactions,0.13995218774285512,-0.0,0.242394846035716,0.035817580591960566,-0.0,0.03229040647405035
Toll Like Receptor TLR1:TLR2 Cascade,0.13976135225320663,0.08563733548179868,0.30474920896866553,0.04909699904031569,-0.0,0.6810290046689259
Norepinephrine Neurotransmitter Release Cycle,0.1396795823313759,-0.0,0.018111828512787326,0.012320497734454282,-0.0,0.05762548912674186
G alpha (i) signalling events,0.13965658059382494,-0.0,0.25310014193548175,0.08385723574514894,0.005681310311140562,0.1390397956244515
Extrinsic Pathway of Fibrin Clot Formation,0.13879273479018925,0.01369460408007836,0.0027093754858092452,0.00461644166067594,0.007741621126637628,-0.0
Detoxification of Reactive Oxygen Species,0.13877260238400405,-0.0,0.09964770200455399,0.1912877211249735,-0.0,0.24360294543893937
Metabolism of carbohydrates,0.13833333917072277,0.22074273103232084,-0.0,0.029613618462474324,-0.0,0.4641942675233537
"Gamma carboxylation, hypusine formation and arylsulfatase activation",0.13808843846167265,0.04889357318050061,0.002674629115025983,0.07060236287222932,0.016414550398181082,-0.0
Methionine salvage pathway,0.13805534207671466,0.02546212881058145,-0.0,0.2004071206541465,0.016057043715374978,0.6252594657670304
TRIF-mediated programmed cell death,0.1376177409168811,-0.0,0.09979542239574274,0.04662053850193764,-0.0,0.19248573909096475
Downstream TCR signaling,0.13761575098148476,0.012791938629168621,0.3057760171213217,0.10372522369456033,-0.0,0.008451360405429053
Negative regulation of activity of TFAP2 (AP-2) family transcription factors,0.13742714956805385,-0.0,0.583377173615791,0.09466222884382186,-0.0,0.09284907008024738
Signal transduction by L1,0.13731775144848307,-0.0,0.0018384456067715136,0.19200329622928367,-0.0,0.21233183902663358
Late endosomal microautophagy,0.13725407657381392,-0.0,0.40514921502262546,0.15107778801290286,-0.0,0.4294954383768542
Regulation of IFNG signaling,0.13717002078433546,0.008213054084987912,0.05464260478413232,0.11163012636742792,-0.0,-0.0
Signaling by PDGF,0.1370271559868563,-0.0,0.14472787186754377,0.06554714926330484,-0.0,6.53339121650602e-05
Type I hemidesmosome assembly,0.13693503082555417,-0.0,0.14861044876229046,0.19598542450195136,0.4081312793713718,0.7822975366083139
Synthesis of PG,0.13664659781102065,0.016013739740662707,0.035326785082556794,0.005783361598461355,0.011306327140715854,0.023305898099367436
Toll Like Receptor 7/8 (TLR7/8) Cascade,0.1364266459719344,0.08524351002587352,0.28069625671787884,0.06523214349259861,-0.0,0.6048474033216715
SUMO E3 ligases SUMOylate target proteins,0.13639524495246869,0.16473204158697674,-0.0,0.2416354400398747,-0.0,0.010781729888383692
Nuclear Envelope Breakdown,0.13638839832648908,0.014401347996792177,-0.0,0.16772141918520603,-0.0,0.1435921709120487
Cilium Assembly,0.13583471127078142,0.31187407122023436,0.09093010511384195,0.2903225113068539,0.001527765282922739,0.24105732179930747
Apoptosis,0.13528095599283704,-0.0,0.05600895392447591,0.024290262281518787,-0.0,0.6092484652848807
Drug-mediated inhibition of ERBB2 signaling,0.13526632502208344,-0.0,0.0012790588568078777,0.3146987555862114,0.24465002128149926,0.015047542921449093
O-glycosylation of TSR domain-containing proteins,0.13410132012692091,-0.0,0.040032255970194656,0.03798700104470201,0.11511915577461679,0.18283911782627216
APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway,0.13403365699210942,-0.0,0.34882196078581124,0.15511224191799317,0.013285515009705961,-0.0
Choline catabolism,0.1334490006987046,0.007565801123417007,0.1112451659546403,0.031154112264071086,0.00601281327483429,-0.0
Cholesterol biosynthesis,0.1331258299852222,0.5099901823841382,-0.0,0.006533010117745119,0.4590412160796327,0.5946946453253273
Biosynthesis of EPA-derived SPMs,0.13312340135667539,0.000610646032076999,-0.0,0.06429017824576302,0.010832403402395259,-0.0
Activation of the pre-replicative complex,0.13307067930407634,0.08186220857158133,-0.0,0.2121048308012571,0.2915639917949043,-0.0
Glutathione conjugation,0.1329691265896135,0.01859683168780128,0.051233389575976826,0.18509669324310798,-0.0,0.7569163419069452
Activated NTRK3 signals through PI3K,0.13289341224567924,-0.0,0.3106717332935781,0.17648765861048676,0.012951205845806115,0.10016866566003413
Ethanol oxidation,0.13274169653289244,0.009655940021601618,0.16796091936967544,0.12976888006328122,0.025310242158549486,0.4020173077463795
Negative regulators of DDX58/IFIH1 signaling,0.13259912353523656,-0.0,0.037036073727363755,0.5393292731988001,-0.0,1.0829761628920576
Inhibition of replication initiation of damaged DNA by RB1/E2F1,0.13144878782867575,0.01567089502160817,0.19312335055729118,0.06821572418650194,-0.0,0.09026698754208894
Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,0.13069624957472833,0.010137662063353358,0.5513409416154824,0.08534559506886315,-0.0,0.13723151655791285
RAF/MAP kinase cascade,0.1304247126926416,-0.0,0.14376457808659046,0.30634560140008266,0.008229692379776258,0.5159660168065061
ER-Phagosome pathway,0.13031948181781897,-0.0,0.26896341942449303,0.2602011189826485,0.010342474420825767,0.31899877390838477
ABC transporters in lipid homeostasis,0.13012890099458238,0.08132548747166876,0.11206074273660299,0.07558632796888624,-0.0,-0.0
Platelet calcium homeostasis,0.13004447175634237,-0.0,0.05611249901150324,0.050506665782139054,0.002182374262554848,0.24289999297093182
Activation of the phototransduction cascade,0.12996184359042368,0.0003052464717165841,-0.0,0.009816962093304116,0.019674542234446955,0.12639287784001474
Mitotic Prometaphase,0.12989543531290867,0.13113446883845933,0.40794354614253886,0.2506051584008845,-0.0,0.007926900301166129
G0 and Early G1,0.12960921582045645,0.01549214313258765,0.03858463638550401,0.11232145709971268,-0.0,0.7443036250993451
Signaling by NTRK3 (TRKC),0.12955926599527018,-0.0,0.17862997881709416,0.03409761349074387,0.012419847512782621,-0.0
Defective SLC7A7 causes lysinuric protein intolerance (LPI),0.12948946748815246,0.008478056537753152,-0.0,0.027986978345478426,0.0119036411066369,0.09043572601424724
G2/M Checkpoints,0.12912872857165417,0.0185126623187942,0.018513575546899048,0.29358038170921713,0.07023262338848188,0.670727343117603
snRNP Assembly,0.1288590319300715,0.007907860642392761,0.01507424991134987,0.09778450706563026,-0.0,0.010159627978733784
Amino Acid conjugation,0.1284535418465626,0.08504213073690023,0.06306095264837272,0.14244707679780363,-0.0,0.006062141383887405
Cyclin A:Cdk2-associated events at S phase entry,0.12732193403608688,-0.0,0.06338982644559009,0.034818473596233204,0.011614832035829907,0.9207425658107384
RNA Polymerase III Abortive And Retractive Initiation,0.12718781070239268,-0.0,0.03289378882689677,0.3370593397792983,-0.0,0.019175507310052443
Regulation of PTEN stability and activity,0.12718402727713218,-0.0,0.164116870300201,0.24526393653171333,0.007152985863004987,0.34023154882392925
Defective CHST6 causes MCDC1,0.12718028843191487,-0.0,-0.0,0.01844262220001092,-0.0,0.5937630610213745
Signaling by Overexpressed Wild-Type EGFR in Cancer,0.1271187315696039,-0.0,-0.0,0.06870878786063428,0.021704588520531594,0.21389995186639502
Class A/1 (Rhodopsin-like receptors),0.12665148118958772,-0.0,0.38976224233577905,0.08101644309463729,-0.0,0.01758385407505436
Signaling downstream of RAS mutants,0.12632515516223478,-0.0,0.24007600772412135,0.25045652468777924,0.013901959321566888,0.015564534178480824
Voltage gated Potassium channels,0.1262547114381002,0.08192318701629117,0.006305309020849897,0.06808160565178172,0.00990156533816201,0.7468892319541013
Peroxisomal protein import,0.1261476670183322,0.7484184190051864,0.30472864861954707,0.11099136550847213,0.09433489714484782,0.6700622765542399
Signaling by NTRK1 (TRKA),0.12608499457706746,-0.0,0.015699234399864856,0.028488523002440834,-0.0,0.5952459041310895
MAP2K and MAPK activation,0.12607518073355853,-0.0,0.2560081771706445,0.10107414576933782,0.0016497002340083613,0.017666703602372116
p53-Independent DNA Damage Response,0.12600357921135358,-0.0,0.16566705432899098,0.1144611670732002,-0.0,0.6441439718034093
Estrogen biosynthesis,0.12585687751655705,-0.0,0.042504523702262376,0.34946834134494204,-0.0,0.5291882581419571
Cysteine formation from homocysteine,0.12585505369294692,0.015344685095227663,0.03217295413814771,0.20615467430911386,-0.0,0.13361871653776694
Vpu mediated degradation of CD4,0.12568065131534062,-0.0,0.17915138643301096,0.11865495615959028,-0.0,0.5010738850449791
Transcriptional Regulation by E2F6,0.12561729774647518,0.012320350683715033,0.009274495743984671,0.007177218084607918,-0.0,-0.0
Glucose metabolism,0.1254881401461206,0.09465197720719987,-0.0,0.10244825176881306,0.002175337184608388,0.1517711293498897
Toll Like Receptor 10 (TLR10) Cascade,0.12541857860849084,0.08516880966422981,0.2567868473258761,0.034243900415658224,-0.0,0.7003252828427027
E2F mediated regulation of DNA replication,0.1252977556654941,0.017426069469853173,0.07180890721780235,0.09980140611420728,-0.0,0.12364238089893428
Leukotriene receptors,0.12525860833326205,-0.0,0.5264895919820397,0.02400814237352723,-0.0,0.01758286592596244
RNA polymerase II transcribes snRNA genes,0.12505915381817295,-0.0,0.37422505338703693,0.19678820403289665,-0.0,0.019860991215885547
RNA Pol II CTD phosphorylation and interaction with CE during HIV infection,0.12498962021067797,-0.0,-0.0,0.04144882147774148,0.002964812411988092,0.5409230460837471
Dopamine receptors,0.12490330397305367,-0.0,0.07520759702977549,0.06909697081032892,-0.0,0.015111061084221219
Gap junction assembly,0.12482606032843142,0.40870238779072604,-0.0,0.02996202257925293,0.28218191048427244,0.24158039394948982
Protein methylation,0.12480894843118506,0.01636600460799961,0.10667475568464048,0.13187262281244605,-0.0,0.29219958583175176
Electron transport from NADPH to Ferredoxin,0.12457396261165288,0.018094926094716267,-0.0,0.24910249668556797,0.044869900187241234,0.0709504499870331
Synthesis of bile acids and bile salts via 24-hydroxycholesterol,0.12453470616148328,0.08578311969254758,0.15014816100039124,0.010442324776622157,0.0037504318827322317,0.18833926690850833
Metal sequestration by antimicrobial proteins,0.124519844343289,-0.0,0.19392260770117645,0.06764070474993729,-0.0,0.1267997951508148
Astrocytic Glutamate-Glutamine Uptake And Metabolism,0.12429473304377228,0.08025584856008697,-0.0,0.1329264410444707,0.2363619508291656,-0.0
Degradation of GLI1 by the proteasome,0.1242786570868832,-0.0,0.10218557154863937,0.11242493023217004,0.016190793140459958,0.4902129086607489
Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC),0.12421420137385203,0.022132174181482774,0.04074641083557743,0.13741108962356055,-0.0,0.02240775141677409
Formation of RNA Pol II elongation complex,0.12394232503033556,-0.0,-0.0,0.25085941063876643,-0.0,0.22104759051296122
TRKA activation by NGF,0.12376683816244935,-0.0,-0.0,0.03251412625440228,-0.0,0.023334175923705403
Infection with Mycobacterium tuberculosis,0.12339297073082238,-0.0,0.26693757701814236,0.20763367416559528,-0.0,0.09070229012756979
RNA Pol II CTD phosphorylation and interaction with CE,0.12334083507375303,-0.0,-0.0,0.03512648775669991,0.007779758328804481,0.5352748649372309
IKBKB deficiency causes SCID,0.12323157039647037,0.08267837791593965,0.3022543961490406,0.027206070820914953,0.0025454900947774277,-0.0
Toll Like Receptor 2 (TLR2) Cascade,0.12296567386240766,0.08058975526372264,0.307692677484833,0.05360232932301833,-0.0,0.7009269338056158
Proton-coupled neutral amino acid transporters,0.12235125419856817,0.016396287880927278,0.0900709693309987,0.034436543634717126,-0.0,0.017147657255642445
MyD88 deficiency (TLR5),0.12203606256302688,0.010160731268114547,-0.0,0.1362508640503028,0.09464225742880654,0.009661948799731455
"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",0.12199705056243652,-0.0,0.03299012768072877,0.022914270145307128,-0.0,0.1945872005126845
Diseases associated with the TLR signaling cascade,0.12188006361653345,0.08135650111018564,0.21218880889297356,0.033573819417708636,-0.0,0.016722294382621905
ROBO receptors bind AKAP5,0.1217319972097839,0.1915500530249176,-0.0,0.13866225574983293,-0.0,0.030708286619274987
Inflammasomes,0.12165696950360533,0.008634946827059115,-0.0,0.0024141730551353806,-0.0,0.009886120969833613
Opioid Signalling,0.12162498752556629,-0.0,-0.0,0.017753672396192428,0.04425450246661261,0.24270398147470526
Sterols are 12-hydroxylated by CYP8B1,0.1216152712763009,0.008583401100770754,-0.0,0.06581043005271195,-0.0,0.04085067695873493
Toll Like Receptor 5 (TLR5) Cascade,0.12113416470564771,0.0787454919110646,0.24250399432022612,0.032320173456123875,-0.0,0.6917367868449639
DNA Repair,0.12107077497616034,0.07053831399139077,0.07120814515093464,0.21176651030578847,-0.0,0.4634415534488876
Asparagine N-linked glycosylation,0.12082096070493842,-0.0,0.039401044627436356,0.2979275333074418,0.11991635405307127,0.7197938705133741
Recycling of eIF2:GDP,0.12051997492424536,0.016342638679090492,-0.0,0.29463266373997793,-0.0,0.021443600244702418
Deubiquitination,0.12019072962648877,0.0712402088288942,0.00945898902809245,0.24701457355203807,-0.0,0.4905675969197609
Neutrophil degranulation,0.12017949929968379,0.6119667654080202,-0.0,0.029422203366622705,0.002768235891082422,0.6740089222218126
Carnitine synthesis,0.12015446805013218,0.08136097912285206,0.06225641799165295,0.18828946447296968,-0.0,0.30312441579520444
Phospholipase C-mediated cascade; FGFR2,0.12011519820826268,0.004769231433612974,0.03246199336941112,0.21295923526639832,-0.0,0.10812885655969708
Pyruvate metabolism and Citric Acid (TCA) cycle,0.12007197534335302,0.4585549656742283,0.018879349876463246,0.06755813878603267,0.4151023344159454,0.8274296096513695
MyD88 cascade initiated on plasma membrane,0.12004982364090847,0.08361769478891115,0.22766036379784024,0.0359338480849603,-0.0,0.650396777146106
Downstream signaling events of B Cell Receptor (BCR),0.12004519771190343,0.013941159210162445,0.1285628528866851,0.19869849527238936,-0.0,0.5108679599786369
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,0.11986662943481756,0.08524248477942308,0.27554945540146086,0.0672207442694413,-0.0,0.5443841222817593
Unwinding of DNA,0.11957063398532658,0.01232136976317382,0.41615962046466987,0.004574978674623917,0.04974081102332573,-0.0
IRAK4 deficiency (TLR2/4),0.11948236226871285,0.0009640952519450593,0.30676709046109846,0.16465813299600768,-0.0,-0.0
Interleukin-37 signaling,0.11937140814043061,0.015385487977155117,-0.0,0.10454526566725121,0.25831095075597804,0.03510135020591213
Activation of SMO,0.11932692236963535,0.015530461424574798,-0.0,0.12562903518535687,-0.0,0.4597948535403333
Entry of Influenza Virion into Host Cell via Endocytosis,0.11914459608043877,-0.0,-0.0,0.20397917420267242,-0.0,0.27258581783273517
Toll Like Receptor 3 (TLR3) Cascade,0.1189093452754311,0.09081241815659254,0.19762254854648661,0.19769337883069152,-0.0,0.6296468476042201
Reversal of alkylation damage by DNA dioxygenases,0.118693018688149,-0.0,0.37418591014943064,0.16818684360174352,-0.0,0.008774683687417097
SUMOylation of transcription cofactors,0.11851809956272562,-0.0,0.10902058161552981,0.552051529215328,-0.0,0.011049417024336875
Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4),0.11812026061628811,-0.0,0.11649823104973632,0.11028938013391454,-0.0,0.0007725546132883347
mRNA Capping,0.1179708085856952,-0.0,4.9056840685685216e-05,0.0360963438398528,-0.0,0.4074915738525531
Estrogen-dependent nuclear events downstream of ESR-membrane signaling,0.1172888749310283,-0.0,0.09402643150171636,0.19727555597382113,0.1298262317071667,0.3383821462419034
DDX58/IFIH1-mediated induction of interferon-alpha/beta,0.11713111304144475,0.018323059530513476,0.0715524754972273,0.3800672545406477,0.02840250141737777,0.2035792913470295
Neurotransmitter uptake and metabolism In glial cells,0.11708809237752903,0.0774003446231484,-0.0,0.12228922900622216,0.19119283473381915,-0.0
Negative regulation of the PI3K/AKT network,0.11701705381494952,-0.0,-0.0,0.14839741284073524,-0.0,0.12810433855412787
CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling,0.11687462901215552,-0.0,-0.0,0.044519850395073855,-0.0,0.42741530246425447
Toll Like Receptor 4 (TLR4) Cascade,0.1167712813308688,0.08055900614012013,0.17350939623500117,0.0333611692170471,-0.0,0.3671040157011679
RNA Polymerase II Transcription Elongation,0.1166918369227277,-0.0,-0.0,0.24642308030085847,-0.0,0.1578225532792701
Reelin signalling pathway,0.11664763293278861,0.07757115320262385,0.2743060254043007,0.15029612845601806,0.15104589247407255,0.33210686722982735
Repression of WNT target genes,0.11438435314914272,-0.0,0.002304349905048141,0.013340259778466998,-0.0,0.0211810699620868
Telomere C-strand synthesis initiation,0.11397554426161653,0.03462350330090906,0.13715378887202492,0.007518627466822491,0.3885344384729445,0.008670526805701616
SUMO is proteolytically processed,0.11374689866889552,0.011811092489247534,-0.0,0.24117336216799393,-0.0,0.2739232005992962
HHAT G278V abrogates palmitoylation of Hh-Np,0.11337391965433317,0.12618551877415274,0.0398919828024103,0.03365287928160405,-0.0,0.19426349408773938
Assembly Of The HIV Virion,0.113308547627575,0.0077603168813758835,0.5297105139192051,0.21353127079249778,-0.0,0.009806585114741532
p53-Independent G1/S DNA damage checkpoint,0.11311798307767501,-0.0,0.16798124509377896,0.12047681364921352,-0.0,0.7455083262377158
Nuclear Envelope Reassembly,0.11278420158585391,-0.0,0.008075885772101925,0.16769918377110637,-0.0,0.01812707007519631
CDK-mediated phosphorylation and removal of Cdc6,0.11238185332633222,-0.0,0.05571116691467679,0.03632832462187072,0.0002510977554392794,0.7354626278344685
SUMOylation of DNA replication proteins,0.11231960726863366,0.03393907225677078,0.09141845740157678,0.20937343101556863,0.010718735813042111,0.15849342352238585
Constitutive Signaling by EGFRvIII,0.11221809477412495,-0.0,0.030619263826160856,0.04373693948363151,-0.0,-0.0
Hormone ligand-binding receptors,0.11208866723269054,-0.0,-0.0,0.2020573410251404,0.157422156927563,0.5131431281007695
Presynaptic phase of homologous DNA pairing and strand exchange,0.11182755318600601,0.08898733212037012,-0.0,0.018310532611142794,-0.0,0.13953155554571375
TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain,0.11171393217297333,0.014739550347242301,-0.0,0.004596083629489832,0.006830958850566317,0.00818294133445916
HIV Life Cycle,0.11162822984867138,-0.0,0.05678391920021756,0.22850946795094346,-0.0,0.4031104303766751
Vpr-mediated nuclear import of PICs,0.11154203540287723,0.01584145178381212,0.007900608287931302,0.2137607975003905,0.15425682939205856,0.0997517554046572
GLI3 is processed to GLI3R by the proteasome,0.11151167703561551,-0.0,0.13987085507119093,0.16820853435664487,0.004135776070430396,0.5118759617514005
Na+/Cl- dependent neurotransmitter transporters,0.1114684253033369,0.013109013807742993,-0.0,0.027663230970374555,0.0008717025353767591,-0.0
FBXL7 down-regulates AURKA during mitotic entry and in early mitosis,0.11125819023263879,-0.0,0.12918541668176278,0.2040215940664887,0.004128320151182039,0.6102076611431912
N-Glycan antennae elongation,0.11124704959802613,-0.0,0.05478650206438258,0.06943777467907555,0.24528201405852354,0.932065018971562
Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5),0.11120051429920864,-0.0,0.18918334940945317,0.1307285091032244,-0.0,-0.0
Establishment of Sister Chromatid Cohesion,0.11105946571333622,0.07413534414100797,0.3943508176449474,0.016770597871466463,-0.0,-0.0
Apoptotic factor-mediated response,0.11102135847633224,0.008298852251433586,0.00040016146977524963,0.1975510617871745,0.0015544554925485175,0.056192911441848875
Synthesis of UDP-N-acetyl-glucosamine,0.11082945847092374,-0.0,0.1926589271919775,0.20937378534695772,0.4254750696799379,0.022547834792218738
Ubiquitin Mediated Degradation of Phosphorylated Cdc25A,0.11068593025073162,-0.0,0.15785147662773236,0.10308483306080851,-0.0,0.6370088755811866
Late Phase of HIV Life Cycle,0.11052255783756434,-0.0,0.06181116889655478,0.20354583614661795,-0.0,0.3536081842409299
RNA Polymerase III Transcription,0.11032941432008699,-0.0,0.01825872971168067,0.3396274543288941,-0.0,0.019507334332378314
FMO oxidises nucleophiles,0.1101814630202695,-0.0,0.12176823400879544,0.07557614173349451,0.01297878222379062,0.017107844956473703
Protein-protein interactions at synapses,0.11004575003965965,-0.0,-0.0,0.10095351828177256,-0.0,0.0392478060833305
Glycogen metabolism,0.11001982979536505,0.1522149230737358,0.35255955455982413,0.14972024754495578,0.35643178567842676,0.35766239535689204
Resistance of ERBB2 KD mutants to lapatinib,0.11001650079556874,-0.0,-0.0,0.26558109502688565,0.23668623667999555,0.006674649286902114
Conjugation of carboxylic acids,0.10993380513391152,0.07550965805743268,0.05498968497081392,0.1620753626204573,-0.0,0.00695517906964978
Resolution of Sister Chromatid Cohesion,0.10988113744917803,0.08614988408413679,0.6051556285987968,0.11652276485949477,0.04895042835363473,0.12494082655219645
Netrin-1 signaling,0.10982860612086685,-0.0,-0.0,0.11108745867994983,-0.0,0.6160930181734735
Activated NOTCH1 Transmits Signal to the Nucleus,0.10981516443279833,0.01550401290156795,0.7294206654658973,0.12163860593093621,-0.0,-0.0
Stimuli-sensing channels,0.10971791371112215,-0.0,0.07290355165819637,0.12111460239783464,-0.0,0.032671097874085876
Telomere Extension By Telomerase,0.10960194254794005,-0.0,0.23996621143786995,0.04675649754808859,0.024819975613590676,0.019111313094602494
Activation of NMDA receptors and postsynaptic events,0.10959478161346291,0.07402660839890372,-0.0,0.005719454266445974,0.0950312946601448,0.7254374786793281
Biosynthesis of E-series 18(S)-resolvins,0.10943455905615104,-0.0,-0.0,0.02523357409920241,0.012041255338828483,0.004336866772020173
Cyclin D associated events in G1,0.1094021872720704,0.010009190982252588,0.2515234244043964,0.0706341048700648,-0.0,0.6389509404570439
Metabolism of water-soluble vitamins and cofactors,0.10937284839788385,0.07832397367404458,0.04068370503514561,0.07726202761207217,-0.0,0.13462353037555574
FGFR1c and Klotho ligand binding and activation,0.10935846353930574,0.017604093148264034,-0.0,0.05780356707987705,0.0004799155469650877,0.0077656457900979
Signaling by Leptin,0.10930352467485102,0.02152880623159697,-0.0,0.006244521768019452,0.021824098723694164,0.1812560155016328
G alpha (z) signalling events,0.10929904292449075,-0.0,-0.0,0.024836544345889906,0.00932379547923751,-0.0
Signal Transduction,0.10927760601098552,-0.0,0.03293506732710314,0.007013733204158945,0.0030288975988306873,0.6130413124634504
Cross-presentation of soluble exogenous antigens (endosomes),0.10923024742122457,-0.0,0.050213028477780655,0.035341731830481206,-0.0,0.6049247322235591
Wax biosynthesis,0.1091800787418814,-0.0,-0.0,0.028025712750789675,-0.0,0.03661484994472676
Acyl chain remodeling of DAG and TAG,0.1089899384925555,0.0007194668740770906,0.041084572999683,0.030404824223347858,0.041794006707327296,0.10542136238390774
Regulation of activated PAK-2p34 by proteasome mediated degradation,0.10898434682052709,-0.0,0.22293470142684868,0.20934750602518723,-0.0,0.6440276688604301
Phosphorylation of Emi1,0.10887124996535338,-0.0,0.38825399745025807,0.04396263318774205,-0.0,0.000701743412484957
The activation of arylsulfatases,0.10876369663309789,-0.0,0.049546695438256044,0.09091219827712926,0.0005003067116985952,0.2319239074340304
Trafficking of GluR2-containing AMPA receptors,0.10873879814274355,0.10096939090990444,0.003953156642863649,0.05194300906228421,-0.0,0.014742677213865607
Programmed Cell Death,0.10866139562514021,-0.0,0.04028299138748767,0.02679165023580245,-0.0,0.49828250720200123
Breakdown of the nuclear lamina,0.10863527339492558,0.01715903378696921,-0.0,0.0009075160832840914,-0.0,-0.0
Ceramide signalling,0.10858694167429217,-0.0,0.024494039547140887,0.017778652237245757,-0.0,0.020997856013598583
Metabolism of polyamines,0.10856348157278699,-0.0,7.83138728386398e-05,0.02635104952095722,-0.0,0.6232924479648893
MyD88:MAL(TIRAP) cascade initiated on plasma membrane,0.10843699590772313,0.08086669073923966,0.3072300807963627,0.0928880553257983,-0.0,0.7068176863909298
Regulation of PTEN localization,0.10841814115226014,0.0290012880645027,0.5981779164719035,0.21095165093222185,-0.0,0.018452277070895987
Metabolism of steroids,0.10841084803182295,0.17880123233275919,0.05514534474996012,0.05314098821747024,0.17165016103623168,0.5361854233694686
Regulation of PTEN gene transcription,0.10834051977435785,-0.0,0.14282989677340371,0.12313021556560574,-0.0,0.005446446377806035
Cam-PDE 1 activation,0.10827117738470153,0.014142909337197808,0.00020263678747183176,0.020428410773639254,-0.0,0.11618449946650292
Trafficking and processing of endosomal TLR,0.10826240015432073,-0.0,-0.0,0.05314868309257641,0.10807759176225323,0.004465124771522865
Cytosolic sensors of pathogen-associated DNA,0.10825905870917443,0.08569263994484481,0.40136366780643795,0.5400534595962239,-0.0,0.47274639227539805
"Platelet activation, signaling and aggregation",0.10824234370891817,0.081748170418212,0.05783125284464113,0.07036911892601612,0.00810171613174769,0.6663270801900909
mRNA decay by 3' to 5' exoribonuclease,0.10806253944045316,-0.0,-0.0,0.006289152152712663,-0.0,0.0933891706049571
ZBP1(DAI) mediated induction of type I IFNs,0.10800734868907211,0.12866060741586183,0.3070092084537211,0.04392472094900458,0.012926044373588253,0.013939482771095154
Heme degradation,0.10798731885092436,0.0014090241126160409,0.19278726225207032,0.15865348610719024,0.09072708995508981,0.029379639354313845
Termination of translesion DNA synthesis,0.10792719719076728,0.02085465208619484,0.33566245397250893,0.2927522703123906,0.0001818729909034646,0.0031571827953297336
Transcription from mitochondrial promoters,0.10790679326010846,0.10264174263031307,0.35514642338494035,0.007629779770424474,0.09151445801448581,0.09281776451707405
Toll Like Receptor TLR6:TLR2 Cascade,0.10777506823658554,0.07738125122573561,0.25864020775212804,0.07078121294019624,-0.0,0.5943413195248196
Regulation of RUNX2 expression and activity,0.10769700803741913,-0.0,-0.0,0.13704316848785855,-0.0,0.5197866225810885
Interleukin-12 signaling,0.10769255006832719,0.014888816975291274,-0.0,0.08441022598787189,-0.0,0.3306932931393834
Prostacyclin signalling through prostacyclin receptor,0.10763503924010662,-0.0,-0.0,0.05453663473850261,0.008463632427314106,0.3343175099620867
Platelet homeostasis,0.1074777451832387,-0.0,0.1256578113990514,0.030229207604608198,-0.0,0.4234368718599037
ERBB2 Regulates Cell Motility,0.10735850241530048,-0.0,-0.0,0.05379753032281027,0.01524095049188479,0.006488449732300985
RNA Polymerase II Transcription,0.1073533641156293,-0.0,0.05507185494668934,0.9701001042889443,0.0909527787735874,0.525919379138439
Transport of fatty acids,0.10727864542776325,-0.0,0.0001655058352072754,0.014617838762129678,-0.0,-0.0
Synthesis of PI,0.1071999530353308,-0.0,0.15638769232635852,0.27417877442862226,-0.0,0.1294753794862729
Diseases of metabolism,0.1071569304099837,0.08300880395507607,-0.0,0.19993989146063876,0.12468878173352459,0.27767636607842394
Regulation of KIT signaling,0.10693245091778211,0.01678183810840041,0.0019454676074523146,0.0918933491954618,-0.0,0.24019176142470974
Glycosaminoglycan metabolism,0.10685322249767586,-0.0,-0.0,0.051333423461830785,-0.0,0.4019086948797353
TP53 Regulates Transcription of Genes Involved in Cytochrome C Release,0.10683383660354225,0.006841057027618906,0.06720889454522788,0.07219012750579352,0.1320533718187156,0.17508852910936917
RUNX3 regulates RUNX1-mediated transcription,0.10681635529126216,-0.0,-0.0,0.12146654873721591,0.010947903008356236,0.036471263175321886
2-LTR circle formation,0.10677295613961908,-0.0,-0.0,0.026882898525059047,0.07989355118179446,0.24669092089779296
IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR),0.10666867976366246,0.0822084017129426,0.23253296137396018,0.017022957739296532,0.0025413662498398157,0.004106153760662332
Synthesis of wybutosine at G37 of tRNA(Phe),0.10624699321567052,0.08121252941885013,0.0631284948377005,0.2722908342483382,-0.0,0.5147139333461036
Regulation of Apoptosis,0.10549921128367849,-0.0,0.22444857428267842,0.1980027389554045,-0.0,0.4994965077552094
Peroxisomal lipid metabolism,0.105393220157242,0.6287164391617651,0.015845365808921673,0.16216560855246087,0.015746305311250923,0.11146800576064265
Mitophagy,0.10525312302373335,-0.0,0.09997405350074848,0.08620645201550742,-0.0,0.10513066618857016
Resistance of ERBB2 KD mutants to sapitinib,0.10484129076811538,-0.0,0.0009890966508238753,0.26543290000932335,0.28565306452165223,0.02861420702191046
NrCAM interactions,0.10445600380449171,-0.0,0.0014325369001779186,0.17373744856252046,0.0023200521947378113,0.10632527847160134
TLR3-mediated TICAM1-dependent programmed cell death,0.10429600879660979,-0.0,0.14782049554669247,0.2948218718923433,-0.0,0.07301672347524003
AUF1 (hnRNP D0) binds and destabilizes mRNA,0.10396473499991192,-0.0,0.13865310815678963,0.2199379780855181,-0.0,0.6453455733527304
Resistance of ERBB2 KD mutants to neratinib,0.10311107481813127,-0.0,-0.0,0.2989686525912789,0.28060917430482013,0.029833539458230713
Digestion,0.10303672466237852,0.0860864682379516,-0.0,0.05332057586329282,-0.0,0.5293641362585709
Androgen biosynthesis,0.10284407914171828,0.08737437494419772,0.798616613458284,0.17422490879886637,-0.0,0.08645849567288595
Deactivation of the beta-catenin transactivating complex,0.10278009454826874,-0.0,0.14606875742805586,0.32798812961053186,0.260112079159154,0.09687894977868859
TRIF(TICAM1)-mediated TLR4 signaling,0.10259377409831318,0.08431479128113759,0.16565194203945938,0.032606305059840086,-0.0,0.6433726732835162
Glycine degradation,0.10258746029992728,-0.0,0.019156120984541003,0.123891095865971,8.981460661763509e-05,0.15917887643977005
Class B/2 (Secretin family receptors),0.10242839120728164,0.05205196875343712,-0.0,0.05356076122361211,0.010819441451883446,0.4424081581483461
SLC transporter disorders,0.10239669189647145,0.03308106918577157,0.10755138605121531,0.13247371293987212,0.006428274013598123,0.05354687188189196
Regulation of mRNA stability by proteins that bind AU-rich elements,0.10189750354001734,-0.0,0.041272436851744906,0.16370675234872364,-0.0,0.6172068238840118
Autophagy,0.10181005834509188,-0.0,0.10223075892450947,0.009006397546876339,0.001126593349939461,0.6264929377360456
MECP2 regulates transcription factors,0.10153607370770672,0.014283388207687592,-0.0,0.1452014586033319,0.011365087295549223,0.16993543452856835
Synthesis of PIPs at the plasma membrane,0.10112370306974536,0.015248185566188701,-0.0,0.012088939788932605,-0.0,0.004655650535702504
PTEN Regulation,0.1007409724083682,-0.0,0.1495143491906969,0.3117586624122489,0.021516412875037975,0.1399700011692469
RAS GTPase cycle mutants,0.10071404645033437,0.0073987973180940254,0.06352407725983092,0.08889680863118934,0.06067887003163368,-0.0
G1 Phase,0.10068541761444672,0.008245347114825833,0.3372426422586439,0.06901550791518682,-0.0,0.6469781440565399
HSP90 chaperone cycle for steroid hormone receptors (SHR),0.10050103273425734,0.08075614410516532,0.1410610931291425,0.19987586748098865,0.014456760617416596,0.534131430073239
ABC-family proteins mediated transport,0.10046104447658649,0.04101518427673217,-0.0,0.24676438604857387,-0.0,0.24415876718023713
Pyrimidine catabolism,0.10035501614591073,-0.0,-0.0,0.05248143470582626,-0.0,0.009539612789439812
PLC beta mediated events,0.09995859224514289,0.014509732954650674,0.19144799391237433,0.012921339678490542,0.00326490216501502,0.12070025804571541
RNA Polymerase III Transcription Initiation From Type 1 Promoter,0.09988112277705542,-0.0,0.05091995879757443,0.2613858710118779,-0.0,0.026537525199417517
DNA replication initiation,0.09960571924089319,0.03749428520555345,0.12655583753015506,0.010228744271631571,0.3582425574449272,0.013830267467841807
Chaperonin-mediated protein folding,0.09958304863009829,-0.0,-0.0,0.02410001023385422,0.019739772404842718,0.4837402604606229
mRNA Editing: C to U Conversion,0.09953935437402212,0.005100053113292885,0.0177696150222716,0.034755333708728076,-0.0,0.3687472352182963
Post-translational modification: synthesis of GPI-anchored proteins,0.09936288234159252,0.015567923364108048,0.051612444832280835,0.03442070534632771,-0.0,0.5004301741859618
Regulation of FZD by ubiquitination,0.09934893642743467,-0.0,0.07338595058627044,0.2088528101287403,0.07449231561649963,0.2321528652022608
Biosynthesis of E-series 18(R)-resolvins,0.09922473973051646,-0.0,-0.0,0.08873107823199453,0.0023454035991282126,0.030796784173040787
Lysosomal oligosaccharide catabolism,0.09917704746019178,0.06421353303385689,-0.0,0.06154040276595916,0.0036433616159395493,-0.0
Formation of the Editosome,0.09893910255227013,0.011026124258024789,0.030522653352172368,0.0348491366771293,-0.0,0.300681939967276
"Metabolism of ingested SeMet, Sec, MeSec into H2Se",0.09886057284709744,0.051711182179395986,-0.0,0.0510848893784862,-0.0,0.02428163522604242
SUMOylation of transcription factors,0.0987560015171423,0.028382491891851318,0.10112619954685248,0.20817557995644623,-0.0,0.10366463130570082
Regulation of cholesterol biosynthesis by SREBP (SREBF),0.09874117340808494,0.03456369722183995,0.36308274859498957,0.2690714551381376,0.09195227319336793,0.6041115008943595
Formation of apoptosome,0.09855085817541023,-0.0,0.002901292478964275,0.011098976328382653,0.0056726003578276285,0.031499868256089164
Processing of SMDT1,0.09853946387899384,-0.0,-0.0,0.27132645698748226,-0.0,0.02625246653017791
Synthesis of pyrophosphates in the cytosol,0.09832568848992185,0.00052830570868674,0.058968304668962024,0.007897557180006419,0.04982192921838312,0.006579060202417543
Diseases of Mismatch Repair (MMR),0.09825895527014866,-0.0,-0.0,0.20051849079449147,-0.0,0.14219475486858338
Transcription of the HIV genome,0.09798809608688529,-0.0,0.0002649450169353575,0.13745781251301947,-0.0,0.2733610560259317
Ion channel transport,0.09796847993631687,-0.0,0.06179608667707717,0.010075932653000464,0.0013086955795036455,0.2403048310453457
Ubiquitin-dependent degradation of Cyclin D,0.0976931101974456,-0.0,0.16635086651225392,0.147787740940597,-0.0,0.42749097468349884
Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes,0.09767943005036986,0.06666573427024315,-0.0,0.0077023844894205315,-0.0,0.25298233763784733
Resistance of ERBB2 KD mutants to tesevatinib,0.0976649937954012,-0.0,0.0015123845633880464,0.30195261658685707,0.2779504333932351,0.007704988013428298
"Activation of NIMA Kinases NEK9, NEK6, NEK7",0.09695682506621589,0.008550370204394614,0.18343470083630006,0.07030609141338665,-0.0,0.33998481417701637
Regulation of Glucokinase by Glucokinase Regulatory Protein,0.09608286505905657,0.018157056360051833,0.05267208836825608,0.11855266812552061,-0.0,0.0022175262102592202
Peptide ligand-binding receptors,0.095972146780207,-0.0,0.7503116291645335,0.05591455670587865,-0.0,0.06210136084031042
Depolymerisation of the Nuclear Lamina,0.09576119975218901,-0.0,0.18128452992776717,0.018043688474744825,-0.0,0.004199530517171989
Signaling by NOTCH3,0.09572175695701397,-0.0,-0.0,0.28130320617447924,0.20336881871032617,0.011352378196754005
"Activation, myristolyation of BID and translocation to mitochondria",0.09555413305242443,-0.0,-0.0,0.19285935859719383,0.000966592977638504,0.004033037595518011
Platelet sensitization by LDL,0.09542416200623806,0.00013776027930098963,0.007697619928196132,0.033217913103259104,-0.0,0.09109807206687678
PPARA activates gene expression,0.09533601135693588,0.08423590767892983,-0.0,0.22245591285587873,-0.0,0.24063576375726708
Ficolins bind to repetitive carbohydrate structures on the target cell surface,0.09522818771959936,-0.0,0.03314222292675052,0.033295676627448624,-0.0,0.2990645500080679
Activated NTRK3 signals through PLCG1,0.09518094520211158,0.05599417217589052,-0.0,0.18308522119122694,0.015524026480602728,0.10381746017119725
Generic Transcription Pathway,0.09517533197707853,-0.0,0.06265228958410338,0.9080302448908183,0.1419944400977149,0.4992301435597651
Plasmalogen biosynthesis,0.09511661146747723,0.05630712569590917,-0.0,0.009997731128086194,0.07043327227629252,0.15935937721679788
mTOR signalling,0.09505925914614757,0.013430959772447333,0.09849492977828551,0.1329395872771206,-0.0,0.4274020890398404
Signaling by EGFRvIII in Cancer,0.09488040689481766,-0.0,0.052615648212776735,0.044005421749212355,-0.0,-0.0
GABA receptor activation,0.09480917602494189,0.08303705412803482,-0.0,0.10353566736656716,0.015944138075372913,0.044961634032315734
Ketone body metabolism,0.09477536876894084,0.01782165420010121,-0.0,0.17331600151535226,-0.0,0.025326680583651943
RUNX1 regulates estrogen receptor mediated transcription,0.09472745675068993,0.07496319690132755,0.016831768067146983,0.04417855528611257,0.011795120113348889,0.01531470475491556
Extra-nuclear estrogen signaling,0.09468196843651423,-0.0,0.09715157392220349,0.033867319168578595,-0.0,0.3693207621239744
Signaling by Activin,0.09427459077114893,-0.0,0.15509275197743935,0.025277200781415394,-0.0,0.02361999043889642
POLB-Dependent Long Patch Base Excision Repair,0.09399606891409357,-0.0,0.010097884476309086,0.20922732408911884,0.0025030208492992038,0.003347713095655733
Biological oxidations,0.09399435055639632,0.6262072045226305,0.07401435118129066,0.07639820277272483,-0.0,0.6356392428648199
Terminal pathway of complement,0.09359299388611317,0.1628317575926662,0.12831962133888994,0.006200778948470162,-0.0,0.12230972676276797
"Synthesis, secretion, and deacylation of Ghrelin",0.09348496197410133,0.04837054227495987,-0.0,0.07226051863297188,0.006784246492835427,0.671448942250051
ATF4 activates genes in response to endoplasmic reticulum  stress,0.09343267241356865,-0.0,0.0746983175167594,0.05167030267314095,-0.0,0.10648262028770657
HIV Infection,0.093205254903304,-0.0,0.03222439575638073,0.2973358561022326,0.007244170525922926,0.497207035087365
RAB geranylgeranylation,0.09315611662041981,0.011512786062457652,0.10566191951214762,0.17571388122287918,-0.0,0.1946700252588502
"Plasma lipoprotein assembly, remodeling, and clearance",0.0930934803713607,0.07546347352415887,-0.0,0.00948748005798112,-0.0,0.007358585631221712
Hydroxycarboxylic acid-binding receptors,0.09307580878011834,-0.0,0.1286425002204672,0.04840834001677047,-0.0,0.25585784693332453
Defective MMAA causes methylmalonic aciduria type cblA,0.09306090550317243,-0.0,0.10926823739322745,0.054513043678895014,-0.0,0.029323956885567156
NGF processing,0.09299991732086532,-0.0,0.0009244020385425346,0.16958568366481097,-0.0,0.03110812787182224
Activation of Na-permeable kainate receptors,0.09293282956304169,0.009063728590994581,0.1376467186379127,0.056741769813199505,-0.0,0.15936885067146056
Highly calcium permeable nicotinic acetylcholine receptors,0.09292156788005197,-0.0,-0.0,0.05304745289507699,0.00017482640123646186,-0.0
BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members,0.09272902468227422,0.08638813235044143,0.018911458614589205,0.11114004344528217,-0.0,-0.0
HS-GAG degradation,0.09271523090205347,0.007299710989361304,0.0006486626570089666,0.1653850654313125,-0.0,0.026645157495009966
Transfer of LPS from LBP carrier to CD14,0.09266631341715902,-0.0,-0.0,0.18237640523738968,-0.0,0.0671127191802216
TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest,0.09261123994115464,0.006336835605575329,0.0220271340510801,0.03291521778925423,-0.0,0.24267967060160198
Host Interactions of HIV factors,0.09254057480418172,-0.0,0.01955779311684997,0.30830535510463825,-0.0,0.3661205115406674
Pre-NOTCH Processing in Golgi,0.09233800989662984,-0.0,0.20948815060712553,0.03274526606705745,-0.0,0.06110365684836887
Defective EXT2 causes exostoses 2,0.09233677998560269,-0.0,-0.0,0.16671542081018023,0.0025519424477347253,0.2545805797635916
"Defective EXT1 causes exostoses 1, TRPS2 and CHDS",0.09232963987185754,-0.0,-0.0,0.15921481282490738,0.007721456440263141,0.212164476399109
Vitamin B2 (riboflavin) metabolism,0.09221695138804517,-0.0,0.4092845121135165,0.03246221300607838,0.010546942953544544,0.49158736341379505
Digestion of dietary lipid,0.09172837375615028,0.01104611150027238,-0.0,0.07224421877078004,-0.0,0.24900126293221814
Signaling by Hippo,0.09151510019215699,0.08309298531971089,0.11668794124914253,0.17710299673892815,1.1924695180007718,0.9273519141824884
Glycogen storage disease type 0 (liver GYS2),0.09136713095741252,0.014558256534066605,5.920301262709381e-05,0.10212245931229645,-0.0,0.09845664464175179
Autodegradation of the E3 ubiquitin ligase COP1,0.09136319081724449,-0.0,0.2260761565911184,0.16988052988653352,-0.0,0.6357679445969467
Suppression of autophagy,0.09058724428875059,0.01774734243014796,-0.0,0.04875890421837812,0.00482083250067983,0.22026830261906535
PI-3K cascade:FGFR1,0.0902316044096201,-0.0,0.054612476462311044,0.03221451172049215,-0.0,0.04873642445791973
Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization,0.09019792511683573,0.008337928541936398,0.01844823842150319,0.20521676877578812,-0.0,0.20101366357813802
E2F-enabled inhibition of pre-replication complex formation,0.08988703086212287,-0.0,-0.0,0.2635013903207665,-0.0,0.054624751975223484
S Phase,0.08956548260214889,0.014217910471827553,-0.0,0.03323030121872075,-0.0,0.6870950015903154
Assembly and cell surface presentation of NMDA receptors,0.08931523896020419,0.015454975985240156,0.005811136328885909,0.05473943820356634,0.11285367321588577,0.6487759751187818
PTK6 promotes HIF1A stabilization,0.08919050217089826,0.007229391966849858,0.14737493875724034,0.032217329051016805,-0.0,0.37766525487244856
Hypusine synthesis from eIF5A-lysine,0.08871264361084413,-0.0,-0.0,0.16376191971388657,0.11551119911110452,0.024097669446209672
Cytochrome c-mediated apoptotic response,0.0885463394465206,0.007615062560152722,0.008149104088582984,0.03516119759577039,0.003272783968124623,0.014201601491457832
NIK-->noncanonical NF-kB signaling,0.08843474111716623,-0.0,0.2523017926978104,0.13414547965466112,0.0035230222994898793,0.6090017984933348
Mitochondrial transcription initiation,0.08764143812627426,0.0877393610097609,-0.0,0.01279326098775574,0.07994471786103768,0.2736976459160346
SCF-beta-TrCP mediated degradation of Emi1,0.0874668758291627,-0.0,0.14693356766463264,0.11049883466901461,0.002651771914905048,0.49197193510070353
Beta oxidation of palmitoyl-CoA to myristoyl-CoA,0.08741918316622706,0.03763046026053177,0.009566516621426081,0.03724321941235277,0.012813696529075862,0.21572481610805289
Cellular response to hypoxia,0.08690736894702669,-0.0,0.04248492151601528,0.16487624515709576,-0.0,0.9255042899335068
Activated NTRK2 signals through CDK5,0.08670262005390252,0.018486434248997527,0.09077329351704018,0.028878413132969988,-0.0,0.09360137221383055
MyD88-independent TLR4 cascade,0.08657285908442298,0.08388852960357576,0.17202989242224853,0.05166011319617788,-0.0,0.645602838185943
Negative regulation of TCF-dependent signaling by DVL-interacting proteins,0.08646569285360567,-0.0,-0.0,0.13939581894750522,-0.0,-0.0
PLCG1 events in ERBB2 signaling,0.08639803793286709,0.01257789196334563,-0.0,0.18410460396808825,0.24788715699858668,-0.0
Dectin-1 mediated noncanonical NF-kB signaling,0.08590634506639862,-0.0,0.2148583149971911,0.1421682517310172,0.0053127405991116265,0.5958186964663974
G alpha (q) signalling events,0.08581161401735156,-0.0,0.25502657295590003,0.03816585330566459,0.00395312295295934,0.3552422376278506
Thromboxane signalling through TP receptor,0.08563484715785431,-0.0,0.19090341226385482,0.06973252781046474,0.055437310297775044,0.6618933446260957
IKK complex recruitment mediated by RIP1,0.08545904742036471,0.01710710548726573,1.0108676667177028,0.24564055856572933,-0.0,0.014187051875688927
Cell Cycle,0.0853513816866914,0.5237805719837264,0.34165220431426646,0.005558815905218531,-0.0,0.43234101654688867
Resistance of ERBB2 KD mutants to trastuzumab,0.08531696993464116,-0.0,0.001225734606554747,0.3008518370534934,0.2930523270588838,0.029362845527224648
Post NMDA receptor activation events,0.0852947033297973,0.03961370154084967,-0.0,0.002929559006752101,0.07417979975933944,0.4966918906125596
G2/M DNA replication checkpoint,0.08501501647875226,0.02671053382228374,0.17040728930660426,0.034218726321255014,-0.0,0.4278592316613915
Resistance of ERBB2 KD mutants to AEE788,0.08470911596988256,-0.0,-0.0,0.28777913772783886,0.27967260806416666,0.025506909361911512
Drug resistance in ERBB2 KD mutants,0.08370095305100368,-0.0,-0.0,0.3039752735173259,0.23414408874980125,0.03021452902616554
Caspase activation via Death Receptors in the presence of ligand,0.08340479927408812,-0.0,0.2856556420262749,0.08362426325827761,-0.0,0.01949047505459659
Defective Mismatch Repair Associated With PMS2,0.08254889223544669,-0.0,0.01927599608573309,0.1434040732547249,-0.0,0.2401420507203557
Agmatine biosynthesis,0.08248159681432499,-0.0,0.0699663526205295,0.11471329553795953,-0.0,0.037317220915143653
Acetylation,0.08212379348074877,0.060579196592726633,0.056244809495443165,0.02722201820643552,0.1083879485972942,0.044001196433236044
EPHA-mediated growth cone collapse,0.08175656539398847,0.07645382393600757,0.07418253922252808,0.08475518089306408,0.37014290806632777,0.4533950697181323
Localization of the PINCH-ILK-PARVIN complex to focal adhesions,0.08172429626395111,-0.0,0.003641552329986118,0.11363850603057925,-0.0,0.4950578121230146
"Cobalamin (Cbl, vitamin B12) transport and metabolism",0.08168486743054464,0.08294827026091917,-0.0,0.02355361456827878,0.030142921321283777,-0.0
Chondroitin sulfate biosynthesis,0.08125474662357286,0.0168109922694452,-0.0,0.010079002648742143,0.01483924684062274,0.24912982530337296
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells,0.0812510060464902,-0.0,-0.0,0.05014215356619063,-0.0,0.06121853451979085
HIV Transcription Elongation,0.08119652933063279,-0.0,-0.0,0.16213826254152708,-0.0,0.0046139894062782565
SCF(Skp2)-mediated degradation of p27/p21,0.0811013651319021,-0.0,0.06984490478201684,0.057638651857191275,0.007779026326931629,0.6894282601219921
Synthesis of PIPs at the ER membrane,0.08095373772539209,0.012588485006704982,-0.0,0.03487212914992812,0.050159816061567594,-0.0
Synthesis of IPs in the nucleus,0.08089487058144837,0.07834399740467818,-0.0,0.004486104816524756,0.005066435968914515,0.10461020277909033
TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain,0.08089202885374032,0.0699196536678757,0.009726328758127418,0.14886810670603426,-0.0,0.10350932695503108
Transport of organic anions,0.08037371462418329,-0.0,0.0429015294879422,0.014336764173521773,0.07872487883862439,0.007268777889378763
Downregulation of ERBB2 signaling,0.08022846666773517,-0.0,0.05300342506311509,0.23961559938510707,0.23722822263667886,0.09847452028737368
Constitutive Signaling by Aberrant PI3K in Cancer,0.08021826745377597,-0.0,0.04736988864959974,0.008588053185766659,-0.0,0.24843526889493237
Resistance of ERBB2 KD mutants to afatinib,0.0800921272624821,-0.0,-0.0,0.2992517912864195,0.28137313317292784,0.006102315905271741
Activation of BIM and translocation to mitochondria,0.07995854663778743,0.015799985322724495,0.08018191498394629,0.00782474269803503,-0.0,0.2431109612141328
Assembly of active LPL and LIPC lipase complexes,0.07956354767349957,0.06573603433642022,0.010254804994888764,0.03928045372287241,-0.0,0.0022071024085695804
Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE,0.07943959709149136,0.039706707509519226,-0.0,0.11144334963408198,-0.0,0.23870899456118122
Glucagon signaling in metabolic regulation,0.07921559290474443,-0.0,0.10860609790252643,0.029199249187871697,0.06835104047390936,0.48672879661933405
TFAP2 (AP-2) family regulates transcription of cell cycle factors,0.07869176061126058,0.0007669915826654186,-0.0,0.06324131211487853,-0.0,0.027011069326476716
Laminin interactions,0.07850406795127875,0.014606859099646824,0.23172121152954103,0.13077849040567122,0.0006234748731093786,0.2416462521846375
Pyrimidine biosynthesis,0.07841069112402571,0.015298111434872643,-0.0,0.206823446861666,0.2803369432334893,0.026857873157976733
Interleukin-36 pathway,0.07839751904200881,0.054417501668640185,0.06338193491008876,0.18557623336660603,-0.0,0.26242018417471275
Initiation of Nuclear Envelope Reformation,0.07839527288962946,-0.0,0.010876233055704674,0.1453806783043508,-0.0,0.02158177951519147
Regulation of TP53 Activity through Phosphorylation,0.07772884720742579,0.14837185677117173,-0.0,0.2739269940662956,0.08434958279324092,0.08020646156968726
Non-integrin membrane-ECM interactions,0.07764549315035094,-0.0,0.0368457041925279,0.09789104451326511,6.581084353784669e-05,0.13666111237264772
Translesion synthesis by REV1,0.07760233664480475,-0.0,0.306086482113941,0.23681885909733144,-0.0,0.6372778542685256
Transcriptional Regulation by TP53,0.07749885485909987,0.10540877671462978,-0.0,0.5204408499729916,-0.0,0.5041658221973383
RNA Polymerase I Transcription Initiation,0.07748718631246705,-0.0,0.015330753327270038,0.17541397567243233,-0.0,0.012423290462388274
PTK6 Regulates Proteins Involved in RNA Processing,0.07747982644596166,0.0748011867559363,0.1066600429152027,0.0012846917549973575,0.12141543177143163,0.39467783999162004
Deadenylation-dependent mRNA decay,0.07740251598854159,0.011016264910281483,-0.0,0.11492881516358609,-0.0,0.006817014216207598
Abasic sugar-phosphate removal via the single-nucleotide replacement pathway,0.07738889638108387,-0.0,0.17399102268071376,0.14137564435554564,0.016326243651039896,0.016316539066967613
Signalling to ERK5,0.07729585381559562,0.016231879938909462,-0.0,0.06181045294057603,0.12677855368074434,0.001961436640373192
Regulation of FOXO transcriptional activity by acetylation,0.07712120856697062,0.050072548837881925,-0.0,0.2418947685822461,-0.0,0.13675977465716116
The role of GTSE1 in G2/M progression after G2 checkpoint,0.07709739537597796,-0.0,0.07515903727894421,0.1495860325339612,-0.0,0.6520835340785183
tRNA processing in the mitochondrion,0.07709225950277686,0.0011511586297419836,0.5363308065874447,0.08970773428883438,-0.0,0.24928009199593992
TP53 Regulates Transcription of Caspase Activators and Caspases,0.07702157277646078,-0.0,0.029807624089958386,0.0350896527111803,-0.0,0.07685797393044526
Metalloprotease DUBs,0.07699825375922409,0.004785095122457842,0.2923860168590615,0.09169019909333635,-0.0,0.21803636900946763
UNC93B1 deficiency - HSE,0.07694890306076287,0.017052252916147054,0.23353846626531102,0.020281007450494028,-0.0,0.09167672874880516
EGFR interacts with phospholipase C-gamma,0.076919434658638,-0.0,0.08722642909274234,0.03555039653473824,-0.0,0.2172689990647244
Macroautophagy,0.07686869337665715,-0.0,0.10885482955420583,0.009231033803158232,0.001051755107082144,0.6251410938750654
Interactions of Vpr with host cellular proteins,0.07637943419672531,0.016762925729852794,0.007305985630664835,0.16932283887210398,0.22518151330055144,0.09819718198059035
Defective MTR causes methylmalonic aciduria and homocystinuria type cblG,0.07628880360752267,0.02859669597994616,-0.0,0.09168341222594621,-0.0,0.2724967585019249
G-protein activation,0.07620885289389737,-0.0,0.5325899306439735,0.027451301927592646,0.12102153175937225,0.5714898131372979
NFG and proNGF binds to p75NTR,0.07606687161713394,-0.0,0.04256808285516719,0.11262524255034805,0.016394751036227482,0.01079924781724016
Vasopressin regulates renal water homeostasis via Aquaporins,0.07605202866458853,0.04075038209324656,-0.0,0.10394953384787968,0.0015200139806887149,0.06501608267909935
Polo-like kinase mediated events,0.07603626098563848,0.014697399163337286,0.7235888615894035,0.1470910531921543,0.1401992668239239,0.18862142990762415
PI-3K cascade:FGFR4,0.07574884744649056,-0.0,0.10451448876919228,0.038758137133164235,-0.0,-0.0
Regulation of RUNX3 expression and activity,0.07571638683915104,-0.0,0.2526970394417799,0.24553756942765326,-0.0,0.30571673700225693
Bicarbonate transporters,0.07562944996828684,0.011592651610374228,0.2542271243108973,0.11667753790222221,0.18758469010432843,0.0036262871688986457
Vitamins,0.07545665356423736,0.008731257923982874,0.007653070933370979,0.01647813805304929,0.020822969688519374,0.024150627121959686
TP53 Regulates Transcription of Cell Death Genes,0.07531555928809135,0.018146407922453436,0.06534389413010579,0.051799955664844036,-0.0,0.13677084468442136
Fructose catabolism,0.07527374201519138,0.015396506456982451,0.010541273063916841,0.11506547003739555,0.10686545168662442,0.025869775390312853
Gap-filling DNA repair synthesis and ligation in TC-NER,0.07516702773938937,-0.0,0.08499063344048631,0.03838448412376528,-0.0,0.7054127304331915
Resistance of ERBB2 KD mutants to osimertinib,0.07497439173055132,-0.0,-0.0,0.3003200904582883,0.2892581914554699,0.026875901009936382
Anchoring of the basal body to the plasma membrane,0.07488391699613081,0.08607944479394394,-0.0,0.2992814756881821,0.024486057362768095,0.01549939720585788
Signaling by MET,0.07486108176382557,-0.0,0.1056092871566667,0.0537860990920054,0.007320813286501554,0.5986372573062199
RUNX2 regulates chondrocyte maturation,0.07473662770267943,0.008567312325916255,-0.0,0.025139030355355488,-0.0,0.2316329935451155
Interleukin-1 signaling,0.07455514088707871,0.08374113351921475,0.13782698776791794,0.07712971983575054,-0.0,0.6427930764423601
PI Metabolism,0.07423341189900892,0.02733640520978775,-0.0,0.05561958914127678,-0.0,0.01103051080829675
CLEC7A (Dectin-1) signaling,0.07404596200027382,0.07281670317885985,0.12847640742358657,0.1425640461175714,-0.0,0.2292327959920907
RHO GTPases regulate CFTR trafficking,0.07385904325190944,0.013846612278272314,0.017461732595761458,0.030504918019607953,-0.0,0.49284281062567054
Disinhibition of SNARE formation,0.07367839787161452,0.07268155669943153,0.032475884803533424,0.011371170899919002,-0.0,0.3690493548102701
Intestinal infectious diseases,0.0734742016394547,-0.0,0.08783761078232295,0.07141860911621593,-0.0,0.008447853418676559
HS-GAG biosynthesis,0.07313588745028084,-0.0,-0.0,0.13067531484700526,0.0013912527703069234,0.32938361187824367
Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha),0.07290568157121512,0.014718657368202954,0.007493122485700264,0.2077692785492799,-0.0,0.31018108748823353
Regulation of innate immune responses to cytosolic DNA,0.072644689020784,-0.0,0.8689553422061651,0.48860467942721886,-0.0,0.020515446978768323
RHO GTPases Activate ROCKs,0.07249438991945527,-0.0,0.01513158110916518,0.18766204288664315,-0.0,0.5100219364972983
Coenzyme A biosynthesis,0.07241443317615504,-0.0,-0.0,0.03785441312207348,0.0008235813684828577,-0.0
Synthesis of bile acids and bile salts via 27-hydroxycholesterol,0.07205391981429131,0.07419656901841927,0.10363357448653518,0.15086862583165847,-0.0,-0.0
CDT1 association with the CDC6:ORC:origin complex,0.07178886549808049,-0.0,0.1951358748076253,0.2234254434560563,-0.0,0.6136570478570057
Translesion synthesis by POLK,0.07151078469208932,0.009969324048148325,0.3316882585993278,0.2127369880030733,-0.0,0.6978336495333869
Defective Mismatch Repair Associated With MLH1,0.07144969765207776,-0.0,0.015754141901127,0.19373117102643586,-0.0,0.24283518342152374
Signaling by plasma membrane FGFR1 fusions,0.07131861126103692,-0.0,-0.0,0.20795036755149207,-0.0,0.5050445009879128
Translesion Synthesis by POLH,0.07106999570377488,-0.0,0.3936981799390867,0.24941320155314395,-0.0,0.1076960045188032
Mitotic G1 phase and G1/S transition,0.0699311045321262,-0.0,0.0013651022989575221,0.010720936016654088,-0.0,0.8178099371645797
Biosynthesis of aspirin-triggered D-series resolvins,0.06982493127482814,-0.0,-0.0,0.007617589581443681,0.1319746522619169,0.02823869902452738
MET activates STAT3,0.06970997314700866,0.08446102032980557,-0.0,0.0924451875196166,-0.0,0.481258027232137
Defective B3GALT6 causes EDSP2 and SEMDJL1,0.06965453502135625,-0.0,-0.0,0.1119801144540488,-0.0,0.11892205304147237
NTRK3 as a dependence receptor,0.06957026009879205,-0.0,-0.0,0.033077184757961745,-0.0,0.018032114139251144
Rho GTPase cycle,0.06956165319637658,-0.0,0.00029883256763401115,0.17114104459821683,-0.0,0.008466581539994454
eNOS activation,0.06942878031053373,0.005715445668558272,0.004311352289200436,0.15820353276295132,0.1583330273814338,0.334505706081506
Nuclear Pore Complex (NPC) Disassembly,0.0693977904132941,0.08527821047081546,-0.0,0.13561961823555965,0.016004768939803564,0.11419047038347158
Gap junction trafficking,0.06933348322794047,0.17980544774560844,0.032947252042308306,0.16525042281143115,0.25411838100283485,0.10040600359127905
Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA,0.06930522563533882,-0.0,0.042492092889253874,0.1437655798076774,-0.0,0.20585940839488334
Arachidonate production from DAG,0.06923168935720767,0.08546837909657432,-0.0,0.15153379299144362,-0.0,0.020435567797460388
Defective CHSY1 causes TPBS,0.06914832341668087,0.08083190073136867,-0.0,0.03669676199640573,0.3108695305427696,0.31149642633610525
Defective GALNT12 causes colorectal cancer 1 (CRCS1),0.06911665235378017,-0.0,0.3319004652604665,0.06568224666075739,-0.0,-0.0
"TICAM1, RIP1-mediated IKK complex recruitment",0.06896217338810638,0.05620276395738612,0.8556397568473494,0.3039253677228439,-0.0,0.005017628297308002
Class I MHC mediated antigen processing & presentation,0.06886816190832339,0.12615404604525637,0.04937220870271744,0.30409651084719264,-0.0,0.38507956025379525
Heparan sulfate/heparin (HS-GAG) metabolism,0.06883074013955898,-0.0,-0.0,0.054634386941515865,-0.0,0.06975293548641169
Expression and Processing of Neurotrophins,0.06877798164258317,-0.0,0.000518610642310357,0.20072368940430657,-0.0,0.03674449194036779
Activated NTRK2 signals through RAS,0.06863155394880946,-0.0,0.12514505916452512,0.052916055767302406,0.01871040213151977,0.019662404043319162
Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC),0.0685986016349957,-0.0,0.16526757607380368,0.07082169955468526,0.021723688282921386,0.007710775894881592
The canonical retinoid cycle in rods (twilight vision),0.06843736335021476,0.008994239593866662,0.05274220658504495,0.049086352513310935,0.08426708791204301,0.6782944263939323
STAT6-mediated induction of chemokines,0.06837752443851627,-0.0,-0.0,0.0919387856216912,-0.0,0.029407672508977713
Gap junction trafficking and regulation,0.06837564834629774,0.3262629018509067,0.07466757777884869,0.10434043049005344,0.45186057995808765,0.09100435161478325
NOTCH1 Intracellular Domain Regulates Transcription,0.06819412078773522,-0.0,-0.0,0.1988406010451108,-0.0,0.28758925631294885
Recruitment of mitotic centrosome proteins and complexes,0.06818002931043222,0.08387872087404943,0.0025028386007383938,0.28713932419879895,0.007078283312460305,0.0037949168444328203
Arachidonic acid metabolism,0.06807506328717401,0.014859687913710593,0.019971555615290217,0.047778253725929205,-0.0,0.05582429718868254
Hh mutants that don't undergo autocatalytic processing are degraded by ERAD,0.06805419443790754,-0.0,0.1656325043967011,0.12869706022513117,0.009461503685737737,0.6147002442807578
VEGF ligand-receptor interactions,0.06800321070415409,0.02826950141909121,0.10013830994952941,0.17248209076818374,0.1301489148328413,0.6993260458332674
"Defective B4GALT7 causes EDS, progeroid type",0.06784640333461099,-0.0,-0.0,0.11439001782796245,-0.0,0.12952267960772534
OAS antiviral response,0.06770601737963668,0.10238293752435726,0.15869422775455433,0.29769280451932445,-0.0,0.021719143225706082
Vesicle-mediated transport,0.06761344684630634,0.7135232364520258,-0.0,0.581388165382905,0.09390243036980822,0.745958246847326
N-glycan trimming and elongation in the cis-Golgi,0.0675024399194536,-0.0,0.09552629475001627,0.04394825828320628,0.000202178939563271,0.49530680137330685
Transport of nucleotide sugars,0.06734208911395578,-0.0,0.10858978811763015,0.017071069315670765,0.24838129427106034,0.09096302441463289
Amino acids regulate mTORC1,0.066778433978536,0.056247778305532806,0.06238752466025878,0.05100774728670134,0.0004587512029266438,0.2440510874930366
Acetylcholine regulates insulin secretion,0.06639977999442909,-0.0,0.02193947036074265,0.009500693688886789,-0.0,0.1260024278594661
Diseases of signal transduction,0.0660661239306733,-0.0,0.04390435341521414,0.3073378742208896,0.003695784984604539,0.5751692002114341
CREB3 factors activate genes,0.065889931073735,0.011373254490626651,0.01774089183040606,0.21076342650762805,0.00900657887915557,0.013091788457956352
Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET),0.06578197051256993,0.016732959034451537,0.3148506056216486,0.2673490442243517,-0.0,0.08692840287110437
RNA Polymerase II Pre-transcription Events,0.06563578877074916,-0.0,0.00010683194374804496,0.19811629893177093,-0.0,0.4202029144627206
Smooth Muscle Contraction,0.0656337646373465,-0.0,0.40248325962619325,0.1910977423562678,-0.0,0.039010319124664496
Diseases associated with glycosylation precursor biosynthesis,0.06557658241646641,0.01648503240117003,-0.0,0.17724784677814726,-0.0,0.2408642035819976
Activation of PUMA and translocation to mitochondria,0.06532450453526983,0.07837047621379165,0.05460803722518311,0.03795723242270605,0.008167955107839742,-0.0
Glyoxylate metabolism and glycine degradation,0.06525168849779002,-0.0,-0.0,0.03354174254631798,-0.0,0.24746406891317896
TP53 Regulates Transcription of DNA Repair Genes,0.06522589277994267,0.021635169687722427,0.0009287428411021443,0.15092123623427783,-0.0,0.1956586722408981
Phospholipid metabolism,0.06509958442040176,0.08457248079978794,-0.0,0.248370621390223,-0.0,0.01922715429322561
Intrinsic Pathway for Apoptosis,0.06496821688537599,0.018768533017813508,-0.0,0.07150829124513233,-0.0,0.4327191206239007
Biosynthesis of protectins,0.06442895024788992,0.016339212368458655,-0.0,0.2053381871812566,0.025093281888533842,0.02144623815792533
Cardiac conduction,0.0643064535387964,-0.0,0.7432909427026233,0.06768010023821064,-0.0,0.48608553511488556
Cation-coupled Chloride cotransporters,0.06413641045194561,-0.0,0.06328215815108677,0.027455222120421507,-0.0,-0.0
Recycling pathway of L1,0.06405740442569104,0.028197212151401148,-0.0,0.20962860430042746,-0.0,0.24136631738019967
TAK1 activates NFkB by phosphorylation and activation of IKKs complex,0.06385624214142777,0.1806671961394943,0.11738898763995721,0.1374584972166848,-0.0,0.12338361733492724
Metabolism of cofactors,0.06376747327253839,-0.0,-0.0,0.008116861506309733,-0.0,0.7364319727231127
Oncogenic MAPK signaling,0.06368507202321004,-0.0,0.11029133816651454,0.2937535993832225,0.011913631930607833,0.03043658765992468
O2/CO2 exchange in erythrocytes,0.06353087107546727,0.08595231808220076,0.13815567708726628,0.1585573531003223,-0.0,0.48915747790599534
Potassium Channels,0.0634659832975683,0.05683008052073581,0.014777451968668929,0.19288898275693397,-0.0,0.5366522608565778
SUMOylation of SUMOylation proteins,0.06335069025852848,0.015460676515096184,0.009034533120120312,0.17118837172092546,-0.0,0.10980844213349589
Regulation of RAS by GAPs,0.06318711403699794,-0.0,0.10974980386171053,0.302078974012627,-0.0,0.4328279122270477
Glucuronidation,0.06305328970229135,-0.0,-0.0,0.11354574577362052,-0.0,0.401691230120354
Vitamin D (calciferol) metabolism,0.0629409605401423,-0.0,0.09896721580662084,0.0353882992115075,-0.0,-0.0
Glutathione synthesis and recycling,0.06292033435640686,0.01612115834535308,-0.0,0.18571932004752692,0.08001278598750218,0.5016786359142448
Defective CD320 causes methylmalonic aciduria,0.06291474631932276,-0.0,0.05883915754932261,0.09664471462591748,-0.0,0.1115158766173496
Budding and maturation of HIV virion,0.06278534314612598,-0.0,0.389095585451316,0.11317918289056245,-0.0,0.33002788986046805
Formation of HIV-1 elongation complex containing HIV-1 Tat,0.06273964708078446,0.04879553109156289,-0.0,0.11086025032897404,-0.0,0.010659429505985292
Signaling by FGFR3 point mutants in cancer,0.06271690817670038,-0.0,0.16971028346942013,0.16697013929910787,-0.0,0.0032833599800888664
Transcriptional  activation of  cell cycle inhibitor p21,0.06236852307335384,0.07945401375228772,-0.0,0.019768582831590775,0.019821431923283703,0.10323779511890516
Synthesis of substrates in N-glycan biosythesis,0.06234500237516476,-0.0,-0.0,0.05207550409060113,0.43247052996158414,0.20463830707036812
NCAM signaling for neurite out-growth,0.06200330482789126,-0.0,0.16666652769440055,0.1124830294318844,-0.0,0.011835644216343614
GRB2:SOS provides linkage to MAPK signaling for Integrins,0.06194730423931845,-0.0,0.6315694533238396,0.16361809478419626,0.11047666232236762,0.00377042402194067
Signaling by EGFR in Cancer,0.06192038274639685,-0.0,0.2448532516086206,0.2295881535169796,-0.0,0.07398954015015101
Export of Viral Ribonucleoproteins from Nucleus,0.061894507891870995,0.07979661196329828,0.061968473884756035,0.14143456716471792,5.9946825337805666e-05,0.1312267719250729
VEGF binds to VEGFR leading to receptor dimerization,0.061725407082057246,0.017560400673852387,0.11547297701730164,0.15689948105224996,0.16591349476800396,0.6560487308575611
Nitric oxide stimulates guanylate cyclase,0.06170990483113405,-0.0,0.6082999633461325,0.06595683561678152,0.00836354588206848,0.057306055063985756
A tetrasaccharide linker sequence is required for GAG synthesis,0.06169637881069808,-0.0,-0.0,0.052627476248600306,-0.0,-0.0
Synthesis of active ubiquitin: roles of E1 and E2 enzymes,0.061690034157606655,-0.0,-0.0,0.08738315791086934,-0.0,0.21053178861180863
ABC transporter disorders,0.06163797991546331,-0.0,0.030768037928289294,0.18210056343059755,0.012976030619404796,0.2716195098307423
Insulin processing,0.06163634841307557,-0.0,0.015271240303789466,0.054095986763015864,-0.0,0.3824126144271767
Defective MUT causes methylmalonic aciduria mut type,0.061624181616659536,-0.0,0.098062438470219,0.05414574128475633,-0.0,0.02287496690882525
Transport of Ribonucleoproteins into the Host Nucleus,0.061606865410909525,0.06163809027520463,0.04055655700102309,0.16423419567290742,0.08812022870172662,0.015393310836175374
Signaling by PTK6,0.06151380647793576,0.07816979309231802,-0.0,0.17456899388186,0.11910431875190608,0.5191432681089646
Telomere C-strand (Lagging Strand) Synthesis,0.06150807320973567,0.012773973533229427,0.03945758270806636,0.09462824008760141,-0.0,0.02001681591675572
Signaling by FGFR3 in disease,0.06142836992082149,-0.0,0.14912000463587902,0.14599229670980046,-0.0,0.0042646724372117275
NEP/NS2 Interacts with the Cellular Export Machinery,0.06142444637501421,0.047628176171980126,0.07255221545894693,0.10155130803879518,0.006332081067183226,0.12715191638939588
DNA Damage Reversal,0.06142138344977727,-0.0,0.31842878766445776,0.13320960929015788,-0.0,0.0024025651996223375
"Sodium-coupled sulphate, di- and tri-carboxylate transporters",0.061397172284771276,0.008229823316852911,0.01017160906130431,0.00404257307657587,-0.0,0.27198943972631495
Biosynthesis of maresins,0.061395073518677075,0.0808545756628441,0.8798880297049233,0.2171227061689319,-0.0,0.15107034362198132
M Phase,0.061361675308415346,0.20777621312872993,0.19312399361004434,0.198667659953218,-0.0,0.3354484416526958
Defective NEU1 causes sialidosis,0.061331742269148344,-0.0,0.055369164593509095,0.1419002884301295,0.0011962544380894654,0.02962099421481197
Mitotic Telophase/Cytokinesis,0.0613316578427135,0.015554368089464105,0.35097452579340793,0.023410172155944823,0.005683567125019561,-0.0
Erythrocytes take up carbon dioxide and release oxygen,0.061327511067384426,0.08749318484668497,0.1791907346165257,0.15027737534872215,-0.0,0.4817287946132251
SUMOylation of immune response proteins,0.06131787926913396,0.015767822230865786,0.10889518578207921,0.2480865057066609,-0.0,0.016041917488876237
Organic anion transport,0.061309686270373254,-0.0,0.4315495263442041,0.19843495234017747,-0.0,0.08331700192151509
Transcriptional activation of p53 responsive genes,0.061294146497312185,0.07879986366282613,0.009728569279609196,0.022101104910425586,-0.0,0.11072305632476372
CYP2E1 reactions,0.06124230154268967,-0.0,0.9037058040890434,0.03424371670265153,0.04223051915113529,0.016086512573346937
SUMOylation of DNA damage response and repair proteins,0.06124108450601212,0.08404918083234979,0.10263121174187563,0.148159758239316,-0.0,0.004220455262524538
ERK/MAPK targets,0.06117419907440292,-0.0,0.0038841251834111196,0.13870779866138003,-0.0,0.4690406034816867
TFAP2 (AP-2) family regulates transcription of growth factors and their receptors,0.06114168321602274,0.007574617050938613,0.11018065169617484,0.11219143838703553,0.28575658261687803,0.19454091980705054
Developmental Biology,0.061141656513631154,0.7262062957344372,0.05499749095512267,0.006242273096568733,-0.0,0.4982953842872346
Sulfide oxidation to sulfate,0.06111645975998501,0.01599376283660652,0.01673246471441857,0.18281448156186786,-0.0,0.09745906406269965
Ca2+ pathway,0.06107192811246225,-0.0,-0.0,0.1403804115365793,0.010833324019534586,0.16632308133140405
Cohesin Loading onto Chromatin,0.06097192868228272,0.06053169495241132,0.10692051875131021,0.015501650789059233,0.023286968691768904,-0.0
Abortive elongation of HIV-1 transcript in the absence of Tat,0.06096970505678185,-0.0,0.0014318369694668717,0.05205003894733346,-0.0,0.00619892413940179
Assembly of the pre-replicative complex,0.060917454107386707,-0.0,0.09721097486263945,0.24520858805866644,-0.0,0.42208324632896943
Serotonin receptors,0.060902594013643896,-0.0,-0.0,0.17837839865908067,-0.0,0.012074225627902153
Defective AMN causes hereditary megaloblastic anemia 1,0.06086084494764156,0.021509313900756725,0.08551762919431624,0.15587237132864046,0.2279711474820002,0.02786073601676055
"SUMO is transferred from E1 to E2 (UBE2I, UBC9)",0.060851740245082275,0.006902649756795167,-0.0,0.1045002004705344,-0.0,0.7808596572190244
Aflatoxin activation and detoxification,0.06084768066876653,0.012060151077619152,0.0005402878924102776,0.1030203183124254,0.041879078598120706,0.12615331137970826
Degradation of beta-catenin by the destruction complex,0.06084046794984633,-0.0,0.06340738085145624,0.24994522496097274,-0.0,0.5119776425060358
NS1 Mediated Effects on Host Pathways,0.06082877262622517,0.018997906267976435,0.01010453744282175,0.30687480236261927,0.04177121117786922,0.03295839782427841
NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis,0.060798349373309774,0.031578372160842756,-0.0,0.1368033349196473,-0.0,0.22889987276934798
Crosslinking of collagen fibrils,0.06077058725721886,-0.0,0.2950273714202722,0.02970390797421861,-0.0,0.01982392390512662
Defects in cobalamin (B12) metabolism,0.06074407451826582,0.05269048141510946,-0.0,0.009530685907567985,0.12987129579498127,0.019488179268760304
Gene expression (Transcription),0.06063891274335842,-0.0,0.045185759324083086,1.074091162455572,0.08968543746293556,0.6204380051769918
Histamine receptors,0.060624917985704886,0.040260792561201575,0.015543465810412474,0.08443954160890248,-0.0,0.0807919446321963
Nuclear Events (kinase and transcription factor activation),0.06054393936452738,-0.0,0.0002447441559805221,0.05830409912355114,-0.0,0.6049516140994685
Reversible hydration of carbon dioxide,0.06047220317421994,0.055709610628748796,0.1088231141840345,0.026154824436847628,-0.0,0.30020596114067044
E3 ubiquitin ligases ubiquitinate target proteins,0.06044674747307789,0.018025400979971445,-0.0,0.17603032793408716,0.07844926317033109,0.1753189095300013
Signaling by FGFR in disease,0.06041087839592507,-0.0,-0.0,0.16704604104898924,-0.0,0.33316800917687217
Chondroitin sulfate/dermatan sulfate metabolism,0.06040766830168025,-0.0,0.018978447766684826,0.11130637637129283,-0.0,0.0697217469046875
"Synthesis And Processing Of GAG, GAGPOL Polyproteins",0.0604024922519092,0.012626881293801046,0.6297723911509023,0.2971227471921541,-0.0,0.028520472563157234
N-glycan antennae elongation in the medial/trans-Golgi,0.06039521196285649,0.01485496501656322,0.07262312581843847,0.06540856268502365,0.1281608015180958,0.4974441937845842
Dual incision in TC-NER,0.06037604912113313,-0.0,0.1280473929953381,0.03562427008371007,-0.0,0.6715559597511449
G1/S Transition,0.06035329080944434,-0.0,-0.0,0.09880810156170146,-0.0,0.7395072433304037
Cargo recognition for clathrin-mediated endocytosis,0.06031806112314955,0.07766309587592879,0.17425372813510942,0.18179621130687948,-0.0,0.6233918081412645
Interleukin-1 family signaling,0.06031302478500626,0.076606544670909,0.09202934671247757,0.058329380360908525,-0.0,0.40258919178950264
Biosynthesis of D-series resolvins,0.060202390004139,-0.0,-0.0,0.06729940481208178,0.1460181078459204,-0.0
Defective ABCA1 causes Tangier disease,0.06016393453899302,0.008231854255658198,-0.0,0.012906655540875967,-0.0,0.09714395533353552
Scavenging by Class A Receptors,0.06014913890393677,0.005043876450264932,-0.0,0.04384874509761871,-0.0,0.3480974945013149
Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS),0.06006138959127042,0.00596238508530162,0.07125864908923427,0.012580267764286793,-0.0,0.26876263424745284
Activation of NOXA and translocation to mitochondria,0.060039841456779666,0.07789589747779493,0.5344162062114676,0.1472069405422406,0.07788604128584414,0.04976729203189542
Transport of Mature Transcript to Cytoplasm,0.06002968559584172,-0.0,0.10862355004794731,0.19077597065790133,-0.0,0.19459860386317893
Negative regulation of FGFR2 signaling,0.059974358808695574,0.007956149494475881,0.30467299876439496,0.3060019643059536,-0.0,0.2865835459084592
Glycogen synthesis,0.05978510176652663,0.08134454771865637,0.4157265594869948,0.16955953403396534,0.23028371686543825,1.23790784677618
Physiological factors,0.05967185474153631,-0.0,0.507562855211931,0.018298745220825745,0.1295108081892469,0.003413433882190393
NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,0.05963485411784168,-0.0,0.050241173554667166,0.28908632877946233,-0.0,0.18802488449532762
Association of TriC/CCT with target proteins during biosynthesis,0.05958278793391233,0.085955230554675,-0.0,0.017181542424780687,-0.0,0.14173779418609228
"Cell Cycle, Mitotic",0.05940920318281152,0.15437256151815143,0.3649124937641173,0.0065778969866554645,-0.0,0.3853015267346453
Regulation of PLK1 Activity at G2/M Transition,0.05937849098164955,0.05177683218633358,-0.0,0.2896346898511601,0.008152631023494403,0.02273331198451589
MAPK targets/ Nuclear events mediated by MAP kinases,0.05930534074540073,-0.0,0.1012444740143475,0.05078068567315142,-0.0,0.9345645624577646
RUNX3 regulates YAP1-mediated transcription,0.059286207770466545,0.08170947170578155,0.3734074889924271,0.1975228021285875,0.44219574814361495,0.7022636362178973
Viral Messenger RNA Synthesis,0.05911261404218514,0.008710640040046841,0.08544755038907774,0.07220289667322714,-0.0,0.19505575891952126
Proline catabolism,0.05908600176856539,0.04729659119287093,0.05420495888069475,0.04981408044101284,-0.0,0.0014864811211672624
Ion homeostasis,0.0589380468446362,-0.0,0.4261002835279959,0.05181548938799441,-0.0,0.5956541014533152
Keratan sulfate degradation,0.058907192414047786,-0.0,-0.0,0.17841942970775193,-0.0,0.7178233260285076
RNA Polymerase III Transcription Initiation From Type 2 Promoter,0.05886224560338065,-0.0,0.05897467288320654,0.2453128708355501,-0.0,0.025179053461323844
Chaperone Mediated Autophagy,0.05883621866822908,0.01138725575359903,0.22888722961640814,0.18707875538025653,0.009487349707292234,1.0802780428313965
Defective B3GAT3 causes JDSSDHD,0.05882410332791106,-0.0,-0.0,0.09150547951180568,-0.0,0.15639392825937978
Small interfering RNA (siRNA) biogenesis,0.058805012062003045,-0.0,0.0001585066264422275,0.03541578665797666,-0.0,0.1869888969686838
Host Interactions with Influenza Factors,0.05879191905262237,0.017597360864322745,0.00923220606731486,0.27176934479925113,0.013272113453791376,0.01427242609898048
Sema4D in semaphorin signaling,0.05878412960296174,-0.0,0.015760565542611862,0.016920805220817736,0.011784992024268548,0.2312655219373471
Rap1 signalling,0.058722647056824895,0.01867715285047995,0.10440957670688077,0.13814466248988597,0.0008588797644576963,0.023302381584456563
Adenosine P1 receptors,0.05865073587842877,0.08995669181700222,0.08246878947167914,0.09772961395934023,0.10861533721621155,0.4975667143275926
DNA Damage Bypass,0.05850629971769199,0.05564111560191651,0.07595702359183083,0.2492261262606534,-0.0,0.12827543143933237
EML4 and NUDC in mitotic spindle formation,0.05850467501237011,0.027602714701063125,0.41045286034260164,0.1182218764007319,0.12167552800285608,0.271929245139751
Regulation of gap junction activity,0.05847021789785495,0.075644582904403,0.030424579741656247,0.014069244573928292,0.09594270169621623,0.007768330887519071
Intrinsic Pathway of Fibrin Clot Formation,0.05835429699939775,0.0216064306634081,0.0060048387663877755,0.029310461890605346,0.0008528535760221769,0.09924872611121807
Fatty acids,0.05831926089421855,-0.0,0.016068245227567092,0.0511969827673367,-0.0,0.003808962049340058
Formation of Senescence-Associated Heterochromatin Foci (SAHF),0.05830057079601483,0.016979797933874052,-0.0,0.028344181719564203,-0.0,0.00781980877059024
NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose,0.05829987456919944,0.01913570842305682,0.018386371837345,0.0542323962976274,-0.0,0.015219544179572957
Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling,0.05792810645355438,-0.0,-0.0,0.09064497887739117,-0.0,0.2688661757892536
Biosynthesis of DPAn-6 SPMs,0.05792140670310387,0.010992429911781738,-0.0,0.16570584440835637,0.024160085461196978,0.01372853749720182
FBXW7 Mutants and NOTCH1 in Cancer,0.057816671243283484,-0.0,-0.0,0.07579724567524335,-0.0,0.24389646225198508
Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta),0.05775242413546209,0.016884984776338336,0.005010555628255614,0.15416282646774024,-0.0,0.13435758410929216
Pentose phosphate pathway,0.057646708828117885,0.03386381611390887,-0.0,0.21029248336605336,7.113591512398233e-05,0.3469841364809105
Signaling by Hedgehog,0.057645790221629446,0.05212971382870092,0.03019107468660337,0.13312478687041904,0.005526508693757015,0.2355548151333675
G beta:gamma signalling through PLC beta,0.05755303681563475,-0.0,0.16551871995321024,0.030683988968472475,0.032173026107398986,0.24092738148041945
Defective ABCG8 causes gallbladder disease 4 and sitosterolemia,0.057389229752596665,-0.0,-0.0,0.08341609199878289,0.011061651970715403,0.03899919360050848
Loss of Function of TGFBR2 in Cancer,0.05729186109875589,0.015000162875458169,-0.0,0.20156384674848146,-0.0,0.18144704911046025
MET receptor recycling,0.057229682954926725,0.00614692218706239,0.09800054868340083,0.05480529259123428,-0.0,0.08307496915528309
Regulation of signaling by NODAL,0.05718815155964589,0.009252009130107212,-0.0,0.23306763600684216,0.16347926771671673,0.008521934575821821
Calnexin/calreticulin cycle,0.05699123066763914,-0.0,0.04221434655465304,0.24647997383655101,0.014904890225504851,0.0765373330107053
Gluconeogenesis,0.056854817704090156,0.0783286721322667,0.03798521030738854,0.07598943119401723,-0.0,0.12314951836075522
Binding of TCF/LEF:CTNNB1 to target gene promoters,0.05684951095065486,-0.0,0.04167662746036093,0.174564750169068,0.2769406054110507,0.19592700416494116
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),0.05656014655990167,-0.0,0.1696853575829338,0.027567298381982328,-0.0,0.723153428596685
Axonal growth stimulation,0.05641973507731635,-0.0,0.0005204665395815475,0.20105883010650366,-0.0,0.052375790385969075
The phototransduction cascade,0.0563673126908537,-0.0,0.009733932608775352,0.006665177031684134,-0.0,0.04448934035617951
Interactions of Rev with host cellular proteins,0.055295092071966014,0.08079123080331709,0.05568717431718277,0.035353961638625565,0.007538393955749405,0.19494733906421646
Kinesins,0.055193808050711966,0.08877659115855141,0.6424986257344476,0.10506205243191682,-0.0,0.27265545963692295
Activation of NF-kappaB in B cells,0.05465156638718148,-0.0,0.23157033306410593,0.1365730250885965,-0.0,0.6110344018674986
TRAF6 mediated NF-kB activation,0.05372607838038875,0.21357961299457906,0.04362539817452765,0.09946440889702418,-0.0,0.02482314025759427
Hedgehog 'off' state,0.053681977557901564,0.016554063359323995,0.03981289017087432,0.17621260892501933,0.01340848543776934,0.24701233848491247
Integration of energy metabolism,0.05356806579119262,0.0806534522265573,0.10776851866585932,0.03316665689773697,0.01266848018524057,0.3389990448038023
Electric Transmission Across Gap Junctions,0.05338023928218102,0.084606836625913,-0.0,0.05716193082361922,-0.0,0.610711573997293
Membrane Trafficking,0.05335022256625086,0.6075839069021691,0.0007072836658596177,0.5999547612853717,0.12740032889888211,0.7553621768364508
Diseases of Base Excision Repair,0.05274446831680772,-0.0,0.34242397251937823,0.016628407591645373,-0.0,0.0173747124829783
G-protein beta:gamma signalling,0.052507923779970704,-0.0,0.09152341514364126,0.046347389969523825,0.04148222177581189,0.10956613819856058
Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA,0.05235783888390028,-0.0,0.00013447137060570833,0.1191492440558946,-0.0,0.08462696703308435
TRP channels,0.05214879948336121,0.013319122486896961,0.10907508734549981,0.05471160554604655,0.007538225913536776,0.026407301911050434
Scavenging by Class H Receptors,0.05181744105708554,-0.0,0.125114961236681,0.00861666795870609,-0.0,0.17973724089114285
Heme biosynthesis,0.051798545404816335,0.011773133108671965,0.103392719851056,0.22350793194012247,0.03055680097262494,0.016300925900961872
SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs,0.05167595059208213,-0.0,-0.0,0.024767948812006932,0.0018593523358599853,0.007869515432272918
Hydrolysis of LPE,0.051673552796363084,0.006381675600042488,-0.0,0.10789566603611082,0.0415107521141346,0.10055360498387005
NGF-independant TRKA activation,0.051526627330703026,-0.0,-0.0,0.17798727199382916,-0.0,0.31003334195020416
"Inactivation, recovery and regulation of the phototransduction cascade",0.051384774725684534,-0.0,0.008951653632436347,0.007241017043493704,-0.0,-0.0
Ion transport by P-type ATPases,0.051373524585004104,-0.0,0.09749914814866774,0.008014469040154144,0.0024738247701064655,0.6074555292499791
UCH proteinases,0.05125951104629355,0.013922625005779484,0.09740361210204285,0.16296819764811432,-0.0,0.49683555415948655
Intraflagellar transport,0.05086465196551568,0.07739064159758595,0.23733026915202374,0.112559429944914,-0.0,0.4269660074163892
Downstream signaling of activated FGFR3,0.05085232574074953,-0.0,0.09682362544893199,0.08858677741858026,-0.0,-0.0
Regulation of the apoptosome activity,0.050843445141549246,-0.0,0.00406185516937298,0.006759083580289434,-0.0,0.028399133267512196
CaMK IV-mediated phosphorylation of CREB,0.0508090959402176,-0.0,-0.0,0.03457758885275673,-0.0,0.15093375184545374
Tie2 Signaling,0.050446403903836916,-0.0,0.29506050688291763,0.12222756238148684,-0.0,0.21426943851123287
FRS-mediated FGFR1 signaling,0.050376054461599144,0.006123642642900409,0.028039285111303852,0.1638442074636335,-0.0,0.06615958979371772
Hh mutants abrogate ligand secretion,0.049736239272002034,-0.0,0.14287163616349371,0.09212891185628246,-0.0,0.6098775348570968
RUNX3 regulates NOTCH signaling,0.04966719972491082,-0.0,-0.0,0.07722389259419342,0.04374962265314107,0.09801421244389871
Cellular hexose transport,0.04936514671849611,0.007885879325317402,0.0066760603891890605,0.07193592404811051,0.23988456187540644,0.420628880584958
MECP2 regulates transcription of genes involved in GABA signaling,0.04927010804210082,0.0371725947906536,-0.0,0.010707320589397693,-0.0,0.14532220474636395
Golgi Associated Vesicle Biogenesis,0.048716671842902695,0.08328413232319808,-0.0,0.031453919814893115,0.04445465688647263,0.49596432107603655
Phenylalanine metabolism,0.04831511838328302,0.06741451406123183,0.11506358255926688,0.054637332371788735,0.00026523539009078775,0.1979282744281704
SLBP independent Processing of Histone Pre-mRNAs,0.04810104344052405,-0.0,-0.0,0.016926451845182926,-0.0,0.027364047628885287
Defective ABCG5 causes sitosterolemia,0.048080513360091795,-0.0,-0.0,0.07593708488512196,0.01050911089234533,0.03259945113801912
PI3K events in ERBB2 signaling,0.048038670375426126,-0.0,-0.0,0.11220640411143065,-0.0,0.04752865572509915
Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS),0.047963405666142066,0.10586708420617769,0.16702924669125963,0.06786662917180232,0.03629544929757095,0.0055006624309759545
Activated point mutants of FGFR2,0.047818169868017166,0.011797073335641948,0.07912898301603583,0.24609031914151427,-0.0,0.09287012572932478
Alpha-protein kinase 1 signaling pathway,0.04765088108793512,0.005561838599196136,0.241468920597062,0.3849301654604916,0.2309021388148214,0.01726495644177135
Diseases of glycosylation,0.0476159470955744,-0.0,0.028395145691379336,0.11207364415243584,-0.0,0.588242510503875
Defective CFTR causes cystic fibrosis,0.0474891355378123,-0.0,0.13963686460657967,0.20604166772024501,0.009575752227599207,0.5182483644426589
Transcriptional regulation of white adipocyte differentiation,0.04726046406027301,-0.0,-0.0,0.29988653325112946,-0.0,0.31775399356254996
Recruitment of NuMA to mitotic centrosomes,0.04710673378796638,0.09911069895801336,-0.0,0.24735465945443105,-0.0,0.0219871927877827
Phospholipase C-mediated cascade; FGFR4,0.046660611892050854,0.014934377527236798,0.10413852281726324,0.11859252404910416,-0.0,0.003998422828840349
Resolution of Abasic Sites (AP sites),0.046637904350174154,-0.0,0.22458705216201091,0.034537641839547564,-0.0,0.006485420894089616
TYSND1 cleaves peroxisomal proteins,0.04657015697508642,0.07307814059554536,0.008918844694091417,0.17847147609909195,0.04566158513085133,-0.0
Disorders of transmembrane transporters,0.04650022374381322,0.0642232371012127,0.04222001714994478,0.2003850499789184,-0.0,0.2458439696197194
mTORC1-mediated signalling,0.04630800221919068,0.00047347549674335695,0.11011630704766559,0.007521717428673211,-0.0,0.3475062929574384
Hedgehog 'on' state,0.04623048613936046,-0.0,0.03639432120291877,0.05656354230558493,-0.0,0.42737861432171
Josephin domain DUBs,0.04577076142958657,-0.0,0.3028574951684554,0.24342880709212028,0.0011082058608998847,0.009016170755885261
Defective CUBN causes hereditary megaloblastic anemia 1,0.04565612386734785,0.04682545059277184,0.017578754386843143,0.1397795228939054,0.1041110140986144,0.02608527253322856
Formation of HIV elongation complex in the absence of HIV Tat,0.045610809733421624,0.07508649731265117,-0.0,0.16473398019110452,-0.0,0.01294104982665265
Stabilization of p53,0.045540942863927646,-0.0,0.11064809805248982,0.16460148939711008,-0.0,0.49348904815775907
TWIK related potassium channel (TREK),0.045054581028264144,-0.0,0.1088573017339695,0.03521314569598732,-0.0,0.15967738391929484
Cargo concentration in the ER,0.04486327404726539,0.08834426851007307,-0.0,0.15457269255496237,-0.0,1.1024213714421118
PCP/CE pathway,0.04478182876318414,-0.0,0.23991861865395223,0.17635321692728034,-0.0,0.6337732557153747
PI3K/AKT activation,0.04477598578254423,-0.0,0.03912063467039811,0.16409034627993557,-0.0,0.10398574315414685
Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol,0.04467834182886322,0.06927870685262653,0.04121708625269741,0.03869878951360741,-0.0,-0.0
Membrane binding and targetting of GAG proteins,0.04447744026395221,0.011828268490298204,0.734737577345077,0.29651286923838843,-0.0,0.02427451947484058
Activated NTRK2 signals through FRS2 and FRS3,0.04439360312815467,-0.0,0.008423060208229234,0.05319717940955761,-0.0,0.0329160417654319
p75NTR negatively regulates cell cycle via SC1,0.044208342541172035,-0.0,0.00577470224163909,0.1489603109394894,0.0922536801068285,0.02277144177606298
Inhibition of Host mRNA Processing and RNA Silencing,0.04415008562534947,0.007819439627533805,0.0697229626062013,0.026576478398827243,-0.0,0.005351681023123681
Conjugation of phenylacetate with glutamine,0.04402841736785184,0.05757928367765958,0.04282671078139164,0.19365060875056128,0.0005810602810681164,0.3113614915011462
FOXO-mediated transcription,0.04396842007794885,-0.0,0.05298766819466888,0.30062619020500625,-0.0,0.67519623682173
Mismatch Repair,0.04361428086750682,0.010575314726194707,0.007330926166474401,0.18966647287317306,-0.0,0.15891489496065964
Presynaptic function of Kainate receptors,0.04344045776993049,-0.0,0.11677401354030216,0.07493054680024047,0.020690162986037618,0.2419872199816642
RHO GTPases Activate Formins,0.04306216827821868,-0.0,0.11614564835969504,0.10061947502011118,0.07573176796582372,0.18125808864931742
Processive synthesis on the C-strand of the telomere,0.042580452954534456,0.08354056339515693,0.032780106890686694,0.05985958897035345,4.958501453731025e-06,0.11112809928518369
Inhibition of TSC complex formation by PKB,0.04254345136272375,-0.0,0.001255337904209795,0.24946660523998196,-0.0,0.0028354026623795816
Highly calcium permeable postsynaptic nicotinic acetylcholine receptors,0.04249167078696149,-0.0,-0.0,0.02076653281815595,-0.0,-0.0
Signaling by Non-Receptor Tyrosine Kinases,0.04224287626741687,0.1274502945102121,-0.0,0.17024016959534338,0.09104448315678945,0.5368533653530231
ATF6 (ATF6-alpha) activates chaperone genes,0.04186833380712851,-0.0,0.043644884913166905,0.23817905171791015,-0.0,0.156578117417688
Activation of BH3-only proteins,0.041859807169894965,-0.0,0.06299622829079018,0.009350142661863108,0.13226965173079613,0.6259898719293331
Tyrosine catabolism,0.04179561567210746,-0.0,-0.0,0.009676532598767816,-0.0,0.006204707505295144
Metabolic disorders of biological oxidation enzymes,0.04140881255685096,-0.0,0.028434623413420256,0.07635134736673015,0.060526026050936335,0.22422291072490153
Centrosome maturation,0.041367938862321214,0.08208586269644529,-0.0,0.26898947703790865,0.013581500458405654,0.024724975832186104
Toxicity of botulinum toxin type G (BoNT/G),0.04133729147854192,0.011395186222078675,0.2719546543960026,0.10431320764243317,-0.0,0.04321418833366601
COPI-independent Golgi-to-ER retrograde traffic,0.041212397163541,-0.0,0.0813628265032852,0.15029408108417353,0.09489062518473523,0.7492307728228143
DARPP-32 events,0.041115011164707546,-0.0,0.06441365049880612,0.02915492048200611,-0.0,0.0061937928109782785
TICAM1 deficiency - HSE,0.04111351746389586,0.01549695754152236,0.21395493716026653,0.012806862661139812,-0.0,0.1115415257432237
"Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA",0.04084696512427175,-0.0,0.0010308995361475385,0.02715250378022123,-0.0,0.2463507605947726
mRNA 3'-end processing,0.04083764711206049,-0.0,0.06395617105191656,0.0913814596544807,-0.0,0.4972232474901644
Regulation of commissural axon pathfinding by SLIT and ROBO,0.04081219528749384,0.02233458518801183,0.14242917524144852,0.16516250194417517,-0.0,0.006065088004807198
TP53 Regulates Transcription of Death Receptors and Ligands,0.04080097017006265,0.010623219022476135,0.06302552517046794,0.017019349572305487,-0.0,0.023365519549753095
Tat-mediated elongation of the HIV-1 transcript,0.04068612068567353,0.03898460731663556,-0.0,0.1004283124454511,-0.0,0.00634765756853159
Toxicity of botulinum toxin type E (BoNT/E),0.040666002121163,0.08461134270149435,-0.0,0.048751124422413666,0.012997253971555192,0.269605104073558
RNA Polymerase II Transcription Termination,0.040647034888280975,-0.0,0.03436724678322335,0.028961108436175654,-0.0,0.3661671308459418
Beta-catenin independent WNT signaling,0.040549724575445006,-0.0,0.22798473741253833,0.20747025651681528,-0.0,0.5531813690118872
"Transport of bile salts and organic acids, metal ions and amine compounds",0.04040570365951206,-0.0,-0.0,0.03177587958249579,-0.0,0.1310246548509278
Metabolism of ingested H2SeO4 and H2SeO3 into H2Se,0.04037996880256032,-0.0,0.18904029323967655,0.18144687952854832,-0.0,0.6409747528252414
Viral RNP Complexes in the Host Cell Nucleus,0.04035006494289007,0.017312028517160856,-0.0,0.14907124145013725,-0.0,0.19305863350149258
Activation of Matrix Metalloproteinases,0.04033832515624293,-0.0,-0.0,0.008304354346261911,0.019747513003920886,0.16185974279891352
Erythropoietin activates STAT5,0.04033122113728251,-0.0,-0.0,0.016874041302752614,0.0024706921045158092,-0.0
RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs),0.040280775607986284,-0.0,-0.0,0.04511371276171807,0.08559664747075736,0.13556686730494974
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer,0.040223093754397046,-0.0,0.047696330528842416,0.14961472413655286,0.0009006339909036012,0.12698559847780042
Nucleotide-like (purinergic) receptors,0.040205656431440626,-0.0,0.10035227278691167,0.20365782452139533,-0.0,0.016808360551380994
Constitutive Signaling by NOTCH1 PEST Domain Mutants,0.040131475061284554,-0.0,0.03265442484205805,0.1995566359166812,-0.0,0.09829480259918416
AURKA Activation by TPX2,0.04012844786083204,0.05748002402172155,0.016778676267548875,0.24613882381698024,0.02141420790147617,0.007370604430243737
Vitamin B1 (thiamin) metabolism,0.04010317954446343,0.014768085055306988,-0.0,0.010496109823520897,-0.0,-0.0
Switching of origins to a post-replicative state,0.04009394450321296,-0.0,-0.0,0.13788777951796144,0.0009810704107200416,0.6365138448551131
Receptor Mediated Mitophagy,0.04008689860872649,-0.0,0.02750618332357244,0.07076772420503237,0.01789647492768817,-0.0
Signaling by BRAF and RAF fusions,0.039941539069484014,-0.0,0.15470888269897493,0.20580980509411742,0.0010339300393176546,0.01060867158989536
Selective autophagy,0.03992000819817482,0.025617788111795405,0.10426440941277852,0.20494656424279936,0.008192172994232763,0.6407936568997302
Mitochondrial Uncoupling Proteins,0.039918389465888944,-0.0,0.017493055320445528,0.008222738089322574,-0.0,-0.0
Diseases associated with O-glycosylation of proteins,0.03989891990191573,-0.0,0.1386945993498851,0.05033737302540243,0.12344803953202378,0.27702606343528
Orc1 removal from chromatin,0.0398538558386862,-0.0,0.062436477878852426,0.299137238464133,-0.0,0.6486671097913046
Free fatty acids regulate insulin secretion,0.03950788362491528,0.0012326563863274069,0.34141293963256875,0.023520111322947967,-0.0,0.5513371809940514
Reactions specific to the complex N-glycan synthesis pathway,0.03935478509940162,0.008976349027627641,0.04548445985841144,0.19846804930235704,0.0066449227469788244,-0.0
Processing of Capped Intronless Pre-mRNA,0.039260410651975206,-0.0,-0.0,0.035525656982517494,-0.0,0.24254452389090145
Removal of the Flap Intermediate,0.03923834343934146,0.08486886420548041,0.17016355003465986,0.017632322879559847,-0.0,0.0950076021697946
Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6,0.039096873705605155,-0.0,-0.0,0.17977208371456144,0.06404886065176943,0.13412627629308327
COPI-dependent Golgi-to-ER retrograde traffic,0.03886887507763059,0.08477710041310144,0.3994605770481532,0.04399000760469061,-0.0,0.5315258973905426
Events associated with phagocytolytic activity of PMN cells,0.03880569309882325,-0.0,0.054942294126564394,0.06676447818574976,-0.0,-0.0
Formation of Fibrin Clot (Clotting Cascade),0.038800046105186316,-0.0,0.19151859441692926,0.19768884556095018,0.001862609091035589,0.020672026533671076
Formyl peptide receptors bind formyl peptides and many other ligands,0.03864403258322818,0.015548026934534316,0.22453671525272434,0.29610954963626923,-0.0,0.37771615428210464
Diseases of Cellular Senescence,0.038558203967969724,-0.0,-0.0,0.16172369965695835,0.05963389631044012,0.13872353211036526
Transport of Mature mRNA derived from an Intron-Containing Transcript,0.038447403052961494,-0.0,0.1355837902144893,0.21057359167828427,-0.0,0.018452572866052324
Common Pathway of Fibrin Clot Formation,0.038395336201695884,-0.0,0.09585152879563615,0.19385430629902958,-0.0,-0.0
"Regulation of glycolysis by fructose 2,6-bisphosphate metabolism",0.03822311687464484,0.08803542492611104,-0.0,0.02527043263842289,-0.0,0.024696559523727544
ARMS-mediated activation,0.03815906944516671,0.023764247160957708,0.006222261985878746,0.030498958192640487,0.0063915677926879915,0.011689651621964224
Transcription of E2F targets under negative control by DREAM complex,0.038094718359054786,-0.0,-0.0,0.18059885241561405,-0.0,0.48945265923519116
Translesion synthesis by POLI,0.03808023077803334,-0.0,0.34540277819620346,0.23223723293176204,-0.0,0.6111237591982592
Erythropoietin activates Phospholipase C gamma (PLCG),0.03805422778333,-0.0,0.11394274756241955,0.064846837116366,-0.0,0.028280071851386892
PECAM1 interactions,0.038046241102211054,0.0008569965288572908,0.006972357375445152,0.17056539924702666,-0.0,0.2745473309655455
CS/DS degradation,0.03799635309146763,0.08151744032380935,-0.0,0.03412820482227097,0.09553047558313248,0.18509067286126907
Formation of the HIV-1 Early Elongation Complex,0.03792045606550535,0.054227411419548135,-0.0,0.13340294444872422,-0.0,0.09263381124740512
Retrograde transport at the Trans-Golgi-Network,0.03782495998439666,-0.0,0.01870183826082558,0.14646246607820304,0.2855851115115618,0.1578526194181362
Evasion of Oncogene Induced Senescence Due to p16INK4A Defects,0.037823254783297476,-0.0,0.0009855728971329084,0.15040910395987556,0.13912332103687125,0.13930718264879036
Thrombin signalling through proteinase activated receptors (PARs),0.03781758165941095,-0.0,0.2495881225476119,0.1693315756835563,0.004743496734148908,0.7486485108249489
Sialic acid metabolism,0.03779497044210822,-0.0,-0.0,0.11302383985376557,0.005547411293408818,0.5900653065127452
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants,0.03778198979870653,-0.0,0.043249850558078735,0.21614153844239384,0.010102795389010046,0.11353601424774545
Rhesus glycoproteins mediate ammonium transport.,0.03772699019890432,0.0058553410986422975,0.03725688745984123,0.1322095219280682,0.12086332308293464,0.24062055693805376
NOTCH4 Intracellular Domain Regulates Transcription,0.03769411256145996,-0.0,-0.0,0.04652041122299343,0.2339671178791359,0.11217384596955529
Formation of the Early Elongation Complex,0.03764345576549963,0.04495400526698008,0.0003325907970600505,0.11385930803364448,-0.0,0.09159384072088844
Opsins,0.03756651305480608,0.01790882455714201,-0.0,0.20043265004560165,-0.0,0.034001370400391806
Golgi Cisternae Pericentriolar Stack Reorganization,0.03756600183541891,-0.0,0.5698150227830403,0.04396985146734892,-0.0,0.24107018146958425
MAPK6/MAPK4 signaling,0.03755785716930595,-0.0,0.019208993350116124,0.27688368122769264,0.014695323830951509,0.648839654987414
Regulation of necroptotic cell death,0.03751757539600012,0.009282499915674315,0.8548630899387504,0.2508249654671447,-0.0,0.09836318575168734
Receptor-type tyrosine-protein phosphatases,0.03734551640160417,-0.0,-0.0,0.026669317166684286,-0.0,0.12653356498940127
Anchoring fibril formation,0.0373449644045377,0.015382015842819096,0.34303340746702116,0.18030039483805155,-0.0,0.0007985592361620895
Histidine catabolism,0.037146335962229646,-0.0,0.034153952613889524,0.019152941271466446,-0.0,0.017323620585072776
Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes,0.037141756936673286,0.005415225583989868,0.038883619794410275,0.1545296149201616,-0.0,0.2421186519518141
O-linked glycosylation,0.03711951998779256,-0.0,-0.0,0.11768455947413124,0.1750491001544787,0.5143292804416923
Erythrocytes take up oxygen and release carbon dioxide,0.03711295744866299,0.024909948319631437,0.16644620632639467,0.18683904553600378,-0.0,0.46858196246469574
SUMOylation of intracellular receptors,0.037025597760255366,0.01558631226249835,0.09974653807720886,0.2328078767814681,-0.0,0.020738260082469998
Fructose biosynthesis,0.03696575499796027,0.005392661722145627,-0.0,0.08343913484385539,-0.0,0.0320345535842137
Fatty acid metabolism,0.03693326864532554,0.7416183202757772,-0.0,0.017976732969027277,0.06135686414060596,0.16846761826466394
TRAF6-mediated induction of TAK1 complex within TLR4 complex,0.03688459694264224,-0.0,0.5583881476664792,0.2866749024079211,0.060549225925429176,-0.0
FGFR2 ligand binding and activation,0.036739163388292785,0.01330363064850542,0.03951145225768249,0.2056435657384854,-0.0,0.5019399222464267
Formation of tubulin folding intermediates by CCT/TriC,0.03664469500946212,0.0883314769128146,0.0147991953479479,0.015415902800148075,0.12407818798874327,0.9381529943458939
Nuclear import of Rev protein,0.03651699701247244,0.07933016603115461,0.1275531251513186,0.034462157652223074,0.05024107287486533,0.1117199086168414
NF-kB is activated and signals survival,0.03643209956893922,-0.0,0.2526124717213583,0.23077941510545338,-0.0,0.00899548747000191
PI3K events in ERBB4 signaling,0.036421241634983746,-0.0,0.009880849654827438,0.20384267251315955,-0.0,0.0032341142587555952
ARL13B-mediated ciliary trafficking of INPP5E,0.0363808647775318,0.034467433118956586,0.07402520151545512,0.10719326672029368,-0.0,0.49722227133551206
trans-Golgi Network Vesicle Budding,0.036374065647339804,0.09251412200757272,-0.0,0.03462759203738799,-0.0,0.46578366480172056
ER Quality Control Compartment (ERQC),0.036341263619749146,-0.0,0.077122443130747,0.21293868696731516,0.015259934286017466,0.08355872639989118
Platelet degranulation,0.03624521585803411,0.08496137716398168,0.04805754221685336,0.050332469906464256,-0.0,0.6993094046901251
Regulation of HSF1-mediated heat shock response,0.03622876425167797,0.0798632350939089,-0.0,0.2405707262442466,-0.0,0.47610134667989185
MAP3K8 (TPL2)-dependent MAPK1/3 activation,0.03612138721619629,0.03565330888680011,0.786159510617583,0.23817621824641966,-0.0,0.00970755960257258
SLC-mediated transmembrane transport,0.03611746013788852,0.07851750212763275,0.008925024292956397,0.03543898278258903,0.28532580026936794,0.24437550682728448
Interaction between PHLDA1 and AURKA,0.03609108378505395,0.008593627870943584,-0.0,0.21093973684932818,0.12269853472854622,0.2590046755474774
WNT mediated activation of DVL,0.03608013701419471,-0.0,-0.0,0.03596729469064022,-0.0,-0.0
SDK interactions,0.036059656741470617,0.005128303965383078,-0.0,0.09049395320951961,-0.0,0.2415094365889615
Biosynthesis of maresin-like SPMs,0.03594542801425316,0.005125972455223655,0.5331974895314793,0.17480255805975348,-0.0,0.10026747848098855
Toxicity of botulinum toxin type A (BoNT/A),0.03566396238823892,0.08100948943340695,-0.0,0.010841182057777801,0.015742974328312943,0.4952824495234074
Glutamate Neurotransmitter Release Cycle,0.0355557337317392,0.07330638923390628,0.018021833525541354,0.015739745760429694,-0.0,0.09795220583693066
Integration of provirus,0.03553583694522936,-0.0,0.09706083393870585,0.05233137306851721,0.13061933793804217,0.4800790053149588
Enzymatic degradation of dopamine by COMT,0.035464441420277486,0.04007040089650844,0.002640129073978793,0.0703764405338059,-0.0,0.21427097399807854
Phase I - Functionalization of compounds,0.03535801016781652,0.08297911700227535,0.2363840203541187,0.03543643646656764,-0.0,0.0900358991197223
Dopamine clearance from the synaptic cleft,0.035322557024537925,0.04043052757526554,0.0021094249331956665,0.08755250050594764,-0.0,0.17368718186458423
CASP8 activity is inhibited,0.03518062461683439,0.0019521623217857715,0.22299448155474325,0.050602178906859856,0.02027228741914483,0.008183835201385967
Nuclear signaling by ERBB4,0.03509940712574897,0.042162538308456,-0.0,0.20281564522833295,-0.0,0.2993949638106612
NTRK2 activates RAC1,0.03500020436596964,0.007544660564719951,0.2226656981090532,0.17502669963209636,-0.0,0.7050613228855115
Activated NTRK2 signals through PLCG1,0.03492378991850493,-0.0,0.3091305706972132,0.17251814347255712,0.014584206634785329,0.09976293622407509
Processive synthesis on the lagging strand,0.03485925683587998,0.08027236989247695,0.09425125268979667,0.03263813508875008,-0.0,0.0280454441913543
Signaling by NOTCH1 in Cancer,0.03483539341909118,-0.0,0.04269941553083843,0.15034889265499465,0.014470198585983578,0.10976933728680364
DNA Replication,0.0348231420653987,-0.0,-0.0,0.006479256745980927,-0.0,0.4876496163806599
Regulation by c-FLIP,0.0347107169438153,0.0005097717337669884,0.16923173690284862,0.05152635839492532,0.0012608006262922317,0.0038905718060074828
TGFBR2 Kinase Domain Mutants in Cancer,0.03468793286806005,0.01115106449742635,-0.0,0.20492687087070272,-0.0,0.18872196485459836
Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects,0.034451918100184116,-0.0,-0.0,0.17016469125277653,0.062307868710994634,0.13643356988777666
"Adrenaline,noradrenaline inhibits insulin secretion",0.03438467640322673,-0.0,0.24293447146873243,0.11086635972172264,0.013698361918356204,0.12963537825340862
Glycerophospholipid catabolism,0.034294488664148616,-0.0,0.019140001488101972,0.17208355460810948,-0.0,0.027947428250831814
Signaling by NOTCH1 PEST Domain Mutants in Cancer,0.03422873695854402,-0.0,0.041847656255249145,0.17557006662260816,0.010781120936348424,0.10417191486044187
Modulation by Mtb of host immune system,0.034201123898265566,0.00014544784676289672,1.0393859827483263,0.300873734405668,-0.0,0.4227245721256763
TWIK-releated acid-sensitive K+ channel (TASK),0.034112744877576,-0.0,0.1679950909431008,0.2008482361450235,0.012456672585559712,0.187231301557022
Uptake and actions of bacterial toxins,0.03383991495806607,0.01897380967602971,0.01835476333157314,0.19125781797773175,0.009431297658305703,0.43009384976663523
RIPK1-mediated regulated necrosis,0.03374845238798021,0.006817990143223683,0.8839890166507207,0.2382178400209751,0.01789626235835797,0.005284444232780222
Hedgehog ligand biogenesis,0.03368940488871846,-0.0,0.14469288608305578,0.09116354686710097,-0.0,0.366848718485355
Regulation of localization of FOXO transcription factors,0.03367409166519777,-0.0,-0.0,0.2225826495133492,-0.0,0.6585929224276391
Loss of proteins required for interphase microtubule organization from the centrosome,0.033502395589206604,0.08370159352699393,-0.0,0.2749463482859472,0.012903817086104889,0.013786336848882988
Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase,0.03339824586781518,-0.0,0.02115534989908485,0.19678342393020717,0.046931847617660304,0.21266841001861964
PERK regulates gene expression,0.03326712067245853,0.01035026394955251,-0.0,0.006715240936365706,-0.0,0.11173140193607149
"TICAM1,TRAF6-dependent induction of TAK1 complex",0.03324671907156698,0.00039795492680378905,0.882952499917588,0.4776597734615157,0.31768454921982986,0.43082201324442776
Metabolism of vitamins and cofactors,0.03321694400412374,0.07664684948903887,0.012305487263719973,0.096966455346738,0.0013707902345855402,0.31973891632588336
p53-Dependent G1/S DNA damage checkpoint,0.033158816640965164,0.014558576653961364,0.02696224674172714,0.1366403709785081,-0.0,0.609034478262085
Signaling by Ligand-Responsive EGFR Variants in Cancer,0.03312519172352479,-0.0,0.344155869588411,0.29578440424396535,-0.0,-0.0
RET signaling,0.033036188404261924,-0.0,0.06241743440999192,0.07667927003169357,0.004640544928777819,0.014412155646919153
FGFR2c ligand binding and activation,0.03299439499699806,0.012219677371688034,0.14798738403582504,0.1760975291226993,0.0006482253484823218,0.008891250520285042
Defective Mismatch Repair Associated With MSH6,0.03297204741717395,-0.0,0.04233032774105278,0.1012916755569685,0.00015759456990260788,0.24313405602175833
Glycosphingolipid metabolism,0.03294665993481265,0.015054611674812729,-0.0,0.11335107358934539,0.0014070125625907544,0.28944298354734316
Transport of inorganic cations/anions and amino acids/oligopeptides,0.0328733631678609,-0.0,0.016645213622145445,0.06539828433400977,0.11433573127004835,-0.0
Invadopodia formation,0.03287238139028623,-0.0,0.0416409057880829,0.0035265885521479703,-0.0,0.025467333195632914
Defective Mismatch Repair Associated With MSH3,0.03286683659709415,-0.0,-0.0,0.007480731168743624,0.008828257237724537,0.028489712603739753
Neurotransmitter release cycle,0.032748234555383574,0.08109918246777144,-0.0,0.1581385290295578,0.1397814374048197,0.6087420527874953
Tachykinin receptors bind tachykinins,0.032690429992210786,0.009796364711206137,0.11021753063835178,0.0016863455673717543,-0.0,0.3850492747397662
Caspase activation via extrinsic apoptotic signalling pathway,0.03257497150531935,-0.0,0.18019437657197282,0.051117186983274075,-0.0,0.01147594650262642
TGFBR2 MSI Frameshift Mutants in Cancer,0.03244485297120528,0.008372401503778139,0.030763471204035307,0.11326591134394486,-0.0,0.2985270889064474
Calmodulin induced events,0.03241884201646367,0.04966204326408911,0.15262953934471957,0.00968997803539561,0.00027094109342042094,0.18900193288766318
Regulated Necrosis,0.03239272229992039,0.007428069004195653,0.8676271040219029,0.24378324008609356,0.013089222843528195,0.005547181844779165
Removal of the Flap Intermediate from the C-strand,0.03230684007043831,0.08088468997337184,0.0951697471362844,0.05256540135782321,-0.0,0.24273913954028303
Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages),0.03230261468603371,0.01574585945307004,0.019768895026895255,0.05493918975050134,-0.0,0.009713949912931534
Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum),0.03228302374406424,0.015274230218960957,0.018632709396911997,0.057753812595409994,-0.0,0.0031890419898173597
Activated NTRK2 signals through FYN,0.03223943773722989,0.009808721936211032,0.45560322615196563,0.14946953810369795,0.01398943146345968,0.6714433309726036
Gamma-carboxylation of protein precursors,0.03214561688056799,0.004555034551754087,0.0034863514936466678,0.010433282585554433,-0.0,0.22656752648307382
IkBA variant leads to EDA-ID,0.03210806131727297,0.07820930026134326,0.07401964295155197,0.04329380635432876,-0.0,0.017968908086402884
Ligand-receptor interactions,0.03207458092379443,-0.0,0.017175231010951194,0.20783004772465433,5.084631548698615e-06,0.027620320421699783
Rev-mediated nuclear export of HIV RNA,0.0319650271197128,0.04962528325647479,0.07563566233529616,0.03764429036306133,0.028501125977927394,0.21823651561169818
Cell junction organization,0.03184667583522653,0.061763491580506306,-0.0,0.07033699565308654,-0.0,0.48380661897313687
WNT5A-dependent internalization of FZD4,0.03184079690016725,-0.0,0.2512533379714255,0.043608796390381344,-0.0,0.01638126492568135
Post-translational protein modification,0.031719119359533185,0.6856085757498518,0.016638407970940215,0.007630990607720382,0.02824998494184611,0.7509977802319584
Beta oxidation of myristoyl-CoA to lauroyl-CoA,0.031700648150308514,0.08860398577581781,0.2528632110242049,0.05257927704045832,-0.0,0.4981186534478776
Urea cycle,0.03163443340891332,-0.0,0.0012731166389846067,0.04655828239956252,0.006771733966957002,-0.0
Early Phase of HIV Life Cycle,0.03153265027402242,-0.0,0.0038537942539524713,0.15332273231842408,0.07453277079668065,0.6045294230510369
Disease,0.031493342414210986,-0.0,0.0412294220023798,0.010092123209053545,-0.0,0.8839421717647713
G protein gated Potassium channels,0.03145636905596833,0.01541693370224163,0.22602275935586394,0.18423631204142224,-0.0,0.24692557089339429
Clathrin-mediated endocytosis,0.03142486352365009,0.173498215252503,0.06275280440330407,0.24593532353519684,-0.0,0.6211813951991645
COPI-mediated anterograde transport,0.03130231144419682,-0.0,0.16273797610988622,0.10976449386153801,0.06307200211769734,0.5290470015057367
HDL assembly,0.03108991737224992,0.016904804054460643,0.16907368616170856,0.09500711032789223,-0.0,0.1320567194416715
Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,0.0310432752983188,0.07524926803829933,0.59328546227604,0.028272962412835202,0.0770737751656106,0.6536953517538667
Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus,0.030991694905384965,-0.0,0.05602292093413316,0.011102284900468357,-0.0,0.11317825383715568
The fatty acid cycling model,0.030577934366824468,-0.0,0.008460773274339993,0.007498146226219841,-0.0,-0.0
Antigen processing: Ubiquitination & Proteasome degradation,0.03035500210606801,0.08072606887530857,0.03359972346845328,0.27304861487100096,-0.0,0.344019322984889
Ca-dependent events,0.03015804136630982,0.016200037718266173,0.39573675972533934,0.029573866724400627,-0.0,0.22974980710905565
Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1,0.030118348955762847,0.015991370282009764,-0.0,0.1960378995627845,-0.0,0.00229595796687921
Release of apoptotic factors from the mitochondria,0.029942277101007882,0.06102410742666655,0.0005352042050083793,0.17435110839175236,-0.0,0.02704220461829955
Mitochondrial iron-sulfur cluster biogenesis,0.029923278613422297,0.0157935822622207,0.006237754990672867,0.06635588403329348,-0.0,0.045505358910946384
Apoptotic cleavage of cell adhesion  proteins,0.029894576194918938,0.07984869195940156,-0.0,0.20320652088491425,0.43056634661653126,0.757972628906138
APOBEC3G mediated resistance to HIV-1 infection,0.029885261736785313,-0.0,-0.0,0.05260178708953481,-0.0,0.7035339617622441
MET activates PTPN11,0.029860284538449383,-0.0,0.09464175516669644,0.03594153243177155,-0.0,0.051284842701294776
Cross-presentation of particulate exogenous antigens (phagosomes),0.02962899945788406,0.01863066450917921,0.0409092617438146,0.20827305335160307,-0.0,0.5118371886259503
Signaling by NOTCH1 HD Domain Mutants in Cancer,0.02948511160693088,-0.0,0.8408043682231571,0.21367194724450278,0.0085655936091968,0.03337417274617865
Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6,0.0294093382155333,-0.0,-0.0,0.16670583333340033,0.13039839873714815,0.15810242779387873
NRIF signals cell death from the nucleus,0.02924845606362174,-0.0,0.5140586759569401,0.2523522800351799,-0.0,-0.0
Defects in biotin (Btn) metabolism,0.02910043304145954,0.07878335868288062,0.1049763000441159,0.16757224484823588,-0.0,0.2725181181425792
Serine biosynthesis,0.029095155076699835,0.015406151913760463,-0.0,0.02348203888105562,-0.0,0.3384158381555505
Lipophagy,0.0288444739970967,0.07672353037226293,0.11056918710772565,0.0062221847152209055,0.17616152854412231,0.23953800179059365
TWIK-related alkaline pH activated K+ channel (TALK),0.028540067326890087,-0.0,-0.0,0.19084536138577926,0.12281764218908701,0.005995002229142073
NR1D1 (REV-ERBA) represses gene expression,0.028494675725686987,-0.0,0.22472368476748586,0.0042630091475848704,-0.0,-0.0
Synthesis of DNA,0.02826906275718703,-0.0,-0.0,0.018769628216536632,-0.0,0.49475993346796016
Defective ABCC6 causes pseudoxanthoma elasticum (PXE),0.027983417089265744,-0.0,0.06513837713695533,0.19110974662186966,-0.0,0.062079744948522114
Regulation of TP53 Expression,0.02740589499812271,0.01415483371635489,-0.0,0.19650762191523302,-0.0,0.044581195591058935
Cyclin A/B1/B2 associated events during G2/M transition,0.02680657477664152,0.013027399439856242,0.04392041894081667,0.0066514508290709965,-0.0,0.6500787020215265
Conjugation of benzoate with glycine,0.026323867754002847,0.08601417770153341,0.001014466349354009,0.17001247643324705,-0.0,0.029329571478544213
Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK),0.026080565095084933,-0.0,-0.0,0.1846386456636015,-0.0,0.49543305280821065
Amine ligand-binding receptors,0.02589462026494304,-0.0,0.19544224877657113,0.09675831285005249,0.036226321240266986,0.006020056879080188
Ca2+ activated K+ channels,0.025238429763883997,-0.0,0.0535963016116308,0.09114026789860605,-0.0,0.025965842460895474
FRS-mediated FGFR3 signaling,0.024790753888488042,0.0017025748462562097,0.07082968716767395,0.17030145100750604,-0.0,0.012178278756008316
SUMOylation of RNA binding proteins,0.024547988355651782,0.016296772708454157,0.052117416438721,0.0921073007460683,-0.0,0.24257739380432736
Downstream signaling of activated FGFR1,0.024416242135853496,-0.0,-0.0,0.02298619637066937,-0.0,0.0344909751111952
FGFR3b ligand binding and activation,0.024239032287865274,-0.0,0.22395433265662132,0.20491071942458883,-0.0,-0.0
Post-chaperonin tubulin folding pathway,0.024168515489013324,0.017708159801049336,-0.0,0.15272341055062252,0.04327307335949085,0.18106124713850613
"Glutamate binding, activation of AMPA receptors and synaptic plasticity",0.0241519969616966,0.08130398360862613,-0.0,0.024264942744019056,0.00970596927770567,0.0004869064284888676
Nicotinate metabolism,0.02404901736969888,-0.0,0.11654182293951043,0.10193668605146863,-0.0,0.1440025855266646
TICAM1-dependent activation of IRF3/IRF7,0.023783875439340747,0.018412715699374534,0.7621478588188678,0.5096266178327151,-0.0,0.22981106557826483
mRNA Editing: A to I Conversion,0.023692856325627384,-0.0,0.07260853436325186,0.050047106738792264,0.0941587114652056,0.05063410776669827
G beta:gamma signalling through PI3Kgamma,0.023688495779823158,-0.0,0.0630022891334197,0.033292402396014144,0.016774261141995834,0.12200539853159581
Chylomicron remodeling,0.02360603944576011,0.08554685493042673,0.021530993935753657,0.062029535921069995,-0.0,0.013212745073858443
Biotin transport and metabolism,0.023314677321058134,0.08285662964160717,0.1736775789063649,0.1803501058280318,-0.0,0.6034438046322192
Proton-coupled monocarboxylate transport,0.02299591944296937,-0.0,-0.0,0.2016542150407028,8.441416484895736e-05,0.272953942545991
Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling,0.022452652176917942,0.016128059299602284,0.049010768558479884,0.02861719388688274,-0.0,0.40222541758225977
Toxicity of botulinum toxin type F (BoNT/F),0.022418824214794415,0.07663870082668994,0.01966914636244215,0.17078222020318395,-0.0,0.057757946765085943
Regulation of TLR by endogenous ligand,0.02220756070702688,-0.0,0.3065193214517807,0.11259109857950772,-0.0,-0.0
Formation of editosomes by ADAR proteins,0.02215130913800941,-0.0,0.06152068417088448,0.056783997294489484,0.16103945028289926,0.03868978365494375
"Biosynthesis of A2E, implicated in retinal degradation",0.021984589888558823,0.01788983606938613,0.21236320672041772,0.057971972039005865,-0.0,0.3445573379217297
Cellular response to heat stress,0.021769598080537033,0.015178714509301056,-0.0,0.18553311227847535,-0.0,0.4409293134765367
Beta-oxidation of very long chain fatty acids,0.02169231104371999,0.17690307254207435,0.0426979752959001,0.13959749088447054,-0.0,0.2745654666127723
Biosynthesis of DPAn-3-derived protectins and resolvins,0.021641524867345444,0.012250251715803408,-0.0,0.20938014471209454,-0.0,0.04044953863461135
G1/S DNA Damage Checkpoints,0.021543084646884716,0.015904599771382318,0.01816773342578368,0.13935951928787363,-0.0,0.6266208713129666
Visual phototransduction,0.02151662637013224,-0.0,-0.0,0.08676530707201095,0.007836563203131676,0.19828596127414053
Nef mediated downregulation of CD28 cell surface expression,0.02143153803034703,-0.0,0.1778691355910447,0.1371564969016863,0.04088626208407515,0.03280825410686374
p53-Dependent G1 DNA Damage Response,0.021221983373056807,0.013768639864812034,0.030334700208392355,0.1342440974961443,-0.0,0.5363615199411039
Alanine metabolism,0.02117116189111114,0.015498766403627321,0.031082190843903294,0.15684179346598254,-0.0,0.12605701912781075
Glycerophospholipid biosynthesis,0.021082924345619536,0.0760652037962166,-0.0,0.16910720514776986,-0.0,0.0902118184748077
DNA Replication Pre-Initiation,0.02096631552225795,-0.0,0.08532051301279223,0.2660230390104561,-0.0,0.32232380617485246
CaM pathway,0.020963149947727033,0.037584305216981966,0.2188315102433775,0.010874509713540438,0.001961085202372017,0.24141233037829754
DAG and IP3 signaling,0.020727243830980086,0.014422802454740074,0.1954271848584515,0.004601165203514987,-0.0,0.12330801963366649
HSF1 activation,0.020639881108992342,0.016336506159800326,-0.0,0.09168858014455261,0.003597523537738497,0.7259350336941996
Biosynthesis of maresin conjugates in tissue regeneration (MCTR),0.020443488440951077,0.06720259042379174,0.0339453368966477,0.05524120757195789,0.11863148770314091,0.004220048569145626
N-glycan trimming in the ER and Calnexin/Calreticulin cycle,0.02043036791054374,-0.0,0.02814565563302256,0.14612655501822494,0.0157920197714893,0.10591377198089898
Loss of Nlp from mitotic centrosomes,0.02039371729614588,0.0552824617452685,0.0018069237145870278,0.2992261049181432,0.010415630082121064,0.020200240651137392
Dimerization of procaspase-8,0.019942185153149536,0.001704947738710171,0.1729477020976215,0.05308359642617965,0.01545296616497992,0.0025525959803778336
Ras activation upon Ca2+ influx through NMDA receptor,0.019870553230728456,-0.0,-0.0,0.09149743898089067,-0.0,0.4810794870787067
RHO GTPases Activate Rhotekin and Rhophilins,0.019623102717200264,-0.0,-0.0,0.050519508317284585,-0.0,0.3778959878072767
Energy dependent regulation of mTOR by LKB1-AMPK,0.019524378622548414,0.08380624950325553,0.19558191913411271,0.11012721930052577,-0.0,0.5109600027018243
Mineralocorticoid biosynthesis,0.019496114637689518,-0.0,0.7283821890368531,0.10055798762572016,-0.0,0.21563496626112522
Defective CP causes aceruloplasminemia (ACERULOP),0.019428346207135353,0.017175370393777457,0.015406417819601824,0.045935220149990366,-0.0,0.011443603427353425
Trafficking of AMPA receptors,0.019415908145778243,0.08582132126550683,-0.0,0.03081764159335422,0.005326043366046904,-0.0
Toxicity of botulinum toxin type D (BoNT/D),0.019199814745513015,0.07261839779076537,0.025828299568884966,0.18193836536819408,0.006234639504825165,0.06892597792827757
DCC mediated attractive signaling,0.019156695566947327,-0.0,0.13727668590675718,0.18744927750265247,-0.0,0.9743383664170321
Response to elevated platelet cytosolic Ca2+,0.019020705895887745,0.07937632811676461,0.05298409334765069,0.05036375736141,-0.0,0.7290292508163092
Transmission across Electrical Synapses,0.018773604098675466,0.06294869949065098,-0.0,0.05783638727283978,-0.0,0.6451364981212654
Lipid particle organization,0.01871989196337411,0.04639099297464076,0.007697435266135611,0.000205407622136472,-0.0,-0.0
CDC6 association with the ORC:origin complex,0.018610559950916344,-0.0,0.010055145985148202,0.2996241932137987,-0.0,-0.0
Chylomicron clearance,0.018573866622421577,0.03306077674144932,-0.0,0.2697918212179045,-0.0,0.02583374649435141
rRNA modification in the mitochondrion,0.01845609832151097,-0.0,0.10472263430124581,0.16560444881934622,0.07565721718310893,0.1755912085317374
"Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein",0.018452230485402937,-0.0,-0.0,0.09577333511563707,0.38585430648397817,0.6884138458399497
Neurodegenerative Diseases,0.018362379984235604,-0.0,0.036626304277183136,0.09470233699883088,-0.0,0.13417475388355815
Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB,0.01835530439921255,-0.0,0.1320464026635997,0.1337353961011053,-0.0,0.11203679190919688
Constitutive Signaling by NOTCH1 HD Domain Mutants,0.01825021630671077,-0.0,0.7622642656496482,0.2063426454496957,0.008185500539597277,0.030504937732559884
Defective CYP21A2 causes Adrenal hyperplasia 3 (AH3),0.018164582422503673,0.04009777936687027,0.08857814204448726,0.15024063723361153,0.006982968932208325,0.03538561439722087
Protein ubiquitination,0.018156051521384328,0.015639203505667488,0.015329029893203623,0.1015040772838735,-0.0,0.27661856005836355
SHC-mediated cascade:FGFR3,0.01800120378756018,0.007437122664223213,0.14017580549096834,0.24776150805809358,-0.0,0.00824550788689062
Calcineurin activates NFAT,0.01795919638541953,0.015778471482267457,-0.0,0.05103972883759244,-0.0,0.15818716125896554
Mitotic Metaphase/Anaphase Transition,0.01781036116428187,-0.0,0.00043622492665041214,0.03378883586484892,-0.0,0.006841092859720475
The proton buffering model,0.01772303139183634,-0.0,0.008071063381337265,0.006514808075047579,-0.0,-0.0
Tight junction interactions,0.017617592235852977,0.018948132857454163,0.5375560254846204,0.19185760235012986,-0.0,0.24683274499359323
RUNX3 regulates BCL2L11 (BIM) transcription,0.01738127383562753,-0.0,0.007626974811518104,0.22416435429845047,-0.0,0.0628677299970156
Defective CHST3 causes SEDCJD,0.015919306786375455,0.03692041685409091,-0.0,0.03813091879589313,0.4476803379279351,0.38463673336480886
Acyl chain remodelling of PI,0.015834300364319116,-0.0,0.1852129105730473,0.028776966418771824,-0.0,0.10190858230806736
Activation of BAD and translocation to mitochondria,0.015594637369811119,0.016412569890553064,-0.0,0.06934587668442099,0.005697097867886751,0.5129759016194583
WNT ligand biogenesis and trafficking,0.015561995758319661,0.03445232655676485,0.010169310174891854,0.05255402658583413,-0.0,0.5518327608074898
cGMP effects,0.01552502142356128,-0.0,0.27226539504493963,0.08910654913900512,0.011277462419168091,0.13925151495583285
Orexin and neuropeptides FF and QRFP bind to their respective receptors,0.015428949713052325,0.015401272680587464,0.053795300813675194,0.03249773976558449,-0.0,0.10424944929595625
Diseases associated with N-glycosylation of proteins,0.015204680412176595,-0.0,-0.0,0.19719503694654875,0.002333656216117764,0.5391902201001832
FGFR2 mutant receptor activation,0.015153939469638104,-0.0,0.05587435373632743,0.028301296779076914,-0.0,0.36695058116682033
TP53 Regulates Transcription of Cell Cycle Genes,0.015152925053899091,0.0829333630668193,0.20191436192587775,0.055543193426060226,-0.0,0.030012673077101065
Negative regulation of FGFR4 signaling,0.015094191853807904,0.014022234496666296,0.3931640218656921,0.31342086477062686,-0.0,0.06953133625110354
Biosynthesis of DHA-derived sulfido conjugates,0.015015146777345745,0.0330764460561837,0.01297464067795916,0.050379001907176764,0.14771262054118578,0.006549456767971726
Synthesis of PIPs at the early endosome membrane,0.01499887926993592,0.008587737204452292,-0.0,0.033680550591640865,-0.0,0.11626955837817862
Biosynthesis of DPAn-3 SPMs,0.014941556110418029,0.05469513029006182,-0.0,0.08746842084059465,-0.0,0.09139219409091295
SMAC (DIABLO) binds to IAPs,0.01483453661828204,-0.0,0.10729123843158761,0.06860440360884816,0.007022433337507663,0.05937122690631319
SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes,0.01476361363930704,-0.0,0.1493705441892574,0.05222741338558896,0.007844348595714735,0.09048908030719238
Cell Cycle Checkpoints,0.014724218104369835,0.08554282266847954,0.16391460613614034,0.25893656549131894,0.016463596857572035,0.6240240794229467
Biosynthesis of protectin and resolvin conjugates in tissue regeneration (PCTR and RCTR),0.014709928790924011,0.037201141723495174,0.026729827939181,0.033692994636205904,0.09558755273527393,0.006861594768968819
Glucagon-like Peptide-1 (GLP1) regulates insulin secretion,0.014656860478469869,-0.0,0.17111359753029903,0.05259703900906565,0.003841050535876256,0.27450890856141413
Sodium/Proton exchangers,0.01465585148060225,0.007671706742919544,-0.0,0.12091104467738316,-0.0,0.00022492509561674914
Plasma lipoprotein remodeling,0.014623552274607146,0.08267924021123496,-0.0,0.010435963146261511,-0.0,0.01629894371286619
Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells,0.014213466963593257,0.012115770488045434,0.04164051788801847,0.10367668114779646,0.003726578796845478,0.03604202032171215
mRNA Editing,0.01417287226302772,0.014443938326955319,0.01892316831142244,0.0033686948408373895,0.09562155864310593,0.23738191772599482
Sphingolipid metabolism,0.013889268288880527,0.06307764253212131,0.08485777419489805,0.1982535498587029,-0.0,0.3477200199226693
Cytosolic sulfonation of small molecules,0.013883362847066582,0.07703463772558296,0.01887436391797354,0.09771184192790595,0.09553191140078826,0.36860045532300373
Nectin/Necl  trans heterodimerization,0.013632241267971013,-0.0,0.10610987342139172,0.00430209347889303,-0.0,-0.0
tRNA processing in the nucleus,0.013616660991167666,0.050243986397321326,0.10984033692824005,0.0347794055266383,0.14346919919009793,0.24085337541303836
Golgi-to-ER retrograde transport,0.01353215972574713,0.0848111751998449,0.11062347211226707,0.1450562493913659,-0.0,0.8046297783563724
DNA strand elongation,0.013409718717662573,0.047832321144231284,0.1598865906176524,0.030047814446119214,-0.0,0.0107478104413589
Notch-HLH transcription pathway,0.013319064655985617,-0.0,-0.0,0.14579591413016252,0.09769355259776125,0.023854754863206408
Activation of GABAB receptors,0.013295603871390633,0.08138441613917916,0.06251334972119292,0.07081532018108706,-0.0,0.0280747762864867
Hyaluronan biosynthesis and export,0.01326209582200194,-0.0,-0.0,0.09757418406438972,0.000693530168913066,0.017012954300814447
Aryl hydrocarbon receptor signalling,0.01324256584662004,0.09599937310846504,0.027980533102846008,0.037241119926417945,0.02139335122570884,0.3062389936576353
Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template,0.013241921827659868,0.015088100200567707,0.24035204320836523,0.2937146579367133,-0.0,0.01531107739769056
EPHB-mediated forward signaling,0.013235727716542384,0.01440659124968426,0.0242678786421633,0.07101290067763238,-0.0,1.086574839443617
Effects of PIP2 hydrolysis,0.013214718664300655,0.06347823182728883,-0.0,0.11203110975171576,-0.0,0.0039912422677445165
Aquaporin-mediated transport,0.013058501000690838,0.0866396613990312,0.06302741171762767,0.09767986808651251,-0.0,-0.0
PI-3K cascade:FGFR2,0.013056121503961765,-0.0,0.06356316912341237,0.10088125813167248,-0.0,0.051156672838864777
Threonine catabolism,0.012933616680267353,0.07683686081341586,-0.0,0.0037981245482843315,-0.0,0.026865045725515485
"Defective ABCC9 causes dilated cardiomyopathy 10, familial atrial fibrillation 12 and hypertrichotic osteochondrodysplasia",0.012860912097678688,0.001708907407497078,0.015036704594600657,0.027349630701809062,-0.0,0.009901681187316406
Glycogen storage disease type XV (GYG1),0.012833531060769496,0.02629873526363198,0.12996717335009503,0.18857144105568252,0.07473833998745806,0.09837971931915965
5-Phosphoribose 1-diphosphate biosynthesis,0.01273370404914982,0.05215205871694736,0.24064199062273325,0.15598315082291447,-0.0,0.4896345102379329
Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits,0.012692438883142053,0.014993081575939825,0.19298465323412187,0.1883735525251512,-0.0,0.14182552778295798
Acyl chain remodelling of PE,0.01255874278027966,0.01110739550541023,0.3089782427877218,0.023731516034056686,-0.0,-0.0
Biosynthesis of electrophilic -3 PUFA oxo-derivatives,0.01255349767540479,0.013897538114557387,0.10419761542657546,0.1903914790613452,0.010546301710765298,0.044005178319680795
Free fatty acid receptors,0.012391756727342381,-0.0,0.010516144745685093,0.04758597102862921,-0.0,0.00022362011544479153
The AIM2 inflammasome,0.012352400575804293,0.008465501959895066,0.0016738357898257413,0.1850973306896687,0.009764524714700993,0.004449521867634858
Neurofascin interactions,0.012037589012482452,-0.0,-0.0,0.1514970279870094,0.11537245349013552,0.32038121474395076
Phospholipase C-mediated cascade; FGFR3,0.01196215968296976,0.011948959929912144,0.07248907117422147,0.19812272650790969,-0.0,0.01434941800190277
"Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)",0.011743458566084664,-0.0,-0.0,0.10824627448614658,-0.0,-0.0
Loss of Function of SMAD4 in Cancer,0.011508400048211343,-0.0,0.03425808849465772,0.19457531541713963,0.008174055689110072,0.007658860387654249
Transport of small molecules,0.01142521232131017,0.6385330432612634,-0.0,0.016468453652789396,-0.0,0.44223751031652814
Recognition of DNA damage by PCNA-containing replication complex,0.010673259654939543,0.056666408903510906,0.16634543563864593,0.09717680904069008,0.04121481733535343,0.3388382980132227
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants,0.010591038523812197,-0.0,0.5875155647441361,0.304996588182826,-0.0,-0.0
C6 deamination of adenosine,0.010344296412213676,-0.0,0.062101850380208594,0.05510137637547436,0.0927958512129406,0.037979174319059554
Activation of G protein gated Potassium channels,0.01020867638321262,0.019161859575428458,0.22384914009619009,0.19855535023475387,-0.0,0.1454235509662907
Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,0.010159695282829876,-0.0,0.03476860668178591,0.09923104812511252,-0.0,0.10329074123568296
FOXO-mediated transcription of cell death genes,0.01010963083252394,-0.0,0.027722937571316386,0.29260256490706227,-0.0,0.11169733224401623
Processing of Intronless Pre-mRNAs,0.009915787808892948,-0.0,0.01041343836827846,0.02615893382776689,0.09223558011698844,0.4397129008506926
SMAD4 MH2 Domain Mutants in Cancer,0.009784029526193816,-0.0,0.04037827714919499,0.19012600526761772,0.015682312296339467,0.007043448045491416
PTK6 Regulates Cell Cycle,0.009658071611249937,0.00014292492529192623,0.0438642932625307,0.10811715467490764,-0.0,0.498150853861758
ATP sensitive Potassium channels,0.009639433093681213,0.05665083179052001,-0.0,0.051069778127690375,0.016989709553998783,0.026301643036874472
IL-6-type cytokine receptor ligand interactions,0.009482486783759698,0.011941168835014756,1.0257779000457403,0.03780660555566721,-0.0,0.2109451467733922
SMAD2/3 MH2 Domain Mutants in Cancer,0.00940256264883843,-0.0,0.0352689839119193,0.20482527066308706,0.004038276065328312,0.005812524242793274
Dissolution of Fibrin Clot,0.009288790987266135,-0.0,0.062089716673815375,0.0108354253630542,-0.0,0.098292817898627
Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA,0.009219634500210707,0.09845801761765641,0.04155227541605216,0.24132274253379393,-0.0,0.27743527587245753
Signaling by ERBB4,0.008613872072346028,0.04897534758534078,0.10078385212874433,0.05132835124829645,-0.0,0.1315008945926434
KSRP (KHSRP) binds and destabilizes mRNA,0.00860795973968441,-0.0,-0.0,0.003609147974793641,-0.0,0.005737028786093264
Myoclonic epilepsy of Lafora,0.008528351964552058,0.014123684091667213,0.6574534208601754,0.30173738007315326,0.35958291383783775,0.1040421976282068
ERBB2 Activates PTK6 Signaling,0.008431168538257323,-0.0,-0.0,0.031692508231338457,0.1736308445708608,0.060845565292134085
SHC-mediated cascade:FGFR2,0.008368311038352713,0.008832280339402797,0.0628409538487759,0.2077094012638406,-0.0,0.048931978452634306
Sodium/Calcium exchangers,0.008252969209292287,0.018554563419035185,0.11082410494202455,0.18964445075232378,-0.0,0.7079599408814133
RHO GTPases Activate WASPs and WAVEs,0.008183483062072654,0.05620357984069605,0.009931855636095244,0.11307396588789109,-0.0,0.936707003556139
STING mediated induction of host immune responses,0.008062219105746525,0.08927019513258982,0.07394486893343936,0.4412481372530165,0.015779558169829247,0.49760069721191824
Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function,0.008012552912245086,0.00626747459874232,0.020099191056449105,0.14787946304694993,-0.0,0.07077440374689484
GABA B receptor activation,0.0079918872011831,0.08508187658383952,0.04851121418401687,0.06894503393244567,-0.0,0.02243886541686899
RUNX1 regulates transcription of genes involved in BCR signaling,0.00781240450878522,-0.0,0.1699341323451221,0.24372499893532942,-0.0,0.22196690389556986
Signaling by FGFR2,0.007810452604767124,-0.0,0.15582104178920145,0.21058254960582584,-0.0,0.846068220477762
Enzymatic degradation of Dopamine by monoamine oxidase,0.00780803855141202,-0.0,0.19500919892776553,0.16599153769498134,-0.0,0.15187917430130407
Diseases associated with glycosaminoglycan metabolism,0.007750294035907939,-0.0,0.0029596237713348924,0.11393813682756987,-0.0,0.19018991061719753
Post-translational protein phosphorylation,0.00767553216980977,0.0712848965323936,0.12208755169734338,0.010182873670831451,-0.0,0.6236596818129306
Sphingolipid de novo biosynthesis,0.007594848068471287,-0.0,0.09606360162475713,0.2725384925738846,-0.0,0.13544147724562364
mitochondrial fatty acid beta-oxidation of unsaturated fatty acids,0.007585665583659296,0.1944359795608848,0.07068596862526375,0.1139383877610568,-0.0,0.4920449023507325
ChREBP activates metabolic gene expression,0.007514046581029397,-0.0,-0.0,0.053645699363012514,0.0015810861136618679,-0.0
"WNT5A-dependent internalization of FZD2, FZD5 and ROR2",0.0073956659178662934,-0.0,0.342751938947487,0.050218217916863386,0.016154092756290987,0.14888529262571965
LGI-ADAM interactions,0.007379291720827374,0.0064531354437803706,-0.0,0.009516846669359372,-0.0,0.021185228087878476
Biosynthesis of DPA-derived SPMs,0.007098922485356118,0.05610886465330972,-0.0,0.09846073565017391,-0.0,0.11404820071705209
Postsynaptic nicotinic acetylcholine receptors,0.007056186858985357,0.050264808780153054,0.019163980985412436,0.04679311486352532,-0.0,-0.0
"SMAC, XIAP-regulated apoptotic response",0.007001451415067429,-0.0,0.09740781250447321,0.1827030621555602,-0.0,0.11519057371815791
MET interacts with TNS proteins,0.006903732352508357,0.0037078766373334925,0.0042436113785543714,0.05050356914510423,-0.0,0.43323377384364864
Synthesis of bile acids and bile salts,0.006697646292831462,0.08192864035417724,0.12264899061675273,0.034773875530847154,-0.0,0.045723634688460996
Defective ABCC8 can cause hypoglycemias and hyperglycemias,0.006578689601847303,0.0026077347766485094,0.020199844020221836,0.027725980430875975,-0.0,0.0270680099515827
Dual Incision in GG-NER,0.006527608911398319,0.03978222168980346,0.1009196380874571,0.11125189622264395,-0.0,0.20998659432954336
Degradation of GABA,0.0064688302284559435,0.013835713543694244,-0.0,0.15675632628238417,0.007627606830075017,0.011689691478913578
VxPx cargo-targeting to cilium,0.006435322334924212,0.016518629249512275,-0.0,0.18772872389457937,-0.0,0.09774384434051257
Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4,0.006388853695582175,0.01006092048367163,0.017768324776463288,0.20614886309638966,-0.0,0.0924901484232095
Downregulation of ERBB4 signaling,0.006355832837093693,-0.0,0.17318088282171723,0.2662411798609446,-0.0,0.005098835306522224
Activation of ATR in response to replication stress,0.006284507628712447,0.008302884668343374,0.0005214845868396997,0.11457999689187366,0.0170058639842268,0.18138490988955436
"Defective CHST14 causes EDS, musculocontractural type",0.0061871537740255545,0.015405176098393116,-0.0,0.04083860600267838,0.19170671411885762,0.08543715149052244
Platelet Adhesion to exposed collagen,0.006161682829110694,-0.0,-0.0,0.0026567896218581562,0.014555722409465456,0.3463754199186321
Activation of caspases through apoptosome-mediated cleavage,0.0061554291642971284,0.014664290046220264,0.19873247273612424,0.05249302646077403,0.015725978442520754,0.2279360948569651
Activation of AMPK downstream of NMDARs,0.006137613716481199,0.07871245109895417,-0.0,0.1895824645173618,0.47995431666538024,0.273981784669442
"Formation of the active cofactor, UDP-glucuronate",0.006050988994300055,-0.0,0.041625412621886786,0.0925671258015055,0.09351407149807948,0.4315448208886647
Acyl chain remodelling of PG,0.006045898868210734,0.01587851670149274,0.2944382890310757,0.06738986576803736,-0.0,0.00609304642154447
Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon,0.005920526268751163,0.0016167261378174887,1.0544244135255363,0.2811180370820055,-0.0,0.22390815169294337
Metabolism of Angiotensinogen to Angiotensins,0.005907816529253247,0.07655653098551529,-0.0,0.007520600015170852,-0.0,0.11414629150671249
Nucleobase biosynthesis,0.005791944051470435,0.0797581929504097,0.34103872670886504,0.24015641897236562,0.29076145073185616,0.014030024991932503
MicroRNA (miRNA) biogenesis,0.005785476245584672,-0.0,-0.0,0.1043905370319361,0.009140687418574194,0.1668428874726723
mRNA Splicing - Minor Pathway,0.00578474287907266,-0.0,-0.0,0.16073955694002717,0.01601430903127456,0.3853813212607892
Synthesis of Ketone Bodies,0.005688463451751855,0.14939520421377644,0.034641031569627515,0.0674707181418205,-0.0,0.016887641837958472
Metabolism of porphyrins,0.005604209304388777,0.008901828158275003,0.16811703790601137,0.4988870444166848,0.26040031596536434,0.024123662284561694
RUNX1 regulates transcription of genes involved in WNT signaling,0.005537024215416234,-0.0,-0.0,0.06141298405812404,0.05688407996277944,0.1644494522261566
Interaction between L1 and Ankyrins,0.005500847191069575,0.015850393968221767,0.5366989000978777,0.05166768953333961,-0.0,0.42778107860230424
FGFR2 alternative splicing,0.005465881861101893,-0.0,0.000315019599688283,0.09872498581813642,-0.0,0.7408540876476766
Cell-cell junction organization,0.0054514820109061324,0.03568841647572497,-0.0,0.05242868774376867,-0.0,0.33556982522257406
RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known,0.005405964250646797,-0.0,0.04561920873273612,0.11243251029625251,0.22662066080856108,0.027253437567596524
tRNA modification in the mitochondrion,0.0053950151126905595,0.008665465368721939,0.006537360253664834,0.1105690698586192,-0.0,0.6164772084836114
Beta oxidation of hexanoyl-CoA to butanoyl-CoA,0.00529657905630817,0.07841551999106866,0.014989600127495898,0.13816568505327237,-0.0,0.15613867434664896
Diseases of Programmed Cell Death,0.005292089808006909,0.006330085618524341,0.020046239117917357,0.17808459774655425,-0.0,0.06060151510667619
Toxicity of botulinum toxin type C (BoNT/C),0.005197444396508578,-0.0,0.12817607427972547,0.06922485108367961,0.016970375533890147,0.27205156603805725
Metabolism of serotonin,0.005142248611136032,-0.0,0.16160325842042994,0.10932376841925087,-0.0,0.09035745626373569
Myogenesis,0.004921733168872962,-0.0,-0.0,0.13801742832945685,-0.0,0.49063216154798667
Signaling by BMP,0.00486739253405715,-0.0,0.007247796277354117,0.14073450237269072,-0.0,0.00711539506374998
Translocation of SLC2A4 (GLUT4) to the plasma membrane,0.004688563714369013,0.32186303169675995,-0.0,0.29792066378755644,0.3532715702698869,0.6259378612369556
Glycogen storage disease type 0 (muscle GYS1),0.0045756671293577245,0.03378463045060276,0.13814262531949767,0.19680614582636546,0.07917744471911797,0.10228151099277084
Hydrolysis of LPC,0.004530234593591804,0.01588870594741845,0.04328507057645503,0.0920067140245298,-0.0,-0.0
Extension of Telomeres,0.004426188340340497,0.007283360472677388,0.09840580505857967,0.051507577408637456,-0.0,7.320425082135616e-05
Biosynthesis of DPAn-3-derived 13-series resolvins,0.004330140225092398,0.00842493250973141,0.0431896025693969,0.010467143832816219,0.017661204660914177,0.030737881422157116
IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation,0.004135412097038515,-0.0,0.5978248721489419,0.32832919207221106,0.08417076850096414,0.004486491719622101
Signaling by NOTCH1,0.004118604650045132,-0.0,0.05913213947743859,0.148654353760195,-0.0,0.13900399656012546
Melanin biosynthesis,0.004086519239690492,0.007936148954484839,-0.0,0.17645043945461208,0.2914031693257501,0.005021146846092803
Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane,0.004055333305555324,0.07820488278935424,0.01801165327119788,0.12137211521557728,0.2532711793969543,0.34148381412222406
Phenylalanine and tyrosine metabolism,0.0038702331274802293,-0.0,-0.0,0.019227691981254694,-0.0,0.15314070825234433
CREB phosphorylation,0.003795166744854852,0.00027615505688097393,-0.0,0.027085696182586515,-0.0,0.5387290758414149
HCN channels,0.0036309401206243027,-0.0,0.013998124036060855,0.0671009965238908,0.011300219127957275,-0.0
Pyrophosphate hydrolysis,0.003508872634190014,0.07712110322099394,0.0301488722893035,0.09117327390306218,-0.0,0.3151182035249768
Pyruvate metabolism,0.003494308506857247,0.08386760108497907,-0.0,0.05885107264713019,0.27833840180464187,0.7490710573080194
Fibronectin matrix formation,0.0034286133572605164,0.02049529012763478,0.00830967877878408,0.010547199878892945,-0.0,0.062221199985230256
FRS-mediated FGFR4 signaling,0.0033950739960638848,0.005202923804901154,0.049598801020246205,0.20279196396056076,-0.0,-0.0
Aspartate and asparagine metabolism,0.0033881704308299297,0.08513864336152874,-0.0,0.001723952007440628,0.2333113327565854,0.24002617543088803
"XAV939 inhibits tankyrase, stabilizing AXIN",0.0033714532047881547,0.011589278277906744,0.25843363849907836,0.18091619653714075,0.020349953159814332,0.21459449000888683
Acetylcholine binding and downstream events,0.0033355145924066853,-0.0,0.019447482111272434,0.04333174797076708,-0.0,-0.0
NR1H2 & NR1H3 regulate gene expression linked to lipogenesis,0.0033343937299634115,0.01043674572480032,-0.0,0.13725095707407817,0.00145220589379503,0.01669825698316421
MHC class II antigen presentation,0.0033058708876013317,-0.0,0.021148996475227756,0.14606252853957344,-0.0,0.34626747653496504
RUNX3 regulates WNT signaling,0.0032812536481239916,-0.0,-0.0,0.19310429396651788,0.28769008372503685,0.37693829539806933
Intra-Golgi and retrograde Golgi-to-ER traffic,0.0031491983271409963,0.08187610958565175,-0.0,0.3214406035374198,0.07919187975210074,0.717692902860902
Signaling by FGFR2 in disease,0.003140730444113459,-0.0,0.06491082611671295,0.03633856937604478,-0.0,0.24213948074608777
Mitochondrial calcium ion transport,0.0031025101426665285,-0.0,0.20662126913469064,0.2364765498508438,0.01718716496375826,0.02328722128034097
Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4,0.0030124399364688972,0.004323193611085731,0.00980979266778893,0.1874366269262602,-0.0,0.06065504068016209
Long-term potentiation,0.002971316846899631,-0.0,-0.0,0.1812506621937042,-0.0,0.18135361025347116
Glutamate and glutamine metabolism,0.0029364866201867885,0.02787633193177713,-0.0,0.05794646934963902,-0.0,0.012305514427593523
p75NTR recruits signalling complexes,0.0029170602158863405,-0.0,0.09717889339366104,0.21707538970073054,-0.0,0.007486177821677882
SHC-mediated cascade:FGFR1,0.0029027741297041228,0.005047190766389342,0.07491495170897514,0.13343898960186296,-0.0,0.02962137848690368
Uptake and function of diphtheria toxin,0.0028774800512138756,-0.0,-0.0,0.18428218784280367,0.07944679064295691,0.35486000670774925
Apoptotic cleavage of cellular proteins,0.0027071658540887516,0.009897737862386504,0.1872846158865791,0.09380019104060669,-0.0,0.6347842623061247
Vitamins B6 activation to pyridoxal phosphate,0.002611479431941302,-0.0,0.014992165739947182,0.05047655857028365,0.042727510322133865,0.02887551902421649
Signaling by FGFR,0.002521402399526951,0.01542108684626614,0.10411599200506756,0.1938964576683171,-0.0,0.7385875807668294
Retrograde neurotrophin signalling,0.0023228948310096784,-0.0,0.002974824704005693,0.1149743583030575,0.00248821797522932,0.22692401502335943
Calcitonin-like ligand receptors,0.0022720987321723646,0.008091891829995982,0.042228352870647655,0.01745032454199276,-0.0,0.272042517159577
Downstream signaling of activated FGFR4,0.002248049390241205,-0.0,0.1033912220318367,0.06656370696708777,-0.0,-0.0
Synthesis of PC,0.0022337009658154354,0.09098667017291669,-0.0,0.05026313664217603,0.0006274755648390575,0.016179166864300456
Sperm Motility And Taxes,0.00221863941131508,0.00013679672412334823,0.10770803485768216,0.014783244168485182,-0.0,0.020574147251014988
Tandem pore domain potassium channels,0.0021897883228022995,-0.0,-0.0,0.17922042992754117,0.09236989327267543,0.0024908563278328686
O-linked glycosylation of mucins,0.0021500431110559387,-0.0,0.003310798263377163,0.180041431580623,0.036812114339663686,0.6499570009851303
"GABA synthesis, release, reuptake and degradation",0.0020460476549487854,0.07854526860349732,-0.0,0.030164529376256098,-0.0,0.14162441424559158
Transferrin endocytosis and recycling,0.0019645772550058362,0.08181016564461362,0.010459474236786883,0.14191812064026096,0.011300546259614934,0.5219859463328126
Resolution of AP sites via the multiple-nucleotide patch replacement pathway,0.0019124835427170904,0.01058315109841304,0.09601286182405173,0.010970599870550662,-0.0,-0.0
Signalling to p38 via RIT and RIN,0.001875207068335655,0.015762882904300394,0.0023545779925659535,0.13797587611495019,-0.0,0.36914498700047516
Plasma lipoprotein assembly,0.0018459272431298071,0.01212651409180775,0.340138271541083,0.051011245986071,-0.0,0.21313661313617524
Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT),0.0018330422372595388,0.013969240841499258,0.001328890680160947,0.13751793556952674,-0.0,0.02579446821904749
Frs2-mediated activation,0.0018173749365272141,-0.0,-0.0,0.010954704317828615,-0.0,0.006139145552447148
Synthesis of PIPs in the nucleus,0.001786118136823155,-0.0,-0.0,0.05408649886951142,0.024943990063981673,0.025365824672821495
Metabolism of nitric oxide: eNOS activation and regulation,0.0017472820152925703,0.01655462859704856,0.07704959604842147,0.03239107722601557,0.03576845296183777,0.24280397764082398
PI5P Regulates TP53 Acetylation,0.0016132562530350883,-0.0,-0.0,0.03594437985970975,-0.0,0.21226802872864486
p130Cas linkage to MAPK signaling for integrins,0.0015981045307195206,-0.0,0.5396807362676804,0.29899733876158807,0.008892139100406394,0.010077159956657911
Metabolism of vitamin K,0.0015477017078445261,-0.0,0.19259534759107602,0.0327536409970516,-0.0,0.04404812045553235
The retinoid cycle in cones (daylight vision),0.001494044226478107,-0.0,0.01779011982299711,0.028657317767747353,-0.0,0.029706308636312635
Apoptotic execution phase,0.0014792797832369933,0.0280310692179191,0.28656308312993706,0.050626366802480005,-0.0,0.4828507514864117
"FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes",0.0014579851846991097,-0.0,0.1045667418465158,0.136792121018054,0.004582056986741609,0.2440246472042923
Activation of AMPA receptors,0.0013752970971409038,0.05621102185385185,0.008899150682677088,0.06895714660933719,0.0756951394498395,0.2759103275569128
Transport of connexons to the plasma membrane,0.001360512186333229,0.06006222780127327,0.008248414221263434,0.13803578508240574,0.2452776633215346,0.4278900934316138
Defective GCLC causes Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency (HAGGSD),0.0013357001626816208,-0.0,0.1675187343100376,0.19459050280006168,-0.0,0.14581611170510045
Signaling by FGFR2 IIIa TM,0.0012865446541603354,-0.0,0.01878802140167929,0.15577250488005998,0.001238431269546291,0.23028803765310693
PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1,0.001259698149580224,0.017056838181650446,0.7921534993262427,0.292634676337547,0.025110955764511448,0.02793638526947831
Inhibition of nitric oxide production,0.0012378630728221976,0.00861049625808115,-0.0,0.01734939776107458,0.07622360731471307,0.007463451161267612
Beta oxidation of octanoyl-CoA to hexanoyl-CoA,0.0012287004402620385,0.11124307047706461,0.22774492835957574,0.29620887545084745,-0.0,0.23691609417838244
SHC-mediated cascade:FGFR4,0.0011525779867219135,0.015463188913085664,0.1390248094417431,0.21346983826475843,-0.0,-0.0
FOXO-mediated transcription of cell cycle genes,0.001138214478621062,-0.0,0.027269864880653867,0.14759412132467328,-0.0,0.49619429964276224
NOTCH2 Activation and Transmission of Signal to the Nucleus,0.0011284575708388053,-0.0,0.5118387454803729,0.21042847877951207,-0.0,0.007312498806431739
Bile acid and bile salt metabolism,0.0010734701587403373,0.07631880802650243,0.10597607054850389,0.028001473054971093,0.008895171018425761,0.0987712666986735
mitochondrial fatty acid beta-oxidation of saturated fatty acids,0.0010679943200027327,0.08304289715961333,0.22254646403090378,0.18941267770345352,0.0333115149695881,0.09993944059609733
Release of Hh-Np from the secreting cell,0.0010379720943406354,0.010877855803584417,0.12618598561785807,0.010407757740383237,0.008659150684692547,0.026289316427085634
Endosomal/Vacuolar pathway,0.00099773998972042,0.01208078516108689,0.07337522312521144,0.22876058286391782,0.009195651691346401,0.059416492124510764
Basigin interactions,0.0009791730975237257,0.013343554016136478,-0.0,0.06687367560959276,0.024550175981467828,0.19788027854868914
RHO GTPases activate PAKs,0.0009752519379202804,-0.0,-0.0,0.16018160011342963,-0.0,0.03884879668370865
Potassium transport channels,0.0009579285848347714,0.08136184008773542,0.1396853007339051,0.07024064445216603,-0.0,0.024623608077794505
Muscarinic acetylcholine receptors,0.0009542736520000997,0.07645275065489028,0.16683871618404444,0.1077349653144518,-0.0,0.024425468220222405
Nef mediated downregulation of MHC class I complex cell surface expression,0.000929943440681537,-0.0,-0.0,0.16623011315717895,-0.0,0.020489106515059825
Keratan sulfate/keratin metabolism,0.0009279060566299583,-0.0,-0.0,0.17471471616677178,-0.0,1.1204156588026022
Attenuation phase,0.0009234688318062231,-0.0,-0.0,0.08508082390540352,-0.0,0.8473521782108319
Insulin receptor recycling,0.0009050266920695978,0.09832903524445291,-0.0,0.03298107135474525,0.03511053093084149,0.24013796547193014
Sema4D induced cell migration and growth-cone collapse,0.0009016837309534204,-0.0,0.009376271816355934,0.024223896517580328,0.007571414095716458,0.013514097502266627
Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation,0.0008543496797862304,0.012881327938831216,-0.0,0.15784434477745948,-0.0,0.21429287035527309
Signaling by ERBB2,0.0008496002992711514,-0.0,0.09736354430058117,0.23748320001238732,-0.0,0.05917655940679606
Loss of MECP2 binding ability to the NCoR/SMRT complex,0.000830895989229323,0.0078502718084732,0.03273584335328926,0.09952686386442745,0.002573657002812321,0.02190091251392637
Neurotoxicity of clostridium toxins,0.0008302509523389186,0.09053095763311216,0.019397682962062558,0.0344744255010504,-0.0,0.22441076991000727
Interleukin-33 signaling,0.0007259228379380769,0.009333408323857872,0.10641294900838257,0.09414054963627128,0.018111674187922935,0.05769334586742003
AKT phosphorylates targets in the cytosol,0.0006993880919110982,0.007599326752021662,-0.0,0.1760825111101071,0.014354899236376267,0.028412633316837087
Apoptosis induced DNA fragmentation,0.0006910568398622431,0.04866601722897448,-0.0,0.24702292853770277,-0.0,0.003916693261833921
Suppression of apoptosis,0.0006253762323872891,-0.0,0.046876852599271386,0.1373971546882693,0.0017217754449285444,-0.0
Phase 2 - plateau phase,0.0006199332294179646,-0.0,0.3378357810560839,0.14253371057252104,-0.0,-0.0
Miscellaneous substrates,0.00061805830587543,-0.0,0.00041572773150397844,0.051828330524160394,0.00389630426328951,0.26493751020614886
Synthesis of PIPs at the late endosome membrane,0.0006060317390893759,0.07968575426887461,0.017677522230102487,0.05599535705358152,0.0007318116635114469,0.1510648652337655
RUNX3 regulates p14-ARF,0.0006031117852940538,-0.0,0.19895353727076825,0.2064963766893173,-0.0,0.07239919380924674
FGFR2b ligand binding and activation,0.0006018575645340035,0.081009965859477,-0.0,0.18556332871422757,-0.0,0.7469511663751276
Transcriptional Regulation by VENTX,0.000568397651099024,-0.0,-0.0,0.19076487541178486,-0.0,0.2893157142792989
Loss of phosphorylation of MECP2 at T308,0.0005384578473206445,0.01566587618912083,-0.0,0.14485050332721774,-0.0,0.01492619962770258
AKT-mediated inactivation of FOXO1A,0.0005280321703003852,-0.0,-0.0,0.009878304244634898,0.00825721056428729,0.005088053055301964
Multifunctional anion exchangers,0.0005186880499804283,-0.0,0.06774400127155857,0.19008557054284408,-0.0,0.1697853810569761
CRMPs in Sema3A signaling,0.0005181754268323802,0.03797537222431341,0.006307301201243635,0.10093076618173026,-0.0,0.011396510898508008
Synthesis of Lipoxins (LX),0.0005063000445872562,0.08459416678429599,0.032112313092458274,0.17409032679495476,-0.0,0.43222846736026527
Signaling by activated point mutants of FGFR1,0.0004752350353714627,-0.0,0.09925219404027724,0.10169906690112461,-0.0,0.0140642017349713
InlB-mediated entry of Listeria monocytogenes into host cell,0.00046080481162577173,0.009048009745529384,0.10287687687807544,0.20372811597912813,-0.0,0.7428002127182853
Activation of TRKA receptors,0.00043055173283659733,-0.0,0.00017173209954310256,0.13993749022120547,-0.0,0.33943620954279946
Catecholamine biosynthesis,0.00039658783963696944,-0.0,-0.0,0.04620415045577297,-0.0,0.03869064471318899
NR1H2 and NR1H3-mediated signaling,0.0003814716064265804,0.05482977622817272,0.1544745910475085,0.2664253668444523,0.013784837518406406,0.10211380363467037
SMAD2/3 Phosphorylation Motif Mutants in Cancer,0.00037641508606373926,-0.0,0.0011881114684829978,0.14774962353139703,-0.0,0.18830003542747542
Intra-Golgi traffic,0.00037549852965118195,0.10060866154640315,-0.0,0.3938206769121643,0.22920017480288063,0.0038837908628826783
Axonal growth inhibition (RHOA activation),0.000369242964869348,0.08295542821110265,0.0991989663958873,0.010633922912864448,0.1290984683063113,-0.0
Inactivation of CDC42 and RAC1,0.0003537599327637836,-0.0,0.09475749697351046,0.24668500944455699,0.012108609714345145,0.030313419380628297
Vitamin C (ascorbate) metabolism,0.00032444698521953214,0.0013764024677844651,-0.0,0.09358295012662006,0.005293924705048802,0.1017774870883577
Gastrin-CREB signalling pathway via PKC and MAPK,0.0003054719447818234,-0.0,-0.0,0.03565720987657509,0.09274443731335623,0.48622431231586793
Signaling by TGF-beta Receptor Complex in Cancer,0.0002776975738144864,-0.0,-0.0,0.2194997312864825,-0.0,0.18459599870707685
Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE),0.0002768604411788019,0.08390248821720704,0.04134866138485917,0.20635686819670931,0.000866092766843004,0.022770494955411644
Noncanonical activation of NOTCH3,0.0002749126605951648,0.015295587951641682,-0.0,0.031142471452115895,-0.0,0.03312800485357787
Negative regulation of NMDA receptor-mediated neuronal transmission,0.00026890548522110646,-0.0,-0.0,0.06808109082481631,0.02282848179417086,0.044283799206609874
TGFBR1 KD Mutants in Cancer,0.00026558144508318914,-0.0,0.00010982626486916432,0.16488731921444627,-0.0,0.205861459671056
TGFBR1 LBD Mutants in Cancer,0.00025829262696282717,0.03527094981715122,-0.0,0.13802702961264826,0.0034605724880079655,-0.0
Acyl chain remodelling of PC,0.00024792769107942036,-0.0,0.17445516848140535,0.00756971223017472,-0.0,0.14095040528857772
Beta oxidation of butanoyl-CoA to acetyl-CoA,0.0002444641874437885,0.10259287285256953,-0.0,0.15293934759006803,-0.0,0.02606190910520289
Transport of connexins along the secretory pathway,0.0002058221168636797,0.005865776460152439,0.15630199358322178,0.006313276896051298,0.22756714972330633,-0.0
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition),0.0001933397365251485,0.00671197382737623,0.3449441695962768,0.4546424938336592,0.13331905561516827,0.04463808930426755
EGFR Transactivation by Gastrin,0.00018535829751510635,-0.0,-0.0,0.20731284512460305,-0.0,0.0983324790165605
Carnitine metabolism,0.00016738867322187766,0.17087677923654437,0.049920024538558684,0.1378081268575253,0.4454049156662078,0.2462346263106138
p75NTR signals via NF-kB,0.00015731048647244606,0.008123241483424552,0.06345064966651684,0.2211351288514676,-0.0,0.025272161876786055
InlA-mediated entry of Listeria monocytogenes into host cells,0.00015534643612729365,-0.0,0.8299439107617241,0.3092635941888965,0.0920422292912336,0.3553902384114859
Presynaptic depolarization and calcium channel opening,0.0001454659417771033,-0.0,0.0561777014344751,0.2487079256340791,0.007793473117255277,0.09803780067575722
Caspase activation via Dependence Receptors in the absence of ligand,0.00012456366327516096,-0.0,0.05308876403585059,0.026523487047810143,-0.0,0.00563861361002108
Biosynthesis of specialized proresolving mediators (SPMs),0.00011927522265264808,0.08833857422679489,0.39599149421380614,0.03228532715041845,-0.0,0.39453197775803706
Biosynthesis of DHA-derived SPMs,0.00010768321821146736,0.056428389487036726,0.2576809137364321,0.098126523517636,-0.0,0.025514638736246438
PP2A-mediated dephosphorylation of key metabolic factors,0.00010652441038659191,-0.0,0.06254705824943914,0.03132115479457161,-0.0,0.008933630938860581
Insertion of tail-anchored proteins into the endoplasmic reticulum membrane,0.00010084849842346607,-0.0,0.05269815346818962,0.09203702054521516,-0.0,0.19521277923326444
Alpha-defensins,9.44177620300897e-05,-0.0,0.00860437143515842,0.05439980554147733,-0.0,0.029411883668565453
Negative regulation of FGFR3 signaling,8.871138626524723e-05,0.008225588017135079,0.5142393332322902,0.3111231375814079,-0.0,0.11431897116079572
NTF4 activates NTRK2 (TRKB) signaling,6.882230275978844e-05,-0.0,0.14658167431029012,0.035098278773262756,-0.0,0.015784987133130684
Synthesis of 12-eicosatetraenoic acid derivatives,5.4291375793185794e-05,-0.0,0.0008193129461777178,0.20276564926821522,-0.0,0.10899612515659605
RHO GTPases activate IQGAPs,2.1549994669561034e-05,0.08340439860360428,0.2417259328886787,0.03388273864533302,0.2734448966560583,0.9467329368503233
Cell-extracellular matrix interactions,1.4426082529088735e-05,-0.0,0.11175973283516125,0.018553030866983684,-0.0,0.2753841454966343
FGFR4 ligand binding and activation,-0.0,0.018545960721364226,0.1130430274405778,0.1650953472915547,-0.0,0.00858204323346708
Formation of xylulose-5-phosphate,-0.0,0.008453019315611656,-0.0,0.00020961177589147063,-0.0,0.014657786894560638
Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane,-0.0,0.015959346432843833,-0.0,0.06642112539503996,0.3485952412899609,0.39967170849320055
Organic anion transporters,-0.0,-0.0,0.01587276497546116,0.05063681501732493,-0.0,-0.0
rRNA processing in the mitochondrion,-0.0,-0.0,0.19480063624689412,0.07051603894104869,-0.0,0.02613276701144019
PKA-mediated phosphorylation of key metabolic factors,-0.0,0.007996856524125637,0.006876173778866669,0.19122611562152306,0.05489578693208823,0.20731346325798788
Degradation of cysteine and homocysteine,-0.0,-0.0,-0.0,0.052691157136451484,-0.0,0.12825190688985394
Ion influx/efflux at host-pathogen interface,-0.0,-0.0,0.27404792475717316,0.1490545259281434,-0.0,0.006810770484751931
FasL/ CD95L signaling,-0.0,0.01583070795913154,0.07184371361523696,0.20457432605061796,-0.0,0.1372965469377111
Acrosome Reaction and Sperm:Oocyte Membrane Binding,-0.0,-0.0,0.29383964982171873,0.06848879771294313,0.002818839401250776,0.0026706056409056
Formation of annular gap junctions,-0.0,0.004771691095289126,0.10041593192687918,0.12146619495622443,-0.0,0.015500080254558287
Dermatan sulfate biosynthesis,-0.0,-0.0,-0.0,0.008732865748658312,0.12406613917729228,0.07326284491475177
Regulation of thyroid hormone activity,-0.0,0.0392441411682267,0.006933332586745657,0.016640873489925236,0.037337489129624674,0.010774891448442417
Gap junction degradation,-0.0,0.015187782266429879,0.10426109817519667,0.1692148750740387,0.011425402442789853,0.004291921560125685
Assembly of the ORC complex at the origin of replication,-0.0,-0.0,0.01889873350015886,0.1863767814305547,0.0016689531175722921,0.003716339070222915
Phosphate bond hydrolysis by NTPDase proteins,-0.0,0.08258854021022795,0.2514472997795353,0.01878167390109815,0.09596578851458944,0.09834178598548604
Pentose phosphate pathway disease,-0.0,0.05680212011822653,-0.0,0.011416938084785635,-0.0,0.3444280097684534
Spry regulation of FGF signaling,-0.0,-0.0,0.7212816521887234,0.3114745039003658,-0.0,0.24177495576253105
NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10,-0.0,0.008577584536876438,-0.0,0.30273922012684434,-0.0,0.22325103901513907
"Gamma-carboxylation, transport, and amino-terminal cleavage of proteins",-0.0,-0.0,-0.0,0.03462141811341264,-0.0,0.05961255101726572
Purine ribonucleoside monophosphate biosynthesis,-0.0,0.09452160663811476,0.41528620010172124,0.3528621761657015,0.2835387871190441,0.019551446479870015
Removal of aminoterminal propeptides from gamma-carboxylated proteins,-0.0,-0.0,-0.0,0.03346463479535234,-0.0,0.01079871453483962
SUMOylation of DNA methylation proteins,-0.0,0.006066887797365935,0.00361254679066784,0.027794110578356707,-0.0,0.006696690113210074
Response to metal ions,-0.0,0.027225294439396135,0.7866827388918621,0.05510685512565658,-0.0,0.8711698467787795
Activation of PPARGC1A (PGC-1alpha) by phosphorylation,-0.0,0.00851306752237238,-0.0,0.006586302926259931,0.18774811714127843,0.6779353007640544
Condensation of Prometaphase Chromosomes,-0.0,-0.0,0.043826990605474056,0.047905410851916255,-0.0,-0.0
Polymerase switching on the C-strand of the telomere,-0.0,-0.0,-0.0,0.1901228942922115,-0.0,0.028055401226564726
"Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2",-0.0,0.005749603319457492,0.2274845772007616,0.03480442081874813,-0.0,0.10652582625158853
HSF1-dependent transactivation,-0.0,-0.0,-0.0,0.05306466692300443,0.02541192572236563,0.703176625617663
TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest,-0.0,0.0752552196865354,0.5421390752747227,0.008998602442441299,-0.0,-0.0
Metabolism of amine-derived hormones,-0.0,-0.0,0.05383336405006096,0.051723268476454795,0.006110577423351554,0.06638514379163817
Fructose metabolism,-0.0,0.01177232647818412,0.010226575658869589,0.008089330509689395,0.045053932896168075,0.07837003397952047
IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation,-0.0,0.01584361054687012,0.9284870939559418,0.1912841802606259,-0.0,0.0045805028881994655
Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells,-0.0,0.015358411109391542,0.0006733169218623007,0.17645933160036648,0.06352589901836875,0.00024969087145792866
Insulin effects increased synthesis of Xylulose-5-Phosphate,-0.0,0.03616838900342402,-0.0,0.01697487975952516,-0.0,0.23896838786015978
Polymerase switching,-0.0,2.693210308442727e-05,0.0007203484180720068,0.20808765467373364,-0.0,0.026113159294388892
"Unblocking of NMDA receptors, glutamate binding and activation",-0.0,-0.0,-0.0,0.06749706009719669,-0.0,0.24852344252270833
Phospholipase C-mediated cascade: FGFR1,-0.0,0.008066589428315523,0.02616929610838728,0.043933653837714415,-0.0,0.10161488259185583
Relaxin receptors,-0.0,-0.0,-0.0,0.0013645551454067016,0.1579641885038681,0.00509577345836888
The IPAF inflammasome,-0.0,0.018392425448046177,0.06211482515544946,0.11232213803973727,-0.0,-0.0
Linoleic acid (LA) metabolism,-0.0,0.0894875042718575,0.2560137120983108,0.11299980238488991,0.13052614523880665,0.007991976182394256
Defective HLCS causes multiple carboxylase deficiency,-0.0,0.08167456619863996,0.019570965721598905,0.2640003330997158,-0.0,0.2319436742635688
NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis,-0.0,0.03475218110421111,-0.0,0.10053840717218636,-0.0,0.01985075850151276
Downregulation of TGF-beta receptor signaling,-0.0,-0.0,0.09861696065454913,0.297448908557216,-0.0,0.3113982275173875
The NLRP1 inflammasome,-0.0,-0.0,-0.0,0.17067316780467826,0.00648874128626755,0.10325547322993094
Loss of Function of SMAD2/3 in Cancer,-0.0,-0.0,0.006562697319976368,0.05705685006048142,-0.0,0.37729573559897983
PLC-gamma1 signalling,-0.0,-0.0,-0.0,0.06613717036110829,0.0009199354907187938,0.024236324508252527
BDNF activates NTRK2 (TRKB) signaling,-0.0,-0.0,0.208593710503061,0.18324048435128512,0.002056629187293433,0.02228039673121451
Glucocorticoid biosynthesis,-0.0,0.0004703728300351406,0.3399576200775147,0.1648977609147231,-0.0,0.20613155306487682
IRAK1 recruits IKK complex,-0.0,0.010342622671494776,0.9654851336436502,0.20831118308890134,-0.0,0.0041185310257775025
Defective Mismatch Repair Associated With MSH2,-0.0,-0.0,-0.0,0.1336403535805836,-0.0,0.006395751537703135
PTK6 Expression,-0.0,0.00893554685368451,0.08797912445346097,0.04083775071261262,-0.0,0.03416410289879667
Metabolism of folate and pterines,-0.0,0.08029413125564595,-0.0,0.028762486685198395,-0.0,0.3653571852664789
Lewis blood group biosynthesis,-0.0,-0.0,-0.0,0.1116040724704289,0.429313894770941,-0.0
Leading Strand Synthesis,-0.0,0.00044155882204129575,0.0005292031014604992,0.210979270938616,-0.0,0.02849013683494188
alpha-linolenic acid (ALA) metabolism,-0.0,0.2051845234376935,0.03643141661141021,0.0344784090556759,0.25970212171337126,0.03832451053265191
p75NTR regulates axonogenesis,-0.0,0.08421889651479798,0.10079210398879086,0.03420254490130309,0.09360326041088225,0.004750444418853385
Glycogen storage diseases,-0.0,0.015397773583477055,0.34188349709034394,0.24186033352599454,-0.0,0.025218546998107858
"Transport of vitamins, nucleosides, and related molecules",-0.0,-0.0,0.03209289198904505,0.007163132707800325,0.49109344389887455,0.40739290094918096
Toxicity of botulinum toxin type B (BoNT/B),-0.0,0.03462853683916605,-0.0,0.07626747775722055,0.2252452687716105,0.004055836786094482
Acetylcholine Neurotransmitter Release Cycle,-0.0,0.018915858372730635,-0.0,0.03477573573845615,-0.0,-0.0
Signaling by activated point mutants of FGFR3,-0.0,0.014067443923844356,0.16679017186172707,0.21262746450972844,-0.0,0.010586547231052101
GABA synthesis,-0.0,0.013487417425793622,-0.0,0.09192090305930617,-0.0,0.06921628244145048
alpha-linolenic (omega3) and linoleic (omega6) acid metabolism,-0.0,0.20913424392679658,0.09422279340340524,0.03411604864630351,0.2910904218842914,0.03108091157394379
FGFR3 mutant receptor activation,-0.0,0.013391527727106941,0.1418982078982696,0.22794719536376848,-0.0,0.01069656010396935
FGFR3 ligand binding and activation,-0.0,0.011677099207545335,0.15686439140894115,0.20197859239160545,-0.0,0.011751683372661578
Synthesis of 15-eicosatetraenoic acid derivatives,-0.0,-0.0,-0.0,0.043814777816196575,0.2795482107992731,0.009666963811087628
SHC-related events triggered by IGF1R,-0.0,-0.0,0.010908463020911117,0.16649263072248752,0.00864266253728206,-0.0
"Activation, translocation and oligomerization of BAX",-0.0,-0.0,-0.0,0.21057048887537957,0.0034915882144367387,0.059116982794445855
FGFR1 ligand binding and activation,-0.0,0.008531771153454538,0.062272886257214985,0.07501149673284849,-0.0,0.24364205210097373
FGFR1b ligand binding and activation,-0.0,0.014771302057141925,-0.0,0.07860699786347061,0.00735221709656262,0.5043044593934792
Synthesis of 5-eicosatetraenoic acids,-0.0,0.08482708595781006,0.007957031481678818,0.19890016854577716,-0.0,0.2312557440171871
Lagging Strand Synthesis,-0.0,0.015159513618692319,0.007708920628424745,0.09708619831220522,-0.0,0.05800284108850559
Serotonin clearance from the synaptic cleft,-0.0,-0.0,0.0011735652946596523,0.11169169837724237,-0.0,0.00731949082270896
Diseases associated with visual transduction,-0.0,-0.0,0.16872946327785887,0.08395996649451287,-0.0,0.668293582515417
Interleukin-1 processing,-0.0,0.06952035870502452,0.3123988024550951,0.1863982119858167,-0.0,0.5129463785794647
Amino acid transport across the plasma membrane,-0.0,0.007573955944711301,0.09137904841250791,0.09206798608311544,-0.0,0.11403394264747858
Retinoid metabolism and transport,-0.0,-0.0,-0.0,0.08849533539822646,-0.0,0.09630974970780211
Retinoid cycle disease events,-0.0,-0.0,0.16729567035888493,0.08751816496408428,-0.0,0.6365303454937518
Negative regulation of FGFR1 signaling,-0.0,0.009297698677250834,0.3550715574281197,0.2646943036049469,-0.0,0.49731552079971214
RUNX1 regulates expression of components of tight junctions,-0.0,0.01667789295232957,0.11006859452396091,0.08588725209679395,0.12843079802635257,-0.0
PCNA-Dependent Long Patch Base Excision Repair,-0.0,0.011859301711382423,0.06274780154879693,0.0504697852697195,-0.0,-0.0
SHC1 events in ERBB2 signaling,-0.0,-0.0,-0.0,0.04436853410130785,0.2538452973034106,0.00406717449769103
Chylomicron assembly,-0.0,0.011239794920177768,0.5851122717363529,0.08384147184484292,-0.0,0.010094312146478069
FGFR3c ligand binding and activation,-0.0,0.01427623586266749,0.10835332454816021,0.19984356820596397,-0.0,0.00805717512327184
Oligomerization of connexins into connexons,-0.0,0.005275712588925788,0.1664351954814143,0.0075828428638232475,0.2354388306747242,0.00012644664675342377
FRS-mediated FGFR2 signaling,-0.0,0.008313538694853836,0.019856504759544136,0.2662072439764261,-0.0,0.06079497054486232
Binding and entry of HIV virion,-0.0,-0.0,0.04158021307521685,0.2711966875715449,0.008887265599218229,0.1565839721879828
Loss of Function of TGFBR1 in Cancer,-0.0,-0.0,-0.0,0.30483215238997513,-0.0,0.09344366082907037
ERKs are inactivated,-0.0,-0.0,0.04176053659529546,0.10364345150801708,0.0016968973257141938,0.20591845990879268
P2Y receptors,-0.0,-0.0,0.07252360787654734,0.15959242281656294,0.012015347836465878,0.025625150998195793
Ubiquinol biosynthesis,-0.0,0.010063536135820906,-0.0,0.005141069312977869,-0.0,0.5892892856797487
Constitutive Signaling by Overexpressed ERBB2,-0.0,0.0037256888711708607,0.00862254042436308,0.2975897062180376,0.12764701445714904,0.00020087474486660896
Inwardly rectifying K+ channels,-0.0,0.06526964646788966,0.09380718642356453,0.0702254940049394,-0.0,0.10358648362864666
NOTCH4 Activation and Transmission of Signal to the Nucleus,-0.0,0.015079778722467511,0.0005517772141024646,0.010757111260374413,-0.0,0.09746893762281587
LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production,-0.0,-0.0,-0.0,0.033064856032348384,-0.0,0.09695654823868936
Phase 0 - rapid depolarisation,-0.0,-0.0,0.7746254885596642,0.13282725699939887,0.0032795323648527907,0.23205738365041187
Prolonged ERK activation events,-0.0,-0.0,-0.0,0.03640512126800054,-0.0,-0.0
Role of ABL in ROBO-SLIT signaling,-0.0,0.007544235820394889,0.3296866637703836,0.043515322727364095,0.12527306047759101,0.00022843080806135652
HDL clearance,-0.0,0.08265668305104533,0.11582689143697096,0.15548271381445997,0.2935976756871996,0.2011915408738734
Keratan sulfate biosynthesis,-0.0,-0.0,0.0012720225120987593,0.19767149246622204,-0.0,0.6824348445740084
Eicosanoids,-0.0,-0.0,-0.0,0.0075692180005270514,0.003998956363576968,0.05714302791510776
Interleukin-38 signaling,-0.0,0.021084347086462344,-0.0,0.13806111924223347,-0.0,0.006329616653415189
Nicotinamide salvaging,-0.0,-0.0,0.017738844750416264,0.17651864229570519,-0.0,0.21692888213865527
Branched-chain amino acid catabolism,-0.0,0.3295063840024287,0.04863268812296161,0.04481921768766958,0.0007773326279856319,0.6331871031253548
Gap-filling DNA repair synthesis and ligation in GG-NER,-0.0,0.00894292974489369,0.3949292530076134,0.12165698277344794,-0.0,0.0005979691267150139
Listeria monocytogenes entry into host cells,-0.0,0.005861574585630756,0.14705919468362005,0.21018851803650146,-0.0,0.7393228461484234
MET activates RAS signaling,-0.0,0.007358180177287158,0.10152999966123226,0.14970049715009912,-0.0,0.10186096522887603
Signaling by FGFR4,-0.0,-0.0,0.7302971020782307,0.29839816323030155,-0.0,0.026252913723737416
Lysosome Vesicle Biogenesis,-0.0,-0.0,-0.0,0.052329936559537465,0.0019023720916867505,0.028665205902246388
FGFRL1 modulation of FGFR1 signaling,-0.0,0.03976150402018234,0.007355524974938744,0.026382596110703926,-0.0,0.023078978286657933
Cytosolic iron-sulfur cluster assembly,-0.0,-0.0,-0.0,0.06910457816309067,0.010796356399046697,0.01638061993304024
Blood group systems biosynthesis,-0.0,-0.0,-0.0,0.07683968274263804,0.2845135519854197,0.003051482735988031
Downstream signaling of activated FGFR2,-0.0,-0.0,0.08198544517635516,0.13736118638490505,-0.0,0.02706400906260943
Recycling of bile acids and salts,-0.0,0.0001744411869371458,0.09845758109403842,0.053117147100666194,0.23131119280318366,0.0035678764112382832
NOTCH3 Activation and Transmission of Signal to the Nucleus,-0.0,0.006700674960326448,0.2745040254702972,0.21024791547747929,-0.0,0.005799484410186176
PIWI-interacting RNA (piRNA) biogenesis,-0.0,-0.0,-0.0,0.0971601366590551,-0.0,0.012257481876084723
Vitamin B5 (pantothenate) metabolism,-0.0,-0.0,-0.0,0.06774159010614089,8.363924543594197e-05,0.15692877326452587
TGF-beta receptor signaling activates SMADs,-0.0,0.00855082518955418,0.0967975457417798,0.20193699117455982,-0.0,0.36680201557497366
Passive transport by Aquaporins,-0.0,0.016056766633898798,0.17419333494958042,0.0069198985109607545,-0.0,0.0059460890310024115
Reduction of cytosolic Ca++ levels,-0.0,-0.0,0.1393833875681962,0.0981513278362162,0.01799528198733053,0.6963983357997696
Purine salvage,-0.0,-0.0,0.22384843584819164,0.1392046905175868,0.032302409166941826,0.44339725264938595
Acyl chain remodelling of PS,-0.0,-0.0,0.2933102389130892,0.07777074228491054,-0.0,0.00367095887740583
GRB2 events in ERBB2 signaling,-0.0,-0.0,0.00024540097568023474,0.10246791597906878,0.09246161999877729,0.009865467600253138
HDL remodeling,-0.0,0.08260681842016604,0.21997087674480897,0.05838343879545073,-0.0,0.04554032124961461
Synthesis of Leukotrienes (LT) and Eoxins (EX),-0.0,-0.0,-0.0,0.06519258067381822,0.00965042863891297,0.24175836872706166
Metabolism of fat-soluble vitamins,-0.0,-0.0,0.05603340950888348,0.10014353046104625,-0.0,0.059515286753347336
Negative regulation of MET activity,-0.0,0.00518665715670095,0.054872507305413216,0.20862620004908866,-0.0,0.4908928477073834
SHC1 events in ERBB4 signaling,-0.0,-0.0,-0.0,0.009375309884040457,-0.0,0.0013348575765523237
Iron uptake and transport,-0.0,0.09981042223996882,-0.0,0.009171026178929464,0.0601914648574259,0.3314802072794937
Adherens junctions interactions,-0.0,0.01189746948108578,0.34938777470019533,0.005830080278902853,0.05043097350834493,0.09521936165744009
"Synthesis of IP2, IP, and Ins in the cytosol",-0.0,-0.0,0.19707843972648867,0.05936191061973364,0.013990426359092372,0.1437875314205474
Signaling by ERBB2 in Cancer,-0.0,-0.0,0.02625579755593772,0.01873761166018072,0.07296925936834188,0.04079460236510029
Mitochondrial Fatty Acid Beta-Oxidation,-0.0,0.3051683998249834,0.026783681429025385,0.06721524812768129,0.2370935919553305,0.0367758926285659
Inositol transporters,-0.0,0.07521033426752727,0.026400968421387012,0.16902314474917693,0.09220848228540152,0.021630033044715488
FGFR1c ligand binding and activation,-0.0,-0.0,0.1477321131719709,0.046823225218545754,-0.0,-0.0
Signaling by ERBB2 KD Mutants,-0.0,-0.0,0.018542519474373916,0.024507585436753895,-0.0,0.006585861569477467
Synthesis of PE,-0.0,-0.0,-0.0,0.027096758434741453,0.28427775872004135,0.025046580428021107
Signaling by FGFR1,-0.0,0.011860437695129006,0.24450135066989398,0.16472336291111214,-0.0,0.23952233762496405
L1CAM interactions,-0.0,0.01450569290279072,0.09703827988730171,0.01735682388933573,-0.0,0.6236512663948303
Nuclear Receptor transcription pathway,-0.0,-0.0,0.009105523857311405,0.017374216475407392,-0.0,0.007661102202855423
Reuptake of GABA,-0.0,0.016603679593418637,-0.0,0.004977996627046659,0.04757737389254253,0.10737811175220999
Signaling by FGFR3,-0.0,-0.0,0.7231914184603041,0.3056270673669945,-0.0,0.06400953170779171
